US2008526A
(en)
|
1932-11-03 |
1935-07-16 |
Wappler Frederick Charles |
Method and means for treating living tissue
|
US3467096A
(en)
|
1966-04-12 |
1969-09-16 |
Ferrell S Horn |
Multiple hypodermic syringe arrangement
|
BE757653A
(fr)
|
1969-10-21 |
1971-04-16 |
Ugine Kuhlmann |
Nouveaux medicaments derives d'acides nucleiques et procedes pour leur preparation
|
BE786542A
(fr)
|
1971-07-22 |
1973-01-22 |
Dow Corning |
Dispositif d'aspiration permettant d'obtenir des echantillons de cellules
|
US3906092A
(en)
|
1971-11-26 |
1975-09-16 |
Merck & Co Inc |
Stimulation of antibody response
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4500707A
(en)
|
1980-02-29 |
1985-02-19 |
University Patents, Inc. |
Nucleosides useful in the preparation of polynucleotides
|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
US5132418A
(en)
|
1980-02-29 |
1992-07-21 |
University Patents, Inc. |
Process for preparing polynucleotides
|
US4411657A
(en)
|
1980-05-19 |
1983-10-25 |
Anibal Galindo |
Hypodermic needle
|
US4973679A
(en)
|
1981-03-27 |
1990-11-27 |
University Patents, Inc. |
Process for oligonucleo tide synthesis using phosphormidite intermediates
|
US4415732A
(en)
|
1981-03-27 |
1983-11-15 |
University Patents, Inc. |
Phosphoramidite compounds and processes
|
US4668777A
(en)
|
1981-03-27 |
1987-05-26 |
University Patents, Inc. |
Phosphoramidite nucleoside compounds
|
US4373071A
(en)
|
1981-04-30 |
1983-02-08 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
US4401796A
(en)
|
1981-04-30 |
1983-08-30 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
US4474569A
(en)
|
1982-06-28 |
1984-10-02 |
Denver Surgical Developments, Inc. |
Antenatal shunt
|
JPS5927900A
(ja)
|
1982-08-09 |
1984-02-14 |
Wakunaga Seiyaku Kk |
固定化オリゴヌクレオチド
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
US4737462A
(en)
|
1982-10-19 |
1988-04-12 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
|
FR2540122B1
(fr)
|
1983-01-27 |
1985-11-29 |
Centre Nat Rech Scient |
Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
|
US4605735A
(en)
|
1983-02-14 |
1986-08-12 |
Wakunaga Seiyaku Kabushiki Kaisha |
Oligonucleotide derivatives
|
US4948882A
(en)
|
1983-02-22 |
1990-08-14 |
Syngene, Inc. |
Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis
|
US4824941A
(en)
|
1983-03-10 |
1989-04-25 |
Julian Gordon |
Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4587044A
(en)
|
1983-09-01 |
1986-05-06 |
The Johns Hopkins University |
Linkage of proteins to nucleic acids
|
US5118802A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
DNA-reporter conjugates linked via the 2' or 5'-primary amino group of the 5'-terminal nucleoside
|
US5118800A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
Oligonucleotides possessing a primary amino group in the terminal nucleotide
|
US4579849A
(en)
|
1984-04-06 |
1986-04-01 |
Merck & Co., Inc. |
N-alkylguanine acyclonucleosides as antiviral agents
|
US4957735A
(en)
|
1984-06-12 |
1990-09-18 |
The University Of Tennessee Research Corporation |
Target-sensitive immunoliposomes- preparation and characterization
|
FR2567892B1
(fr)
|
1984-07-19 |
1989-02-17 |
Centre Nat Rech Scient |
Nouveaux oligonucleotides, leur procede de preparation et leurs applications comme mediateurs dans le developpement des effets des interferons
|
US5258506A
(en)
|
1984-10-16 |
1993-11-02 |
Chiron Corporation |
Photolabile reagents for incorporation into oligonucleotide chains
|
US5430136A
(en)
|
1984-10-16 |
1995-07-04 |
Chiron Corporation |
Oligonucleotides having selectably cleavable and/or abasic sites
|
US4828979A
(en)
|
1984-11-08 |
1989-05-09 |
Life Technologies, Inc. |
Nucleotide analogs for nucleic acid labeling and detection
|
US4959314A
(en)
|
1984-11-09 |
1990-09-25 |
Cetus Corporation |
Cysteine-depleted muteins of biologically active proteins
|
US5036006A
(en)
|
1984-11-13 |
1991-07-30 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
US5116943A
(en)
|
1985-01-18 |
1992-05-26 |
Cetus Corporation |
Oxidation-resistant muteins of Il-2 and other protein
|
CA1288073C
(en)
|
1985-03-07 |
1991-08-27 |
Paul G. Ahlquist |
Rna transformation vector
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
EP0204401A1
(en)
|
1985-04-09 |
1986-12-10 |
Biogen, Inc. |
Method of improving the yield of polypeptides produced in a host cell by stabilizing mRNA
|
US4762779A
(en)
|
1985-06-13 |
1988-08-09 |
Amgen Inc. |
Compositions and methods for functionalizing nucleic acids
|
US5017691A
(en)
|
1986-07-03 |
1991-05-21 |
Schering Corporation |
Mammalian interleukin-4
|
US5317098A
(en)
|
1986-03-17 |
1994-05-31 |
Hiroaki Shizuya |
Non-radioisotope tagging of fragments
|
US5153319A
(en)
|
1986-03-31 |
1992-10-06 |
University Patents, Inc. |
Process for preparing polynucleotides
|
US4879111A
(en)
|
1986-04-17 |
1989-11-07 |
Cetus Corporation |
Treatment of infections with lymphokines
|
JPS638396A
(ja)
|
1986-06-30 |
1988-01-14 |
Wakunaga Pharmaceut Co Ltd |
ポリ標識化オリゴヌクレオチド誘導体
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
JP2774121B2
(ja)
|
1987-07-31 |
1998-07-09 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
標的ポリヌクレオチド配列の選択的増幅
|
US6090591A
(en)
|
1987-07-31 |
2000-07-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Selective amplification of target polynucleotide sequences
|
US5585481A
(en)
|
1987-09-21 |
1996-12-17 |
Gen-Probe Incorporated |
Linking reagents for nucleotide probes
|
US5525465A
(en)
|
1987-10-28 |
1996-06-11 |
Howard Florey Institute Of Experimental Physiology And Medicine |
Oligonucleotide-polyamide conjugates and methods of production and applications of the same
|
DE3738460A1
(de)
|
1987-11-12 |
1989-05-24 |
Max Planck Gesellschaft |
Modifizierte oligonukleotide
|
CA1327358C
(en)
|
1987-11-17 |
1994-03-01 |
Morio Fujiu |
Fluoro cytidine derivatives
|
EP0359789B1
(en)
|
1988-01-21 |
1993-08-04 |
Genentech, Inc. |
Amplification and detection of nucleic acid sequences
|
CA1340807C
(en)
|
1988-02-24 |
1999-11-02 |
Lawrence T. Malek |
Nucleic acid amplification process
|
JP2650159B2
(ja)
|
1988-02-24 |
1997-09-03 |
アクゾ・ノベル・エヌ・ベー |
核酸増幅方法
|
US5082830A
(en)
|
1988-02-26 |
1992-01-21 |
Enzo Biochem, Inc. |
End labeled nucleotide probe
|
AU3353989A
(en)
|
1988-03-04 |
1989-09-22 |
Cancer Research Campaign Technology Limited |
Improvements relating to antigens
|
EP0362371A4
(en)
|
1988-04-15 |
1990-10-24 |
Protein Design Labs, Inc. |
Il-2 receptor-specific chimeric antibodies
|
US5109124A
(en)
|
1988-06-01 |
1992-04-28 |
Biogen, Inc. |
Nucleic acid probe linked to a label having a terminal cysteine
|
US5021335A
(en)
|
1988-06-17 |
1991-06-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
In situ transcription in cells and tissues
|
US5168038A
(en)
|
1988-06-17 |
1992-12-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
In situ transcription in cells and tissues
|
US5130238A
(en)
|
1988-06-24 |
1992-07-14 |
Cangene Corporation |
Enhanced nucleic acid amplification process
|
US5262536A
(en)
|
1988-09-15 |
1993-11-16 |
E. I. Du Pont De Nemours And Company |
Reagents for the preparation of 5'-tagged oligonucleotides
|
US5759802A
(en)
|
1988-10-26 |
1998-06-02 |
Tonen Corporation |
Production of human serum alubumin A
|
US5512439A
(en)
|
1988-11-21 |
1996-04-30 |
Dynal As |
Oligonucleotide-linked magnetic particles and uses thereof
|
US5221732A
(en)
|
1988-12-06 |
1993-06-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Antimicrobial magainin modified peptides
|
US5262530A
(en)
|
1988-12-21 |
1993-11-16 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
US5047524A
(en)
|
1988-12-21 |
1991-09-10 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5457183A
(en)
|
1989-03-06 |
1995-10-10 |
Board Of Regents, The University Of Texas System |
Hydroxylated texaphyrins
|
US5599923A
(en)
|
1989-03-06 |
1997-02-04 |
Board Of Regents, University Of Tx |
Texaphyrin metal complexes having improved functionalization
|
US6673776B1
(en)
|
1989-03-21 |
2004-01-06 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
|
ES2200016T3
(es)
|
1989-03-21 |
2004-03-01 |
Vical Incorporated |
Expresion de secuencias polinucleotidicas exogenas en un vertebrado.
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US6867195B1
(en)
|
1989-03-21 |
2005-03-15 |
Vical Incorporated |
Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
US5693622A
(en)
|
1989-03-21 |
1997-12-02 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
|
US5012818A
(en)
|
1989-05-04 |
1991-05-07 |
Joishy Suresh K |
Two in one bone marrow surgical needle
|
IE66597B1
(en)
|
1989-05-10 |
1996-01-24 |
Akzo Nv |
Method for the synthesis of ribonucleic acid (RNA)
|
US5332671A
(en)
|
1989-05-12 |
1994-07-26 |
Genetech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
US5240855A
(en)
|
1989-05-12 |
1993-08-31 |
Pioneer Hi-Bred International, Inc. |
Particle gun
|
US5391723A
(en)
|
1989-05-31 |
1995-02-21 |
Neorx Corporation |
Oligonucleotide conjugates
|
US4958013A
(en)
|
1989-06-06 |
1990-09-18 |
Northwestern University |
Cholesteryl modified oligonucleotides
|
CA2020958C
(en)
|
1989-07-11 |
2005-01-11 |
Daniel L. Kacian |
Nucleic acid sequence amplification methods
|
US5451463A
(en)
|
1989-08-28 |
1995-09-19 |
Clontech Laboratories, Inc. |
Non-nucleoside 1,3-diol reagents for labeling synthetic oligonucleotides
|
US5254469A
(en)
|
1989-09-12 |
1993-10-19 |
Eastman Kodak Company |
Oligonucleotide-enzyme conjugate that can be used as a probe in hybridization assays and polymerase chain reaction procedures
|
US5591722A
(en)
|
1989-09-15 |
1997-01-07 |
Southern Research Institute |
2'-deoxy-4'-thioribonucleosides and their antiviral activity
|
US5545522A
(en)
|
1989-09-22 |
1996-08-13 |
Van Gelder; Russell N. |
Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
|
ATE168416T1
(de)
|
1989-10-05 |
1998-08-15 |
Optein Inc |
Zellfreie synthese und isolierung von genen und polypeptiden
|
WO1991006556A1
(en)
|
1989-10-24 |
1991-05-16 |
Gilead Sciences, Inc. |
2' modified oligonucleotides
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
US5215899A
(en)
|
1989-11-09 |
1993-06-01 |
Miles Inc. |
Nucleic acid amplification employing ligatable hairpin probe and transcription
|
NO904633L
(no)
|
1989-11-09 |
1991-05-10 |
Molecular Diagnostics Inc |
Amplifikasjon av nukleinsyrer ved transkriberbar haarnaalsprobe.
|
US5292873A
(en)
|
1989-11-29 |
1994-03-08 |
The Research Foundation Of State University Of New York |
Nucleic acids labeled with naphthoquinone probe
|
US5633076A
(en)
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
US5697901A
(en)
|
1989-12-14 |
1997-12-16 |
Elof Eriksson |
Gene delivery by microneedle injection
|
US5486603A
(en)
|
1990-01-08 |
1996-01-23 |
Gilead Sciences, Inc. |
Oligonucleotide having enhanced binding affinity
|
US5646265A
(en)
|
1990-01-11 |
1997-07-08 |
Isis Pharmceuticals, Inc. |
Process for the preparation of 2'-O-alkyl purine phosphoramidites
|
US7037646B1
(en)
|
1990-01-11 |
2006-05-02 |
Isis Pharmaceuticals, Inc. |
Amine-derivatized nucleosides and oligonucleosides
|
US5578718A
(en)
|
1990-01-11 |
1996-11-26 |
Isis Pharmaceuticals, Inc. |
Thiol-derivatized nucleosides
|
US5670633A
(en)
|
1990-01-11 |
1997-09-23 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides that detect and modulate gene expression
|
US6783931B1
(en)
|
1990-01-11 |
2004-08-31 |
Isis Pharmaceuticals, Inc. |
Amine-derivatized nucleosides and oligonucleosides
|
AU7579991A
(en)
|
1990-02-20 |
1991-09-18 |
Gilead Sciences, Inc. |
Pseudonucleosides and pseudonucleotides and their polymers
|
US5214136A
(en)
|
1990-02-20 |
1993-05-25 |
Gilead Sciences, Inc. |
Anthraquinone-derivatives oligonucleotides
|
CA2028849A1
(en)
|
1990-03-08 |
1991-09-09 |
Michinao Mizugaki |
Monoclonal antibodies, assay method, reagent kit, sarching method and drug missiles using them
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
GB9009980D0
(en)
|
1990-05-03 |
1990-06-27 |
Amersham Int Plc |
Phosphoramidite derivatives,their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
|
ES2116977T3
(es)
|
1990-05-11 |
1998-08-01 |
Microprobe Corp |
Soportes solidos para ensayos de hibridacion de acidos nucleicos y metodos para inmovilizar oligonucleotidos de modo covalente.
|
US5194370A
(en)
|
1990-05-16 |
1993-03-16 |
Life Technologies, Inc. |
Promoter ligation activated transcription amplification of nucleic acid sequences
|
CA2042448A1
(en)
|
1990-06-05 |
1991-12-06 |
Jonathan P. Duvick |
Antimicrobial peptides and plant disease resistance based thereon
|
US5637459A
(en)
|
1990-06-11 |
1997-06-10 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chimeric selex
|
US5447914A
(en)
|
1990-06-21 |
1995-09-05 |
Emory University |
Antimicrobial peptides
|
JPH06500014A
(ja)
|
1990-07-25 |
1994-01-06 |
シンジーン,インコーポレイテッド |
多数の核酸相補体を生成させる環状伸長法
|
US5489677A
(en)
|
1990-07-27 |
1996-02-06 |
Isis Pharmaceuticals, Inc. |
Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
|
US5138045A
(en)
|
1990-07-27 |
1992-08-11 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
US5688941A
(en)
|
1990-07-27 |
1997-11-18 |
Isis Pharmaceuticals, Inc. |
Methods of making conjugated 4' desmethyl nucleoside analog compounds
|
US5602240A
(en)
|
1990-07-27 |
1997-02-11 |
Ciba Geigy Ag. |
Backbone modified oligonucleotide analogs
|
US5608046A
(en)
|
1990-07-27 |
1997-03-04 |
Isis Pharmaceuticals, Inc. |
Conjugated 4'-desmethyl nucleoside analog compounds
|
US5218105A
(en)
|
1990-07-27 |
1993-06-08 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
US5245022A
(en)
|
1990-08-03 |
1993-09-14 |
Sterling Drug, Inc. |
Exonuclease resistant terminally substituted oligonucleotides
|
US5512667A
(en)
|
1990-08-28 |
1996-04-30 |
Reed; Michael W. |
Trifunctional intermediates for preparing 3'-tailed oligonucleotides
|
US6140496A
(en)
|
1990-10-09 |
2000-10-31 |
Benner; Steven Albert |
Precursors for deoxyribonucleotides containing non-standard nucleosides
|
ATE198598T1
(de)
|
1990-11-08 |
2001-01-15 |
Hybridon Inc |
Verbindung von mehrfachreportergruppen auf synthetischen oligonukleotiden
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
AU648140B2
(en)
|
1991-02-01 |
1994-04-14 |
Virtual Drug Development, Inc. |
Reverse antimicrobial peptides and antimicrobial compositions
|
US6100024A
(en)
|
1991-02-08 |
2000-08-08 |
Promega Corporation |
Methods and compositions for nucleic acid detection by target extension and probe amplification
|
DE07012625T1
(de)
|
1991-03-18 |
2010-01-21 |
New York University |
Monoklonale und chimäre Antikörper gegen humanen Tumornekrosefaktor
|
US5426180A
(en)
|
1991-03-27 |
1995-06-20 |
Research Corporation Technologies, Inc. |
Methods of making single-stranded circular oligonucleotides
|
KR100249937B1
(ko)
|
1991-04-25 |
2000-04-01 |
나가야마 오사무 |
인간 인터루킨-6 수용체에 대한 재구성 인간 항체
|
US5714331A
(en)
|
1991-05-24 |
1998-02-03 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
|
US5719262A
(en)
|
1993-11-22 |
1998-02-17 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having amino acid side chains
|
US5539082A
(en)
|
1993-04-26 |
1996-07-23 |
Nielsen; Peter E. |
Peptide nucleic acids
|
US5169766A
(en)
|
1991-06-14 |
1992-12-08 |
Life Technologies, Inc. |
Amplification of nucleic acid molecules
|
US5371241A
(en)
|
1991-07-19 |
1994-12-06 |
Pharmacia P-L Biochemicals Inc. |
Fluorescein labelled phosphoramidites
|
US5199441A
(en)
|
1991-08-20 |
1993-04-06 |
Hogle Hugh H |
Fine needle aspiration biopsy apparatus and method
|
EP0538194B1
(de)
|
1991-10-17 |
1997-06-04 |
Novartis AG |
Bicyclische Nukleoside, Oligonukleotide, Verfahren zu deren Herstellung und Zwischenprodukte
|
US5298422A
(en)
|
1991-11-06 |
1994-03-29 |
Baylor College Of Medicine |
Myogenic vector systems
|
US5359044A
(en)
|
1991-12-13 |
1994-10-25 |
Isis Pharmaceuticals |
Cyclobutyl oligonucleotide surrogates
|
US5824307A
(en)
|
1991-12-23 |
1998-10-20 |
Medimmune, Inc. |
Human-murine chimeric antibodies against respiratory syncytial virus
|
US5565552A
(en)
|
1992-01-21 |
1996-10-15 |
Pharmacyclics, Inc. |
Method of expanded porphyrin-oligonucleotide conjugate synthesis
|
US5595726A
(en)
|
1992-01-21 |
1997-01-21 |
Pharmacyclics, Inc. |
Chromophore probe for detection of nucleic acid
|
CA2128616A1
(en)
|
1992-01-23 |
1993-08-05 |
Gary H. Rhodes |
Ex vivo gene transfer
|
FR2687679B1
(fr)
|
1992-02-05 |
1994-10-28 |
Centre Nat Rech Scient |
Oligothionucleotides.
|
JP3368603B2
(ja)
|
1992-02-28 |
2003-01-20 |
オリンパス光学工業株式会社 |
遺伝子治療用処置具
|
ES2149768T3
(es)
|
1992-03-25 |
2000-11-16 |
Immunogen Inc |
Conjugados de agentes enlazantes de celulas derivados de cc-1065.
|
US6174666B1
(en)
|
1992-03-27 |
2001-01-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of eliminating inhibitory/instability regions from mRNA
|
US6132419A
(en)
|
1992-05-22 |
2000-10-17 |
Genetronics, Inc. |
Electroporetic gene and drug therapy
|
US5514545A
(en)
|
1992-06-11 |
1996-05-07 |
Trustees Of The University Of Pennsylvania |
Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics
|
EP0577558A2
(de)
|
1992-07-01 |
1994-01-05 |
Ciba-Geigy Ag |
Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte
|
US5272250A
(en)
|
1992-07-10 |
1993-12-21 |
Spielvogel Bernard F |
Boronated phosphoramidate compounds
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
WO1994003637A1
(en)
|
1992-07-31 |
1994-02-17 |
Syntex (Usa) Inc. |
Method for introducing defined sequences at the 3' end of polynucleotides
|
US5273525A
(en)
|
1992-08-13 |
1993-12-28 |
Btx Inc. |
Injection and electroporation apparatus for drug and gene delivery
|
US5240885A
(en)
|
1992-09-21 |
1993-08-31 |
Corning Incorporated |
Rare earth-doped, stabilized cadmium halide glasses
|
AU5665694A
(en)
|
1992-11-04 |
1994-05-24 |
Denver Biomaterials Inc. |
Apparatus for removal of pleural effusion fluid
|
ES2091684T3
(es)
|
1992-11-13 |
1996-11-01 |
Idec Pharma Corp |
Aplicacion terapeutica de anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de las celulas b.
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
US5429923A
(en)
*
|
1992-12-11 |
1995-07-04 |
President And Fellows Of Harvard College |
Method for detecting hypertrophic cardiomyophathy associated mutations
|
US5574142A
(en)
|
1992-12-15 |
1996-11-12 |
Microprobe Corporation |
Peptide linkers for improved oligonucleotide delivery
|
NZ261259A
(en)
|
1993-01-12 |
1996-12-20 |
Biogen Inc |
Humanised recombinant anti-vla4 antibody and diagnostic compositions and medicaments
|
US5607914A
(en)
|
1993-01-13 |
1997-03-04 |
Pioneer Hi-Bred International, Inc. |
Synthetic antimicrobial peptides
|
US5459235A
(en)
|
1993-03-19 |
1995-10-17 |
The Regents Of The University Of California |
Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
|
FR2703253B1
(fr)
|
1993-03-30 |
1995-06-23 |
Centre Nat Rech Scient |
Applicateur d'impulsions electriques pour traitement de tissus biologiques.
|
EP0691968B1
(en)
|
1993-03-30 |
1997-07-16 |
Sanofi |
Acyclic nucleoside analogs and oligonucleotide sequences containing them
|
DE4311944A1
(de)
|
1993-04-10 |
1994-10-13 |
Degussa |
Umhüllte Natriumpercarbonatpartikel, Verfahren zu deren Herstellung und sie enthaltende Wasch-, Reinigungs- und Bleichmittelzusammensetzungen
|
US7135312B2
(en)
|
1993-04-15 |
2006-11-14 |
University Of Rochester |
Circular DNA vectors for synthesis of RNA and DNA
|
US5773244A
(en)
|
1993-05-19 |
1998-06-30 |
Regents Of The University Of California |
Methods of making circular RNA
|
US6541498B2
(en)
|
1993-05-20 |
2003-04-01 |
Texas Biotechnology |
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
|
US5851829A
(en)
|
1993-07-16 |
1998-12-22 |
Dana-Farber Cancer Institute |
Method of intracellular binding of target molecules
|
US6294664B1
(en)
|
1993-07-29 |
2001-09-25 |
Isis Pharmaceuticals, Inc. |
Synthesis of oligonucleotides
|
US5672491A
(en)
|
1993-09-20 |
1997-09-30 |
The Leland Stanford Junior University |
Recombinant production of novel polyketides
|
US6432711B1
(en)
|
1993-11-03 |
2002-08-13 |
Diacrin, Inc. |
Embryonic stem cells capable of differentiating into desired cell lines
|
US6096503A
(en)
|
1993-11-12 |
2000-08-01 |
The Scripps Research Institute |
Method for simultaneous identification of differentially expresses mRNAs and measurement of relative concentrations
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
US5840299A
(en)
|
1994-01-25 |
1998-11-24 |
Athena Neurosciences, Inc. |
Humanized antibodies against leukocyte adhesion molecule VLA-4
|
US7435802B2
(en)
|
1994-01-25 |
2008-10-14 |
Elan Pharaceuticals, Inc. |
Humanized anti-VLA4 immunoglobulins
|
DK0668350T4
(da)
|
1994-02-16 |
2009-02-23 |
Us Gov Health & Human Serv |
Melanomassocieret antigen, epitoper deraf samt vacciner mod melanom
|
IL112820A0
(en)
|
1994-03-07 |
1995-05-26 |
Merck & Co Inc |
Coordinate in vivo gene expression
|
US5965720A
(en)
|
1994-03-18 |
1999-10-12 |
Lynx Therapeutics, Inc. |
Oligonucleotide N3'→P5' phosphoramidates
|
WO1995026204A1
(en)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
US5457041A
(en)
|
1994-03-25 |
1995-10-10 |
Science Applications International Corporation |
Needle array and method of introducing biological substances into living cells using the needle array
|
US5627053A
(en)
|
1994-03-29 |
1997-05-06 |
Ribozyme Pharmaceuticals, Inc. |
2'deoxy-2'-alkylnucleotide containing nucleic acid
|
US6074642A
(en)
|
1994-05-02 |
2000-06-13 |
Alexion Pharmaceuticals, Inc. |
Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
|
RU2201963C2
(ru)
|
1994-05-18 |
2003-04-10 |
Плант Тек Биотехнологи Гмбх Форшунг Унд Энтвиклунг |
ПОСЛЕДОВАТЕЛЬНОСТЬ ДНК (ВАРИАНТЫ), РЕКОМБИНАНТНАЯ ДНК, ПРОТЕИН, СПОСОБ ПОЛУЧЕНИЯ ПРОТЕИНА, СПОСОБ ПОЛУЧЕНИЯ МИКРООРГАНИЗМОВ, СПОСОБ ПОЛУЧЕНИЯ КЛЕТОК ГРИБА, СПОСОБ ПОЛУЧЕНИЯ ЛИНЕЙНЫХ α-1,4-ГЛЮКАНОВ И/ИЛИ ФРУКТОЗЫ И СПОСОБ ПОЛУЧЕНИЯ ЛИНЕЙНЫХ α-1,4-ГЛЮКАНОВ И/ИЛИ ФРУКТОЗЫ IN VITRO
|
US5550109A
(en)
|
1994-05-24 |
1996-08-27 |
Magainin Pharmaceuticals Inc. |
Inducible defensin peptide from mammalian epithelia
|
US6355247B1
(en)
|
1994-06-02 |
2002-03-12 |
Chiron Corporation |
Nucleic acid immunization using a virus-based infection/transfection system
|
GB9412230D0
(en)
|
1994-06-17 |
1994-08-10 |
Celltech Ltd |
Interleukin-5 specific recombiant antibodies
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US5597696A
(en)
|
1994-07-18 |
1997-01-28 |
Becton Dickinson And Company |
Covalent cyanine dye oligonucleotide conjugates
|
DE69534530T2
(de)
|
1994-08-12 |
2006-07-06 |
Immunomedics, Inc. |
Für b-zell-lymphom und leukämiezellen spezifische immunkonjugate und humane antikörper
|
US5580731A
(en)
|
1994-08-25 |
1996-12-03 |
Chiron Corporation |
N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith
|
US5597909A
(en)
|
1994-08-25 |
1997-01-28 |
Chiron Corporation |
Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
|
US5641665A
(en)
|
1994-11-28 |
1997-06-24 |
Vical Incorporated |
Plasmids suitable for IL-2 expression
|
US5665545A
(en)
|
1994-11-28 |
1997-09-09 |
Akzo Nobel N.V. |
Terminal repeat amplification method
|
US5588960A
(en)
|
1994-12-01 |
1996-12-31 |
Vidamed, Inc. |
Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence
|
US5807718A
(en)
|
1994-12-02 |
1998-09-15 |
The Scripps Research Institute |
Enzymatic DNA molecules
|
US5585108A
(en)
|
1994-12-30 |
1996-12-17 |
Nanosystems L.L.C. |
Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays
|
ATE373094T1
(de)
|
1995-01-06 |
2007-09-15 |
Plant Res Int Bv |
Für kohlenhydratpolymere-bildende enzyme- kodierende dna-sequenzen und verfahren zur herstellung transgener pflanzen
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
US5824497A
(en)
|
1995-02-10 |
1998-10-20 |
Mcmaster University |
High efficiency translation of mRNA molecules
|
EP0727187B1
(en)
|
1995-02-15 |
2003-08-06 |
Joseph Eldor |
Multiple hole spinal needle
|
DE69621507T2
(de)
|
1995-03-28 |
2003-01-09 |
Japan Science & Tech Corp |
Verfahren zur molekularen Indexierung von Genen unter Verwendung von Restriktionsenzymen
|
US5869230A
(en)
|
1995-03-30 |
1999-02-09 |
Beth Israel Hospital Association |
Gene transfer into the kidney
|
US5986054A
(en)
|
1995-04-28 |
1999-11-16 |
The Hospital For Sick Children, Hsc Research And Development Limited Partnership |
Genetic sequences and proteins related to alzheimer's disease
|
FR2733762B1
(fr)
|
1995-05-02 |
1997-08-01 |
Genset Sa |
Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
|
US5700642A
(en)
|
1995-05-22 |
1997-12-23 |
Sri International |
Oligonucleotide sizing using immobilized cleavable primers
|
US6057291A
(en)
|
1995-06-02 |
2000-05-02 |
University Of British Columbia |
Antimicrobial cationic peptides
|
US6111095A
(en)
|
1995-06-07 |
2000-08-29 |
Merck & Co., Inc. |
Capped synthetic RNA, analogs, and aptamers
|
US6051429A
(en)
|
1995-06-07 |
2000-04-18 |
Life Technologies, Inc. |
Peptide-enhanced cationic lipid transfections
|
US5889136A
(en)
|
1995-06-09 |
1999-03-30 |
The Regents Of The University Of Colorado |
Orthoester protecting groups in RNA synthesis
|
US5734015A
(en)
|
1995-06-19 |
1998-03-31 |
Magainin Pharmaceuticals Inc. |
Family of linear antimicrobial peptides from hagfish intestine
|
JP3860838B2
(ja)
|
1995-08-23 |
2006-12-20 |
ユニバーシティー オブ ブリティッシュ コロンビア |
抗微生物性陽イオン性ペプチドおよびそのスクリーニング方法
|
US5766903A
(en)
|
1995-08-23 |
1998-06-16 |
University Technology Corporation |
Circular RNA and uses thereof
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
AU7073096A
(en)
|
1995-09-19 |
1997-04-09 |
University Of Massachusetts |
Inhibited biological degradation of oligodeoxynucleotides
|
US5830879A
(en)
|
1995-10-02 |
1998-11-03 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Treatment of vascular injury using vascular endothelial growth factor
|
US6265387B1
(en)
|
1995-10-11 |
2001-07-24 |
Mirus, Inc. |
Process of delivering naked DNA into a hepatocyte via bile duct
|
US5871697A
(en)
|
1995-10-24 |
1999-02-16 |
Curagen Corporation |
Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
|
US6132988A
(en)
|
1995-10-27 |
2000-10-17 |
Takeda Chemical Industries, Ltd. |
DNA encoding a neuronal cell-specific receptor protein
|
CU22584A1
(es)
|
1995-11-17 |
1999-11-03 |
Centro Inmunologia Molecular |
Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
JP2000502254A
(ja)
|
1995-12-13 |
2000-02-29 |
ゼネカ・リミテッド |
抗真菌タンパク質
|
US5962271A
(en)
|
1996-01-03 |
1999-10-05 |
Cloutech Laboratories, Inc. |
Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end
|
US5789578A
(en)
|
1996-01-11 |
1998-08-04 |
Massey University |
Methods for the preparation of resins with ligands attached thereto through a linking group comprising sulfide, sulfoxide or sulfone functionality
|
US7291463B2
(en)
|
1996-01-23 |
2007-11-06 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US5714577A
(en)
|
1996-01-26 |
1998-02-03 |
University Of Pittsburgh |
Antimicrobial peptides
|
US6261584B1
(en)
|
1996-02-02 |
2001-07-17 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6395292B2
(en)
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
WO1997030064A1
(en)
|
1996-02-16 |
1997-08-21 |
Stichting Rega Vzw |
Hexitol containing oligonucleotides and their use in antisense strategies
|
US6534312B1
(en)
|
1996-02-22 |
2003-03-18 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
US6090391A
(en)
|
1996-02-23 |
2000-07-18 |
Aviron |
Recombinant tryptophan mutants of influenza
|
US5994308A
(en)
|
1996-02-28 |
1999-11-30 |
Board Of Trustees Of Southern Illinois University |
Broad spectrum antimicrobial peptides containing a tryptophan triplet and methods of use
|
US6300487B1
(en)
*
|
1996-03-19 |
2001-10-09 |
Cell Therapuetics, Inc. |
Mammalian lysophosphatidic acid acyltransferase
|
SE9601245D0
(sv)
|
1996-03-29 |
1996-03-29 |
Pharmacia Ab |
Chimeric superantigens and their use
|
TW517061B
(en)
|
1996-03-29 |
2003-01-11 |
Pharmacia & Amp Upjohn Ab |
Modified/chimeric superantigens and their use
|
US5773696A
(en)
|
1996-03-29 |
1998-06-30 |
Monsanto Company |
Antifungal polypeptide and methods for controlling plant pathogenic fungi
|
JPH09278726A
(ja)
*
|
1996-04-11 |
1997-10-28 |
Takeshi Imanishi |
新規リポソーム
|
US5712127A
(en)
|
1996-04-29 |
1998-01-27 |
Genescape Inc. |
Subtractive amplification
|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
ES2331441T3
(es)
|
1996-06-05 |
2010-01-04 |
Novartis Vaccines And Diagnostics, Inc. |
Dna que codifica dp-75 y un proceso para su uso.
|
US7329741B2
(en)
|
1996-06-05 |
2008-02-12 |
Chiron Corporation |
Polynucleotides that hybridize to DP-75 and their use
|
WO1997048370A2
(en)
|
1996-06-21 |
1997-12-24 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
US6234990B1
(en)
|
1996-06-28 |
2001-05-22 |
Sontra Medical, Inc. |
Ultrasound enhancement of transdermal transport
|
US5939262A
(en)
|
1996-07-03 |
1999-08-17 |
Ambion, Inc. |
Ribonuclease resistant RNA preparation and utilization
|
US5677124A
(en)
|
1996-07-03 |
1997-10-14 |
Ambion, Inc. |
Ribonuclease resistant viral RNA standards
|
US5856127A
(en)
|
1996-07-26 |
1999-01-05 |
The Research Foundation Of State University Of New York |
Antimicrobial peptides
|
US7288266B2
(en)
|
1996-08-19 |
2007-10-30 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
EP0960191A4
(en)
|
1996-08-22 |
2003-07-23 |
Univ Pennsylvania |
COMPOSITIONS AND METHODS FOR THE USE OF DEFENSIN
|
US5849546A
(en)
|
1996-09-13 |
1998-12-15 |
Epicentre Technologies Corporation |
Methods for using mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates
|
US6114148C1
(en)
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
PT932678E
(pt)
|
1996-09-24 |
2006-07-31 |
Tanox Inc |
Familia de genes que codificam peptidos relacionados com apoptose, peptidos por eles codificados e metodos para sua utilizacao
|
US6214966B1
(en)
|
1996-09-26 |
2001-04-10 |
Shearwater Corporation |
Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
|
CA2268825C
(en)
|
1996-10-11 |
2006-04-18 |
The Regents Of The University Of California |
Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
|
EP0839912A1
(en)
|
1996-10-30 |
1998-05-06 |
Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) |
Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
|
GB9623051D0
(en)
|
1996-11-06 |
1997-01-08 |
Schacht Etienne H |
Delivery of DNA to target cells in biological systems
|
US5980887A
(en)
|
1996-11-08 |
1999-11-09 |
St. Elizabeth's Medical Center Of Boston |
Methods for enhancing angiogenesis with endothelial progenitor cells
|
US6121436A
(en)
|
1996-12-13 |
2000-09-19 |
Monsanto Company |
Antifungal polypeptide and methods for controlling plant pathogenic fungi
|
US5759179A
(en)
|
1996-12-31 |
1998-06-02 |
Johnson & Johnson Medical, Inc. |
Needle and valve assembly for use with a catheter
|
AU738328B2
(en)
|
1997-01-21 |
2001-09-13 |
General Hospital Corporation, The |
Selection of proteins using RNA-protein fusions
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
US6228640B1
(en)
|
1997-02-07 |
2001-05-08 |
Cem Cezayirli |
Programmable antigen presenting cell of CD34 lineage
|
US6696291B2
(en)
|
1997-02-07 |
2004-02-24 |
Merck & Co., Inc. |
Synthetic HIV gag genes
|
US6251665B1
(en)
|
1997-02-07 |
2001-06-26 |
Cem Cezayirli |
Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
|
EE9900343A
(et)
|
1997-02-07 |
2000-02-15 |
Merck & Co., Inc. |
Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon
|
US6576752B1
(en)
|
1997-02-14 |
2003-06-10 |
Isis Pharmaceuticals, Inc. |
Aminooxy functionalized oligomers
|
US5998374A
(en)
|
1997-02-28 |
1999-12-07 |
The Regents Of University Of California |
Clavaspirins
|
US5837860A
(en)
|
1997-03-05 |
1998-11-17 |
Molecular Tool, Inc. |
Covalent attachment of nucleic acid molecules onto solid-phases via disulfide bonds
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
US6306393B1
(en)
|
1997-03-24 |
2001-10-23 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
US6261281B1
(en)
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
US5914269A
(en)
|
1997-04-04 |
1999-06-22 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide inhibition of epidermal growth factor receptor expression
|
GB2324370B
(en)
|
1997-04-14 |
1999-03-03 |
Stuart Harbron |
Detection of hybrid double-stranded DNA with antibody after enzyme degradation of excess single-standed DNA
|
AU6972798A
(en)
|
1997-04-18 |
1998-11-13 |
University Of Medicine And Dentistry Of New Jersey |
Inhibition of hiv-1 replication by a tat rna-binding domain peptide analog
|
US5958688A
(en)
|
1997-04-28 |
1999-09-28 |
The Trustees Of The University Of Pennsylvania |
Characterization of mRNA patterns in neurites and single cells for medical diagnosis and therapeutics
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
US5989911A
(en)
|
1997-05-09 |
1999-11-23 |
University Of Massachusetts |
Site-specific synthesis of pseudouridine in RNA
|
EP2113247A3
(en)
*
|
1997-05-14 |
2010-05-05 |
The University Of British Columbia |
High efficiency encapsulation of nucleic acids in lipid vesicles
|
AU7600098A
(en)
*
|
1997-05-27 |
1998-12-30 |
Icos Corporation |
Novel lysophosphatidic acid acyltransferase
|
NL1006164C2
(nl)
|
1997-05-29 |
1998-12-01 |
Univ Leiden |
Antimicrobiële peptiden.
|
US6124091A
(en)
|
1997-05-30 |
2000-09-26 |
Research Corporation Technologies, Inc. |
Cell growth-controlling oligonucleotides
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
JP4101888B2
(ja)
|
1997-06-06 |
2008-06-18 |
ダイナバックス テクノロジーズ コーポレイション |
免疫刺激オリゴヌクレオチド、その組成物およびその使用方法
|
DE19726167B4
(de)
*
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
JP2002510319A
(ja)
|
1997-07-01 |
2002-04-02 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
オリゴヌクレオチドの消化管を介したデリバリーのための組成物及び方法
|
US5994511A
(en)
|
1997-07-02 |
1999-11-30 |
Genentech, Inc. |
Anti-IgE antibodies and methods of improving polypeptides
|
EA002688B1
(ru)
|
1997-07-21 |
2002-08-29 |
Фармациа Энд Апджон Аб |
Способы инактивации клеток-мишеней, агенты и композиции, вызывающие цитолиз, и соединения, используемые для получения этих агентов
|
FR2766191B1
(fr)
|
1997-07-21 |
2000-11-10 |
Ifremer |
Peptides anti-microbiens de crustaces
|
US20030073640A1
(en)
|
1997-07-23 |
2003-04-17 |
Ribozyme Pharmaceuticals, Inc. |
Novel compositions for the delivery of negatively charged molecules
|
AU8763898A
(en)
|
1997-07-31 |
1999-02-22 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Method for the treatment of grafts
|
AU759636B2
(en)
|
1997-07-31 |
2003-04-17 |
Academisch Ziekenhuis Bij De Universiteit Van Amsterdam |
Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
|
US6576755B1
(en)
|
1997-09-10 |
2003-06-10 |
Zymogenetics, Inc. |
Beta-defensins
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
CA2304125A1
(en)
|
1997-09-18 |
1999-03-25 |
Velpandi Ayyavoo |
Attenuated vif dna immunization cassettes for genetic vaccines
|
WO1999014346A2
(en)
|
1997-09-19 |
1999-03-25 |
Sequitur, Inc. |
SENSE mRNA THERAPY
|
JP2001517422A
(ja)
|
1997-09-25 |
2001-10-09 |
アカデミス・ジーケンハイス・ベイ・デ・ウニフェルジテイト・ファン・アムステルダム |
単離したおよび組換えによる抗菌ペプチドトロンボシジン−1(tc−1)およびトロンボシジン−2(tc−2)またはその変異体
|
US6004573A
(en)
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
WO1999018221A1
(en)
|
1997-10-07 |
1999-04-15 |
University Of Maryland Biotechnology Institute |
Method for introducing and expressing rna in animal cells
|
EP1025233A2
(en)
|
1997-10-20 |
2000-08-09 |
Genzyme Transgenics Corporation |
Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems
|
US6019747A
(en)
|
1997-10-21 |
2000-02-01 |
I-Flow Corporation |
Spring-actuated infusion syringe
|
JP2001520889A
(ja)
|
1997-10-24 |
2001-11-06 |
バレンティス,インコーポレイティド |
ポリヌクレオチドトランスフェクション複合体を調製する方法
|
AU1387299A
(en)
|
1997-11-12 |
1999-05-31 |
Valentis, Inc. |
Expression plasmids for multiepitope nucleic acid-based vaccines
|
US6548633B1
(en)
|
1998-12-22 |
2003-04-15 |
Genset, S.A. |
Complementary DNA's encoding proteins with signal peptides
|
ATE243045T1
(de)
|
1997-11-20 |
2003-07-15 |
Vical Inc |
Behandlung von krebs durch verwendung von zytokin-exprimierender polynukleotiden und zusammensetzungen dafür
|
US7655777B2
(en)
|
1997-11-24 |
2010-02-02 |
Monsanto Technology Llc |
Nucleic acid molecules associated with the tocopherol pathway
|
US6517869B1
(en)
|
1997-12-12 |
2003-02-11 |
Expression Genetics, Inc. |
Positively charged poly(alpha-(omega-aminoalkyl)lycolic acid) for the delivery of a bioactive agent via tissue and cellular uptake
|
AR014940A1
(es)
|
1997-12-12 |
2001-04-11 |
Expression Genetics Inc |
Un portador para la liberacion de un agente bioactivo, un polimero poliester biodegradable, copolimeros y composiciones farmaceuticas que loscontienen.
|
US6320017B1
(en)
|
1997-12-23 |
2001-11-20 |
Inex Pharmaceuticals Corp. |
Polyamide oligomers
|
JP2002500010A
(ja)
|
1997-12-23 |
2002-01-08 |
カイロン コーポレイション |
ヒト遺伝子および遺伝子発現産物i
|
US6383811B2
(en)
|
1997-12-30 |
2002-05-07 |
Mirus Corporation |
Polyampholytes for delivering polyions to a cell
|
JP2002500201A
(ja)
|
1998-01-05 |
2002-01-08 |
ユニバーシティ オブ ワシントン |
膜破壊剤を使用する増強された輸送
|
US8287483B2
(en)
|
1998-01-08 |
2012-10-16 |
Echo Therapeutics, Inc. |
Method and apparatus for enhancement of transdermal transport
|
US6190315B1
(en)
|
1998-01-08 |
2001-02-20 |
Sontra Medical, Inc. |
Sonophoretic enhanced transdermal transport
|
NL1008139C2
(nl)
|
1998-01-27 |
1999-07-28 |
Stichting Tech Wetenschapp |
Antimicrobiële peptiden.
|
AU2683699A
(en)
|
1998-02-18 |
1999-09-06 |
Harbor-Ucla Research And Education Institute |
Antimicrobial peptides and derived metapeptides
|
US6365346B1
(en)
|
1998-02-18 |
2002-04-02 |
Dade Behring Inc. |
Quantitative determination of nucleic acid amplification products
|
US5888793A
(en)
*
|
1998-02-25 |
1999-03-30 |
Incyte Pharmaceuticals, Inc. |
Human lysophosphatidic acid acyltransferase
|
US5955310A
(en)
|
1998-02-26 |
1999-09-21 |
Novo Nordisk Biotech, Inc. |
Methods for producing a polypeptide in a bacillus cell
|
WO1999051637A1
(en)
*
|
1998-04-06 |
1999-10-14 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Mammalian selenoprotein differentially expressed in tumor cells
|
US6849417B1
(en)
*
|
1998-04-06 |
2005-02-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Mammalian selenoprotein differentially expressed in tumor cells
|
US6432925B1
(en)
|
1998-04-16 |
2002-08-13 |
John Wayne Cancer Institute |
RNA cancer vaccine and methods for its use
|
US6429301B1
(en)
|
1998-04-17 |
2002-08-06 |
Whitehead Institute For Biomedical Research |
Use of a ribozyme to join nucleic acids and peptides
|
GB9808327D0
(en)
|
1998-04-20 |
1998-06-17 |
Chiron Spa |
Antidiotypic compounds
|
EP2116600B1
(en)
|
1998-04-23 |
2013-09-18 |
Takara Bio Inc. |
Method for synthesizing DNA
|
US6395253B2
(en)
|
1998-04-23 |
2002-05-28 |
The Regents Of The University Of Michigan |
Microspheres containing condensed polyanionic bioactive agents and methods for their production
|
US20020064517A1
(en)
|
1998-04-30 |
2002-05-30 |
Stewart A. Cederholm-Williams |
Fibrin sealant as a transfection/transformation vehicle for gene therapy
|
US20090208418A1
(en)
|
2005-04-29 |
2009-08-20 |
Innexus Biotechnology Internaltional Ltd. |
Superantibody synthesis and use in detection, prevention and treatment of disease
|
CA2329147A1
(en)
|
1998-05-20 |
1999-11-25 |
Feng Liu |
A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier
|
US6503231B1
(en)
|
1998-06-10 |
2003-01-07 |
Georgia Tech Research Corporation |
Microneedle device for transport of molecules across tissue
|
US7091192B1
(en)
|
1998-07-01 |
2006-08-15 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
BR9912070A
(pt)
|
1998-07-13 |
2001-04-10 |
Expression Genetics Inc |
Análogo de poliéster de poli-l-lisina como um solúvel, veìculo de distribuição de gene biodegradável
|
US6222030B1
(en)
|
1998-08-03 |
2001-04-24 |
Agilent Technologies, Inc. |
Solid phase synthesis of oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection
|
EA004107B1
(ru)
|
1998-08-11 |
2003-12-25 |
Айдек Фармацевтикалс Корпорэйшн |
Комбинированная терапия в-клеточных лимфом, предусматривающая введение антитела против cd20
|
US6476189B1
(en)
|
1998-08-12 |
2002-11-05 |
National Institute Of Agrobiological Sciences |
Antibacterial peptides and antibacterial agents containing such peptides as an effective ingredient
|
GB9817662D0
(en)
|
1998-08-13 |
1998-10-07 |
Crocker Peter J |
Substance delivery
|
US6288212B1
(en)
|
1998-08-28 |
2001-09-11 |
The University Of British Columbia |
Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
|
US20020065236A1
(en)
*
|
1998-09-09 |
2002-05-30 |
Yew Nelson S. |
CpG reduced plasmids and viral vectors
|
US20090042283A1
(en)
|
1998-09-29 |
2009-02-12 |
Shire Human Genetic Therapies, Inc., A Delaware Corporation |
Optimized messenger rna
|
US6924365B1
(en)
|
1998-09-29 |
2005-08-02 |
Transkaryotic Therapies, Inc. |
Optimized messenger RNA
|
WO2000026226A1
(en)
|
1998-11-03 |
2000-05-11 |
Yale University |
Multidomain polynucleotide molecular sensors
|
MY155913A
(en)
|
1998-11-09 |
2015-12-15 |
Biogen Inc |
Chimeric anti-cd20 antibody treatment of patients receiving bmt or pbsc transpants
|
DK1616572T3
(da)
|
1998-11-09 |
2010-12-06 |
Biogen Idec Inc |
Kimært anti-CD20-antistof, rituxan, til anvendelse i behandling af kronisk lymfatisk leukæmi
|
WO2000027340A2
(en)
|
1998-11-12 |
2000-05-18 |
The Children's Medical Center Corporation |
USE OF t-RNA AND FRAGMENTS FOR INHIBITING ANGIOGENESIS AND COMPOSITIONS THEREOF
|
JP3141107B2
(ja)
|
1998-11-16 |
2001-03-05 |
工業技術院長 |
ヒト由来ブラディオン蛋白質、それをコードするdna及びそれらの使用
|
US6248268B1
(en)
|
1998-11-16 |
2001-06-19 |
Xc Corporation |
Process of making microparticles of a thermally-gelled polysaccharide
|
US6210931B1
(en)
|
1998-11-30 |
2001-04-03 |
The United States Of America As Represented By The Secretary Of Agriculture |
Ribozyme-mediated synthesis of circular RNA
|
JP2000175684A
(ja)
*
|
1998-12-14 |
2000-06-27 |
Eiken Chem Co Ltd |
新規アシルトランスフェラーゼをコードする遺伝子
|
US20040171980A1
(en)
|
1998-12-18 |
2004-09-02 |
Sontra Medical, Inc. |
Method and apparatus for enhancement of transdermal transport
|
EP1141376A4
(en)
*
|
1998-12-23 |
2002-03-13 |
Human Genome Sciences |
PEPTIDOGLYCANE RECOGNITION PROTEINS
|
WO2000044914A1
(en)
|
1999-01-28 |
2000-08-03 |
Medical College Of Georgia Research Institute, Inc. |
Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
|
GB9902000D0
(en)
*
|
1999-01-30 |
1999-03-17 |
Delta Biotechnology Ltd |
Process
|
AU2685200A
(en)
|
1999-02-22 |
2000-09-14 |
European Molecular Biology Laboratory |
Translation system
|
US6255476B1
(en)
|
1999-02-22 |
2001-07-03 |
Pe Corporation (Ny) |
Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
|
US7629311B2
(en)
|
1999-02-24 |
2009-12-08 |
Edward Lewis Tobinick |
Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
|
DE60020677T2
(de)
|
1999-02-26 |
2006-05-04 |
Chiron Corp., Emeryville |
Mikroemulsionen mit adsorbierten makromolekülen und mikropartikeln
|
US6107460A
(en)
|
1999-03-01 |
2000-08-22 |
The Board Of Regents Of The University Of Oklahoma |
Antimicrobial peptides and methods of use thereof
|
US8410248B2
(en)
|
1999-03-12 |
2013-04-02 |
Human Genome Sciences Inc. |
HWBAO62 polypeptides
|
US7084125B2
(en)
|
1999-03-18 |
2006-08-01 |
Exiqon A/S |
Xylo-LNA analogues
|
US7244710B2
(en)
|
2002-05-21 |
2007-07-17 |
Zengen, Inc. |
Treatment of ophthalmic infections using antimicrobial peptides
|
WO2000029561A2
(en)
|
1999-03-29 |
2000-05-25 |
Statens Serum Institut |
Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
|
US7217762B1
(en)
|
1999-04-09 |
2007-05-15 |
Invitrogen Corporation |
Process for the preparation of monodisperse polymer particles
|
DK1178999T3
(da)
|
1999-05-04 |
2007-08-06 |
Santaris Pharma As |
L-RIBO-LNA-analoger
|
EP1642596A3
(en)
|
1999-05-07 |
2006-04-12 |
Genentech, Inc. |
Treatment of autoimmune diseases with antagonists which bind to B cell surface markers
|
KR20020011985A
(ko)
|
1999-05-07 |
2002-02-09 |
파르마솔 게엠베하 |
액상 및 고체상 지질 혼합물에 기초한 지질입자들 및 그의제조방법
|
DE60000665T3
(de)
|
1999-05-17 |
2009-10-29 |
ConjuChem Biotechnologies Inc., Montreal |
Lang wirkende peptidinhibitoren der virusfusion mit körperzellen bei viralen infektionen
|
US6346382B1
(en)
|
1999-06-01 |
2002-02-12 |
Vanderbilt University |
Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
|
US6743211B1
(en)
|
1999-11-23 |
2004-06-01 |
Georgia Tech Research Corporation |
Devices and methods for enhanced microneedle penetration of biological barriers
|
US6611707B1
(en)
|
1999-06-04 |
2003-08-26 |
Georgia Tech Research Corporation |
Microneedle drug delivery device
|
AU4332399A
(en)
|
1999-06-04 |
2000-12-28 |
Cheng-Ming Chuong |
Rna polymerase chain reaction
|
US6303573B1
(en)
|
1999-06-07 |
2001-10-16 |
The Burnham Institute |
Heart homing peptides and methods of using same
|
WO2000075304A1
(fr)
|
1999-06-08 |
2000-12-14 |
Aventis Pasteur |
Oligonucleotide immunostimulant
|
DE60042785D1
(de)
|
1999-06-09 |
2009-10-01 |
Immunomedics Inc |
Immuntherapie von autoimmunerkrankungen durch die verwendung von b-zell spezifischen antikörpern
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
US20030153050A1
(en)
|
1999-06-28 |
2003-08-14 |
Conklin Darrell C. |
Helical polypeptide zalpha29
|
NZ516236A
(en)
|
1999-06-30 |
2004-12-24 |
Advanced Cell Tech Inc |
Altering life span of a recipient cell by transferring cell cytoplasm from a donor cell for use in gene therapy and cloning
|
US6514948B1
(en)
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
FR2796072B1
(fr)
|
1999-07-08 |
2003-09-19 |
Centre Nat Rech Scient |
Peptides anti-microbiens de mollusques
|
JP2003504061A
(ja)
|
1999-07-09 |
2003-02-04 |
ワイス |
プラスミド配列の転写の間における異常型rnaの形成を防止するための方法および組成物
|
CA2311201A1
(en)
|
1999-08-05 |
2001-02-05 |
Genset S.A. |
Ests and encoded human proteins
|
US8557244B1
(en)
|
1999-08-11 |
2013-10-15 |
Biogen Idec Inc. |
Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
|
US7071293B1
(en)
|
1999-08-18 |
2006-07-04 |
The University Of Iowa Research Foundation |
Alpha helical peptides with broad spectrum antimicrobial activity that are insensitive to salt
|
JP2002300878A
(ja)
|
1999-08-19 |
2002-10-15 |
Chugai Pharmaceut Co Ltd |
新規bHLH型転写因子遺伝子、DEC2
|
EP1212422B1
(en)
|
1999-08-24 |
2007-02-21 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
US20050112141A1
(en)
|
2000-08-30 |
2005-05-26 |
Terman David S. |
Compositions and methods for treatment of neoplastic disease
|
US20040106567A1
(en)
|
1999-09-07 |
2004-06-03 |
Hagstrom James E. |
Intravascular delivery of non-viral nucleic acid
|
DE69923840T2
(de)
|
1999-09-09 |
2006-04-06 |
Curevac Gmbh |
Transfer von mRNAs unter Verwendung von polykationischen Verbindungen
|
WO2001021810A1
(en)
|
1999-09-17 |
2001-03-29 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
US6623457B1
(en)
|
1999-09-22 |
2003-09-23 |
Becton, Dickinson And Company |
Method and apparatus for the transdermal administration of a substance
|
WO2002064799A2
(en)
|
1999-09-28 |
2002-08-22 |
Transkaryotic Therapies, Inc. |
Optimized messenger rna
|
WO2001025488A2
(en)
|
1999-10-06 |
2001-04-12 |
Quark Biotech, Inc. |
Method for enrichment of natural antisense messenger rna
|
US6511832B1
(en)
|
1999-10-06 |
2003-01-28 |
Texas A&M University System |
In vitro synthesis of capped and polyadenylated mRNAs using baculovirus RNA polymerase
|
EP1101771A1
(en)
|
1999-11-15 |
2001-05-23 |
Korea Kumho Petrochemical Co. Ltd. |
Pathogen-induced genes from Capsicum annuum
|
US7060291B1
(en)
|
1999-11-24 |
2006-06-13 |
Transave, Inc. |
Modular targeted liposomal delivery system
|
US6573361B1
(en)
|
1999-12-06 |
2003-06-03 |
Monsanto Technology Llc |
Antifungal proteins and methods for their use
|
US6613026B1
(en)
|
1999-12-08 |
2003-09-02 |
Scimed Life Systems, Inc. |
Lateral needle-less injection apparatus and method
|
US6277974B1
(en)
|
1999-12-14 |
2001-08-21 |
Cogent Neuroscience, Inc. |
Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
|
AU784942B2
(en)
|
1999-12-15 |
2006-08-03 |
Cubist Pharmaceuticals, Inc. |
Daptomycin analogs and their use as antibacterial agents
|
US6245929B1
(en)
|
1999-12-20 |
2001-06-12 |
General Electric Company |
Catalyst composition and method for producing diaryl carbonates, using bisphosphines
|
JP4758583B2
(ja)
|
1999-12-22 |
2011-08-31 |
バセル テクノロジー カンパニー ビー.ブイ. |
芳香族シラン化合物を含むα−オレフィン重合触媒系
|
WO2001051092A2
(en)
|
2000-01-07 |
2001-07-19 |
University Of Washington |
Enhanced transport of agents using membrane disruptive agents
|
EP1276901A2
(en)
|
2000-01-13 |
2003-01-22 |
Amsterdam Support Diagnostics B.V. |
A universal nucleic acid amplification system for nucleic acids in a sample
|
DE10001377A1
(de)
*
|
2000-01-14 |
2001-08-02 |
Univ Mainz Johannes Gutenberg |
bHLH-Transkriptionsfaktor ASCL3 und diesen enthaltendes Arzneimittel
|
CA2395811A1
(en)
*
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
CA2398756A1
(en)
|
2000-01-31 |
2001-08-02 |
Eyal Raz |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
|
US7833992B2
(en)
|
2001-05-18 |
2010-11-16 |
Merck Sharpe & Dohme |
Conjugates and compositions for cellular delivery
|
US7491805B2
(en)
|
2001-05-18 |
2009-02-17 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
AU2001238595A1
(en)
|
2000-02-22 |
2001-09-03 |
Shearwater Corporation |
N-maleimidyl polymer derivatives
|
AU4178601A
(en)
|
2000-02-24 |
2001-09-03 |
Univ Washington |
Humanized antibodies that sequester abeta peptide
|
US6936432B2
(en)
|
2000-03-01 |
2005-08-30 |
Message Pharmaceuticals |
Bacterial RNase P proteins and their use in identifying antibacterial compounds
|
BR0108962A
(pt)
|
2000-03-03 |
2002-12-24 |
Valentis Inc |
Formulações de ácido nucléico para distribuição de genes e métodos de uso
|
GB0006572D0
(en)
|
2000-03-17 |
2000-05-10 |
Isis Innovation |
Novel transcription transactivator protein
|
EP1276702A2
(en)
*
|
2000-03-31 |
2003-01-22 |
Genentech, Inc. |
Compositions and methods for detecting and quantifying gene expression
|
JP2004500412A
(ja)
|
2000-03-31 |
2004-01-08 |
アイデック ファーマスーティカルズ コーポレイション |
B細胞リンパ腫の治療のための抗サイトカイン抗体またはアンタゴニストおよび抗cd20の併用
|
US6565572B2
(en)
|
2000-04-10 |
2003-05-20 |
Sdgi Holdings, Inc. |
Fenestrated surgical screw and method
|
US6368801B1
(en)
|
2000-04-12 |
2002-04-09 |
Molecular Staging, Inc. |
Detection and amplification of RNA using target-mediated ligation of DNA by RNA ligase
|
CA2747325A1
(en)
|
2000-04-12 |
2001-10-25 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US20010046496A1
(en)
|
2000-04-14 |
2001-11-29 |
Brettman Lee R. |
Method of administering an antibody
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US20040229271A1
(en)
|
2000-05-19 |
2004-11-18 |
Williams Richard B. |
Compositions and methods for the identification and selection of nucleic acids and polypeptides
|
WO2001092523A2
(en)
|
2000-05-30 |
2001-12-06 |
Curagen Corporation |
Human polynucleotides and polypeptides encoded thereby
|
WO2001093902A2
(en)
|
2000-06-07 |
2001-12-13 |
Biosynexus Incorporated |
Immunostimulatory rna/dna hybrid molecules
|
DK1292615T3
(da)
|
2000-06-23 |
2007-02-19 |
Wyeth Corp |
Modificerede morbillivirus V-proteiner
|
US6337317B1
(en)
|
2000-06-27 |
2002-01-08 |
The University Of British Columbia |
Antimicrobial peptides and methods of use thereof
|
US6492328B2
(en)
|
2000-06-28 |
2002-12-10 |
The University Of Iowa Research Foundation |
Novispirins: antimicrobial peptides
|
ATE440861T1
(de)
|
2000-07-03 |
2009-09-15 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia pneumoniae
|
US6440096B1
(en)
|
2000-07-14 |
2002-08-27 |
Becton, Dickinson And Co. |
Microdevice and method of manufacturing a microdevice
|
ATE346947T1
(de)
|
2000-07-21 |
2006-12-15 |
Glaxo Group Ltd |
Kodon-optimierte papillomavirussequenzen
|
US6727066B2
(en)
|
2000-07-28 |
2004-04-27 |
Incyte Corporation |
Genes expressed in treated human C3A liver cell cultures
|
EP1305040B1
(en)
|
2000-07-28 |
2009-09-09 |
Christopher J. Murphy |
Transplant media
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
US7052888B2
(en)
*
|
2000-08-21 |
2006-05-30 |
Millennium Pharmaceuticals, Inc. |
ACTR-1 a novel human acyltransferase and uses thereof
|
US6875907B2
(en)
|
2000-09-13 |
2005-04-05 |
Pioneer Hi-Bred International, Inc. |
Antimicrobial peptides and methods of use
|
US20040142474A1
(en)
|
2000-09-14 |
2004-07-22 |
Expression Genetics, Inc. |
Novel cationic lipopolymer as a biocompatible gene delivery agent
|
US6696038B1
(en)
|
2000-09-14 |
2004-02-24 |
Expression Genetics, Inc. |
Cationic lipopolymer as biocompatible gene delivery agent
|
AU2001290078A1
(en)
|
2000-09-20 |
2002-04-02 |
Ruggero Della Bitta |
Stem cell therapy
|
AU2002211524B2
(en)
|
2000-10-04 |
2007-03-22 |
The Trustees Of The University Of Pennsylvania |
Highly expressible genes
|
US6998484B2
(en)
|
2000-10-04 |
2006-02-14 |
Santaris Pharma A/S |
Synthesis of purine locked nucleic acid analogues
|
DE10050274A1
(de)
*
|
2000-10-09 |
2002-04-18 |
Henkel Kgaa |
Verfahren zur in vitro Bestimmung der Hautalterung
|
US6998115B2
(en)
|
2000-10-10 |
2006-02-14 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
US6649138B2
(en)
|
2000-10-13 |
2003-11-18 |
Quantum Dot Corporation |
Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
|
US7202226B2
(en)
|
2000-10-23 |
2007-04-10 |
Detroit R & D |
Augmentation of wound healing by elF-4E mRNA and EGF mRNA
|
US20030077604A1
(en)
|
2000-10-27 |
2003-04-24 |
Yongming Sun |
Compositions and methods relating to breast specific genes and proteins
|
GB0026924D0
(en)
|
2000-11-03 |
2000-12-20 |
Univ Cambridge Tech |
Antibacterial agents
|
US20020132788A1
(en)
|
2000-11-06 |
2002-09-19 |
David Lewis |
Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo
|
WO2002040545A2
(en)
|
2000-11-17 |
2002-05-23 |
The Government Of The United States, As Represented By The Secretary Of The Department Of Health And Human Services |
Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point
|
US7229765B2
(en)
|
2000-11-28 |
2007-06-12 |
Rosetta Inpharmatics Llc |
Random-primed reverse transcriptase-in vitro transcription method for RNA amplification
|
WO2002046477A2
(en)
|
2000-12-07 |
2002-06-13 |
Chiron Corporation |
Endogenous retroviruses up-regulated in prostate cancer
|
US7708915B2
(en)
|
2004-05-06 |
2010-05-04 |
Castor Trevor P |
Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
|
US20020130430A1
(en)
|
2000-12-29 |
2002-09-19 |
Castor Trevor Percival |
Methods for making polymer microspheres/nanospheres and encapsulating therapeutic proteins and other products
|
EP1224943A1
(en)
|
2001-01-19 |
2002-07-24 |
Crucell Holland B.V. |
Fibronectin as a tumor marker detected by phage antibodies
|
PL213926B1
(pl)
|
2001-01-19 |
2013-05-31 |
Vironovative Bv |
Wyizolowany ssaczy metapneumowirus o ujemnej pojedynczej nici RNA (MPV), kompozycja immunogenna, wyizolowane kwasy nukleinowe, sposoby wykrywania ssaczego metapneumowirusa, wektor, komórka gospodarza, wyizolowane bialko, przeciwcialo, sposób wirologicznego diagnozowania infekcji MPV, sposób serologicznego diagnozowania infekcji MPV, kompozycja farmaceutyczna, zestaw diagnostyczny oraz zastosowanie kompozycji farmaceutycznej
|
US20040110191A1
(en)
|
2001-01-31 |
2004-06-10 |
Winkler Matthew M. |
Comparative analysis of nucleic acids using population tagging
|
US20040142433A1
(en)
|
2001-02-02 |
2004-07-22 |
Padgett Hal S. |
Polynucleotide sequence variants
|
JP2004527236A
(ja)
|
2001-02-14 |
2004-09-09 |
ベイラー カレッジ オブ メディスン |
Rna増幅の方法及び組成物
|
US6887847B2
(en)
|
2001-02-16 |
2005-05-03 |
University Of Pittsburgh |
Virus derived antimicrobial peptides
|
US6652886B2
(en)
|
2001-02-16 |
2003-11-25 |
Expression Genetics |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
|
US6835713B2
(en)
|
2001-02-16 |
2004-12-28 |
University Of Pittsburgh |
Virus derived antimicrobial peptides
|
DE10109897A1
(de)
|
2001-02-21 |
2002-11-07 |
Novosom Ag |
Fakultativ kationische Liposomen und Verwendung dieser
|
US7232425B2
(en)
|
2001-03-02 |
2007-06-19 |
Sorenson Development, Inc. |
Apparatus and method for specific interstitial or subcutaneous diffusion and dispersion of medication
|
KR100917939B1
(ko)
|
2001-03-09 |
2009-09-21 |
진 스트림 피티와이 리미티드 |
신규한 발현 벡터
|
JP2002262882A
(ja)
|
2001-03-12 |
2002-09-17 |
Nisshinbo Ind Inc |
Rnaの増幅法
|
FR2822164B1
(fr)
|
2001-03-19 |
2004-06-18 |
Centre Nat Rech Scient |
Polypeptides derives des arn polymerases, et leurs utilisations
|
US6520949B2
(en)
|
2001-04-02 |
2003-02-18 |
Martin St. Germain |
Method and apparatus for administering fluid to animals subcutaneously
|
WO2003008537A2
(en)
*
|
2001-04-06 |
2003-01-30 |
Mannkind Corporation |
Epitope sequences
|
DE10119005A1
(de)
|
2001-04-18 |
2002-10-24 |
Roche Diagnostics Gmbh |
Verfahren zur Proteinexpression ausgehend von stabilisierter linearer kurzer DNA in zellfreien in vitro-Transkription/Translations-Systemen mit Exonuklease-haltigen Lysaten oder in einem zellulären System enthaltend Exonukleasen
|
US7314858B2
(en)
|
2001-04-18 |
2008-01-01 |
The Regents Of The University Of California |
Retrocyclins: antiviral and antimicrobial peptides
|
US20030171253A1
(en)
|
2001-04-19 |
2003-09-11 |
Averil Ma |
Methods and compositions relating to modulation of A20
|
DE50211110D1
(de)
|
2001-04-21 |
2007-12-06 |
Curevac Gmbh |
INJEKTIONSGERÄT FÜR mRNA APPLIKATION
|
ATE278796T1
(de)
|
2001-04-23 |
2004-10-15 |
Amaxa Gmbh |
Pufferlössung für die elektroporation und verfahren umfassend die verwendung derselben
|
US7560424B2
(en)
|
2001-04-30 |
2009-07-14 |
Zystor Therapeutics, Inc. |
Targeted therapeutic proteins
|
US6777187B2
(en)
|
2001-05-02 |
2004-08-17 |
Rubicon Genomics, Inc. |
Genome walking by selective amplification of nick-translate DNA library and amplification from complex mixtures of templates
|
AU2002308623A1
(en)
|
2001-05-08 |
2002-11-18 |
Magnatech International, L.P. |
Electronic length control wire pay-off system and method
|
US7514099B2
(en)
|
2005-02-14 |
2009-04-07 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
US20050137155A1
(en)
|
2001-05-18 |
2005-06-23 |
Sirna Therapeutics, Inc. |
RNA interference mediated treatment of Parkinson disease using short interfering nucleic acid (siNA)
|
US8137911B2
(en)
|
2001-05-22 |
2012-03-20 |
Cellscript, Inc. |
Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
|
RU2294192C2
(ru)
|
2001-05-30 |
2007-02-27 |
Дзе Скриппс Рисерч Инститьют |
Система доставки нуклеиновых кислот
|
EP1392341B1
(de)
|
2001-06-05 |
2005-03-30 |
Curevac GmbH |
Stabilisierte mrna mit erhöhtem g/c-gehalt und optimierter codon usage für die gentherapie
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
JP2005503135A
(ja)
|
2001-06-18 |
2005-02-03 |
ノバルティス アクチエンゲゼルシャフト |
新規gタンパク質共役受容体およびそのdna配列
|
US7547551B2
(en)
|
2001-06-21 |
2009-06-16 |
University Of Antwerp. |
Transfection of eukaryontic cells with linear polynucleotides by electroporation
|
EP1270732A1
(en)
|
2001-06-21 |
2003-01-02 |
Schuler, Gerold |
Improved transfection of eukaryontic cells with linear polynucleotides by electroporation
|
US7785610B2
(en)
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
US20040175789A1
(en)
|
2001-06-26 |
2004-09-09 |
Umesh Bhatia |
G protein coupled receptors and dna sequences thereof
|
SE0102327D0
(sv)
|
2001-06-28 |
2001-06-28 |
Active Biotech Ab |
A novel engineered superantigen for human therapy
|
WO2003029401A2
(en)
*
|
2001-07-13 |
2003-04-10 |
Advanced Research And Technology Institute |
Peptidoglycan recognition protein encoding nucleic acids and methods of use thereof
|
US6872705B2
(en)
|
2001-07-13 |
2005-03-29 |
Allergan, Inc. |
Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
|
US6586524B2
(en)
|
2001-07-19 |
2003-07-01 |
Expression Genetics, Inc. |
Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
|
AU2002354893A1
(en)
*
|
2001-07-20 |
2003-03-03 |
Technion Research And Development Foundation Ltd. |
Methods of generating human cardiac cells and tissues and uses thereof
|
ES2367280T3
(es)
*
|
2001-07-25 |
2011-11-02 |
Oncomedx Inc. |
Métodos para evaluar estados patológicos usando arn extracelular.
|
US7169750B2
(en)
|
2001-07-31 |
2007-01-30 |
Anormed, Inc. |
Methods to mobilize progenitor/stem cells
|
ATE481497T1
(de)
|
2001-08-01 |
2010-10-15 |
Univ Utah |
Am n-terminus trunkierte isoformen von zyklischen phosphodiesterasen pde3a
|
AU2002335668A1
(en)
|
2001-08-08 |
2003-02-24 |
The Research Foundation Of The State University Of New York |
Muc7d1 peptides as antifungal and antibacterial agents
|
US6743598B2
(en)
|
2001-08-10 |
2004-06-01 |
Mycologics, Inc. |
Methods for the identification of fungal glucose utilization inhibitors and antifungal agents
|
US6835536B2
(en)
|
2001-08-21 |
2004-12-28 |
Micrologix Biotech Inc. |
Antimicrobial cationic peptides and formulations thereof
|
US20050106659A1
(en)
|
2001-08-27 |
2005-05-19 |
Klemens Kaupmann |
Novel g-protein coupled receptor and dna sequences thereof
|
US7456335B2
(en)
*
|
2001-09-03 |
2008-11-25 |
Basf Plant Science Gmbh |
Nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
|
US20040142325A1
(en)
*
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
EP1435932A4
(en)
|
2001-09-21 |
2006-12-06 |
Message Pharmaceuticals Inc |
INHIBITORS OF RNASE P PROTEINS AS ANTIBACTERIAL COMPOUNDS
|
WO2003029459A2
(en)
|
2001-09-28 |
2003-04-10 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Micro-rna molecules
|
US20060051424A1
(en)
|
2001-10-03 |
2006-03-09 |
Johns Hopkins University |
Compositions of oral gene therapy and methods of using same
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
DE10148886A1
(de)
|
2001-10-04 |
2003-04-30 |
Avontec Gmbh |
Inhibition von STAT-1
|
US7276489B2
(en)
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
AU2002338926B2
(en)
|
2001-11-05 |
2007-05-24 |
Janssen Pharmaceutica N.V. |
Method for the in vitro synthesis of short double stranded RNAs
|
EP1452593B1
(en)
|
2001-11-14 |
2009-04-08 |
Toyo Boseki Kabushiki Kaisha |
Dna synthesis promoters, dna polymerase-associated factors and utilization thereof
|
US20040076978A1
(en)
|
2001-11-14 |
2004-04-22 |
Catherine Verfaillie |
Method to identify genes associated with chronic myelogenous leukemia
|
WO2003044482A2
(en)
|
2001-11-16 |
2003-05-30 |
The University Of Tennessee Research Corporation |
Recombinant antibody fusion proteins and methods for detection of apoptotic cells
|
US6478825B1
(en)
|
2001-11-28 |
2002-11-12 |
Osteotech, Inc. |
Implant, method of making same and use of the implant for the treatment of bone defects
|
WO2003046578A2
(en)
|
2001-11-29 |
2003-06-05 |
Novartis Ag |
Method for the assessment and prognosis of sarcoidosis
|
CA2409775C
(en)
|
2001-12-03 |
2010-07-13 |
F. Hoffmann-La Roche Ag |
Reversibly modified thermostable enzymes for dna synthesis and amplification in vitro
|
US20060275747A1
(en)
|
2001-12-07 |
2006-12-07 |
Hardy Stephen F |
Endogenous retrovirus up-regulated in prostate cancer
|
AU2002351332A1
(en)
|
2001-12-07 |
2003-06-23 |
Chiron Corporation |
Endogenous retrovirus polypeptides linked to oncogenic transformation
|
ATE458003T1
(de)
|
2001-12-07 |
2010-03-15 |
Novartis Vaccines & Diagnostic |
Bei prostatakrebs hochreguliertes endogenes retrovirus
|
JP2005520498A
(ja)
|
2001-12-17 |
2005-07-14 |
ノバルティス アクチエンゲゼルシャフト |
新規gタンパク質共役受容体およびそのdna配列
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
JP2005514429A
(ja)
|
2001-12-21 |
2005-05-19 |
アルコン、インコーポレイテッド |
眼/耳用薬物のキャリヤーとしての合成無機質ナノ粒子の使用
|
AU2003235707A1
(en)
|
2002-01-18 |
2003-07-30 |
Curevac Gmbh |
Immunogenic preparations and vaccines on the basis of mrna
|
WO2003063792A2
(en)
|
2002-01-30 |
2003-08-07 |
The Brigham And Women's Hospital, Inc. |
Compositions and methods related to tim-3, a th1-specific cell surface molecule
|
WO2003066649A1
(en)
|
2002-02-04 |
2003-08-14 |
Biomira Inc. |
Immunostimulatory, covalently lipidated oligonucleotides
|
ATE417858T1
(de)
|
2002-02-05 |
2009-01-15 |
Genentech Inc |
Proteinaufreinigung
|
FR2835749B1
(fr)
|
2002-02-08 |
2006-04-14 |
Inst Nat Sante Rech Med |
Composition pharmaceutique ameliorant le transfert de gene in vivo
|
DE10207178A1
(de)
|
2002-02-19 |
2003-09-04 |
Novosom Ag |
Komponenten für die Herstellung amphoterer Liposomen
|
US20050222064A1
(en)
|
2002-02-20 |
2005-10-06 |
Sirna Therapeutics, Inc. |
Polycationic compositions for cellular delivery of polynucleotides
|
AR038568A1
(es)
|
2002-02-20 |
2005-01-19 |
Hoffmann La Roche |
Anticuerpos anti-a beta y su uso
|
US7354742B2
(en)
|
2002-02-22 |
2008-04-08 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method for generating amplified RNA
|
WO2003102166A2
(en)
|
2002-02-26 |
2003-12-11 |
Maxygen, Inc. |
Novel flavivirus antigens
|
DK1487856T3
(da)
|
2002-03-04 |
2010-10-18 |
Imclone Llc |
KDR-specifikke humane antistoffer og deres anvendelse
|
EP1487857A4
(en)
*
|
2002-03-07 |
2006-08-09 |
Ludwig Inst Cancer Res |
BLOOD AND LYMPHATIC ENDOTHELIAL CELL GENES
|
EP1485070A1
(en)
|
2002-03-13 |
2004-12-15 |
Novartis AG |
Pharmaceutical microparticles
|
EP1487999B1
(en)
|
2002-03-15 |
2006-12-27 |
Epigenomics AG |
Discovery and diagnostic methods using 5-methylcytosine dna glycosylase
|
US7074596B2
(en)
|
2002-03-25 |
2006-07-11 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Synthesis and use of anti-reverse mRNA cap analogues
|
IL164376A0
(en)
*
|
2002-04-03 |
2005-12-18 |
Applied Research Systems |
Ox4or binding agents, their preparation and pharmaceutical compositions containing them
|
US8153141B2
(en)
|
2002-04-04 |
2012-04-10 |
Coley Pharmaceutical Gmbh |
Immunostimulatory G, U-containing oligoribonucleotides
|
EP1494714A4
(en)
*
|
2002-04-05 |
2008-03-05 |
Amgen Inc |
HUMAN ANTI-OPGL NEUTRALIZING ANTIBODIES AS SELECTIVE OPGL PATH HEMMER
|
AU2003226820A1
(en)
|
2002-04-17 |
2003-10-27 |
Novartis Ag |
Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein
|
GB0209539D0
(en)
|
2002-04-26 |
2002-06-05 |
Avecia Ltd |
Monomer Polymer and process
|
EP1361277A1
(en)
|
2002-04-30 |
2003-11-12 |
Centre National De La Recherche Scientifique (Cnrs) |
Optimization of transgene expression in mammalian cells
|
AU2003217531A1
(en)
|
2002-05-02 |
2003-11-17 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
PL224150B1
(pl)
|
2002-05-02 |
2016-11-30 |
Wyeth Corp |
Kompozycja zawierająca koniugat leku obejmujący pochodne kalicheamycyny i przeciwciało, oraz kompozycja farmaceutyczna ją zawierająca
|
US20040018525A1
(en)
|
2002-05-21 |
2004-01-29 |
Bayer Aktiengesellschaft |
Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasma
|
US7374930B2
(en)
|
2002-05-21 |
2008-05-20 |
Expression Genetics, Inc. |
GLP-1 gene delivery for the treatment of type 2 diabetes
|
DE10224200C1
(de)
|
2002-05-31 |
2003-08-21 |
Artus Ges Fuer Molekularbiolog |
Vermehrung von Ribonukleinsäuren
|
US7198899B2
(en)
|
2002-06-03 |
2007-04-03 |
Chiron Corporation |
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
|
SE0201907D0
(sv)
|
2002-06-19 |
2002-06-19 |
Atos Medical Ab |
Plaster for tracheostoma valves
|
ATE432347T1
(de)
|
2002-06-24 |
2009-06-15 |
Exiqon As |
Methoden und systeme zur detektion und isolation von nucleinsäuresequenzen
|
DK1519714T3
(da)
|
2002-06-28 |
2011-01-31 |
Protiva Biotherapeutics Inc |
Fremgangsmåde og apparat til fremstilling af liposomer
|
WO2004003176A2
(en)
|
2002-07-01 |
2004-01-08 |
The Kenneth S. Warren Institute, Inc. |
Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
|
DE10229872A1
(de)
|
2002-07-03 |
2004-01-29 |
Curevac Gmbh |
Immunstimulation durch chemisch modifizierte RNA
|
GB0215509D0
(en)
|
2002-07-04 |
2002-08-14 |
Novartis Ag |
Marker genes
|
US7316925B2
(en)
|
2002-07-16 |
2008-01-08 |
Vgx Pharmaceuticals, Inc. |
Codon optimized synthetic plasmids
|
CA2493808A1
(en)
|
2002-07-24 |
2004-01-29 |
Ptc Therapeutics, Inc. |
Methods for identifying small molecules that modulate premature translation termination and nonsense mediated mrna decay
|
EP1393745A1
(en)
|
2002-07-29 |
2004-03-03 |
Hybridon, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5'ends
|
US6653468B1
(en)
|
2002-07-31 |
2003-11-25 |
Isis Pharmaceuticals, Inc. |
Universal support media for synthesis of oligomeric compounds
|
EP1386925A1
(en)
|
2002-07-31 |
2004-02-04 |
Girindus AG |
Method for preparing oligonucleotides
|
AU2003264041A1
(en)
|
2002-08-09 |
2004-02-25 |
California Institute Of Technology |
Method and compositions relating to 5'-chimeric ribonucleic acids
|
EP1873180B1
(en)
|
2002-08-14 |
2014-05-07 |
Novartis AG |
Ophthalmic device made from a radiation-curable prepolymer
|
CN104383554B
(zh)
|
2002-09-06 |
2018-06-08 |
天蓝制药公司 |
用于传递治疗剂的以环糊精为基础的聚合物
|
CA2497980C
(en)
|
2002-09-09 |
2011-06-21 |
Nektar Therapeutics Al, Corporation |
Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
|
US7534872B2
(en)
|
2002-09-27 |
2009-05-19 |
Syngen, Inc. |
Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis
|
KR20100050587A
(ko)
|
2002-10-17 |
2010-05-13 |
젠맵 에이/에스 |
Cd20에 대한 인간 모노클로날 항체
|
EP1795595A1
(en)
|
2002-10-22 |
2007-06-13 |
Eisai R&D Management Co., Ltd. |
Gene specifically expressed in postmitotic dopaminergic neuron precursor cells
|
AU2003291726A1
(en)
|
2002-11-04 |
2004-06-07 |
Xenoport, Inc. |
Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
|
WO2004048596A2
(en)
|
2002-11-21 |
2004-06-10 |
Epicentre Technologies |
Methods for using primers that encode one strand of a double-stranded promoter
|
US7491234B2
(en)
|
2002-12-03 |
2009-02-17 |
Boston Scientific Scimed, Inc. |
Medical devices for delivery of therapeutic agents
|
JP4351674B2
(ja)
|
2002-12-16 |
2009-10-28 |
ジェネンテック・インコーポレーテッド |
免疫グロブリン変異体とその使用法およびその使用
|
JP2006516099A
(ja)
|
2002-12-23 |
2006-06-22 |
ダイナバックス テクノロジーズ コーポレイション |
分枝状の免疫調節化合物及び該化合物の使用方法
|
US7169892B2
(en)
|
2003-01-10 |
2007-01-30 |
Astellas Pharma Inc. |
Lipid-peptide-polymer conjugates for long blood circulation and tumor specific drug delivery systems
|
MXPA05007652A
(es)
*
|
2003-01-16 |
2006-02-22 |
Hybridon Inc |
Modulacion de propiedades inmunoestimulantes de compuestos basados en oligonucleotido mediante la utilizacion de dinucleotidos inmunoestimulantes modificados.
|
US20080227085A1
(en)
|
2003-01-17 |
2008-09-18 |
Pellegrini Matthew C |
Methods and Systems for the Identification of Rna Regulatory Sequences and Compounds that Modulate their Function
|
EP2500437B1
(en)
|
2003-01-21 |
2016-11-30 |
PTC Therapeutics, Inc. |
Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same
|
US9068234B2
(en)
|
2003-01-21 |
2015-06-30 |
Ptc Therapeutics, Inc. |
Methods and agents for screening for compounds capable of modulating gene expression
|
US8426194B2
(en)
|
2003-01-21 |
2013-04-23 |
Ptc Therapeutics, Inc. |
Methods and agents for screening for compounds capable of modulating VEGF expression
|
US20040147027A1
(en)
|
2003-01-28 |
2004-07-29 |
Troy Carol M. |
Complex for facilitating delivery of dsRNA into a cell and uses thereof
|
CN1771053B
(zh)
|
2003-02-10 |
2012-10-03 |
伊兰药品公司 |
免疫球蛋白制剂及其制备方法
|
US20040167090A1
(en)
|
2003-02-21 |
2004-08-26 |
Monahan Sean D. |
Covalent modification of RNA for in vitro and in vivo delivery
|
US7091185B2
(en)
|
2003-02-24 |
2006-08-15 |
Dow Global Technologies Inc. |
Periodic antimicrobial peptides
|
EP1599584B1
(en)
*
|
2003-02-27 |
2009-07-01 |
Basf Se |
Modified nitrilases and their use in methods for the production of carboxylic acids
|
CA2450289A1
(en)
|
2003-03-20 |
2005-05-19 |
Imclone Systems Incorporated |
Method of producing an antibody to epidermal growth factor receptor
|
US7320961B2
(en)
|
2003-03-24 |
2008-01-22 |
Abbott Laboratories |
Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate
|
AU2004225520A1
(en)
|
2003-03-25 |
2004-10-14 |
Stratagene |
DNA polymerase fusions and uses thereof
|
WO2004092329A2
(en)
|
2003-04-08 |
2004-10-28 |
Galenica Pharmaceuticals, Inc. |
Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines
|
RS51686B
(sr)
|
2003-04-09 |
2011-10-31 |
Genentech Inc. |
Lečenje autoimune bolesti kod pacijenata sa neadekvatnim odgovorom na tnf-alfa inhibitor
|
EP1625138A4
(en)
|
2003-04-17 |
2010-06-23 |
Alnylam Pharmaceuticals Inc |
PROTECTED MONOMERS
|
KR101180896B1
(ko)
|
2003-05-05 |
2012-09-07 |
벤-구리온 유니버시티 오브 더 네게브 리서치 앤드 디벨럽먼트 어쏘러티 |
주사용 가교결합된 폴리머 제제 및 그의 용도
|
US7348004B2
(en)
|
2003-05-06 |
2008-03-25 |
Syntonix Pharmaceuticals, Inc. |
Immunoglobulin chimeric monomer-dimer hybrids
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
DK2298347T3
(en)
|
2003-05-06 |
2016-01-11 |
Biogen Hemophilia Inc |
COAGULATION FACTOR CHEMICAL PROTEINS FOR TREATING A HEMOSTATIC DISORDER
|
US9567591B2
(en)
|
2003-05-15 |
2017-02-14 |
Mello Biotechnology, Inc. |
Generation of human embryonic stem-like cells using intronic RNA
|
GB0313132D0
(en)
|
2003-06-06 |
2003-07-09 |
Ich Productions Ltd |
Peptide ligands
|
KR20060054196A
(ko)
*
|
2003-06-10 |
2006-05-22 |
주식회사 툴젠 |
전달가능한 dna-결합 단백질
|
EP1636385A4
(en)
|
2003-06-24 |
2010-06-02 |
Mirus Bio Corp |
INHIBITION OF GENE FUNCTION BY IN VIVO DISTRIBUTION OF GENE EXPRESSION INHIBITORS BASED ON POLYNUCLEOTIDES IN MAMMALIAN CELLS
|
GB0316089D0
(en)
|
2003-07-09 |
2003-08-13 |
Xo Bioscience Ltd |
Differentiation method
|
KR100992646B1
(ko)
|
2003-07-09 |
2010-11-05 |
제이에스알 가부시끼가이샤 |
파장판
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
US7575572B2
(en)
|
2003-07-15 |
2009-08-18 |
Spinal Generations, Llc |
Method and device for delivering medicine to bone
|
US20050013870A1
(en)
|
2003-07-17 |
2005-01-20 |
Toby Freyman |
Decellularized extracellular matrix of conditioned body tissues and uses thereof
|
KR20110129988A
(ko)
|
2003-07-18 |
2011-12-02 |
암젠 인코포레이티드 |
간세포 성장인자에 결합하는 특이 결합제
|
DE10334371A1
(de)
|
2003-07-25 |
2005-02-17 |
Bavarian Nordic A/S |
Reaktorboden eines Reaktors
|
US7683036B2
(en)
|
2003-07-31 |
2010-03-23 |
Regulus Therapeutics Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
|
DE10335833A1
(de)
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
CL2004001996A1
(es)
|
2003-08-08 |
2005-05-06 |
Eyetech Pharmaceuticals Inc |
Aptameros anti-vegf (factor de crecimiento endotelial vascular) con bloqueo nucleotidico 5'-5' o 3'-3' invertido, composicion que lo contiene, util para trastornos de neovascularizacion.
|
US8668926B1
(en)
|
2003-09-15 |
2014-03-11 |
Shaker A. Mousa |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
|
US7135010B2
(en)
|
2003-09-30 |
2006-11-14 |
Damage Control Surgical Technologies, Inc. |
Method and apparatus for rapid deployment chest drainage
|
ATE515577T1
(de)
|
2003-10-06 |
2011-07-15 |
Novartis Pharma Gmbh |
Verwendung von mit der wirksamkeit der behandlung einer entzündungskrankheit assoziierten genetischen polymorphismen
|
US20050130201A1
(en)
|
2003-10-14 |
2005-06-16 |
Dharmacon, Inc. |
Splint-assisted enzymatic synthesis of polyribounucleotides
|
DE10347710B4
(de)
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
WO2005044859A2
(en)
|
2003-11-05 |
2005-05-19 |
Glycart Biotechnology Ag |
Cd20 antibodies with increased fc receptor binding affinity and effector function
|
WO2005047536A2
(en)
|
2003-11-13 |
2005-05-26 |
Novartis Ag |
Detection of genomic amplification and deletion in cancer
|
US20070054278A1
(en)
|
2003-11-18 |
2007-03-08 |
Applera Corporation |
Polymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof
|
US7699852B2
(en)
|
2003-11-19 |
2010-04-20 |
Zimmer Spine, Inc. |
Fenestrated bone tap and method
|
US20050153333A1
(en)
|
2003-12-02 |
2005-07-14 |
Sooknanan Roy R. |
Selective terminal tagging of nucleic acids
|
WO2007062495A1
(en)
|
2005-11-30 |
2007-06-07 |
Roy Rabindranauth Sooknanan |
Selective terminal tagging of nucleic acids
|
EP1691746B1
(en)
|
2003-12-08 |
2015-05-27 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
US7674884B2
(en)
|
2003-12-10 |
2010-03-09 |
Novimmune S.A. |
Neutralizing antibodies and methods of use thereof
|
JP2005179268A
(ja)
|
2003-12-19 |
2005-07-07 |
Gc Corp |
口腔用組成物
|
WO2005062854A2
(en)
|
2003-12-19 |
2005-07-14 |
University Of Cincinnati |
Polyamides for nucleic acid delivery
|
SG10201404273QA
(en)
|
2003-12-23 |
2014-10-30 |
Genentech Inc |
Novel anti-il 13 antibodies and uses thereof
|
US20050143336A1
(en)
*
|
2003-12-30 |
2005-06-30 |
Board Of Regents, The University Of Texas System |
Methods and compositions for improved non-viral gene therapy
|
WO2005072710A2
(en)
|
2004-01-28 |
2005-08-11 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
DK1716233T3
(da)
|
2004-01-30 |
2009-10-26 |
Maxygen Holdings Ltd |
Reguleret stopkodongennemlæsning
|
US7309487B2
(en)
*
|
2004-02-09 |
2007-12-18 |
George Inana |
Methods and compositions for detecting and treating retinal diseases
|
JP4805848B2
(ja)
|
2004-02-12 |
2011-11-02 |
モルフォテック、インク. |
腫瘍抗原の生物活性を特異的に阻止するモノクローナル抗体
|
US20070265220A1
(en)
|
2004-03-15 |
2007-11-15 |
City Of Hope |
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
|
EP3269738A1
(en)
|
2004-03-24 |
2018-01-17 |
Chugai Seiyaku Kabushiki Kaisha |
Subtypes of humanized antibody against interleukin-6 receptor
|
WO2005098433A2
(en)
|
2004-04-01 |
2005-10-20 |
Novartis Ag |
Diagnostic assays for alzheimer’s disease
|
AU2005329255B2
(en)
|
2004-04-15 |
2010-09-30 |
Chiasma, Inc. |
Compositions capable of facilitating penetration across a biological barrier
|
EP1740946B1
(en)
|
2004-04-20 |
2013-11-06 |
Genmab A/S |
Human monoclonal antibodies against cd20
|
ES2246694B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
US20080119645A1
(en)
|
2004-05-05 |
2008-05-22 |
Isis Pharmaceuticals, Inc. |
Amidites and Methods of Rna Synthesis
|
EP2072040B1
(en)
|
2004-05-12 |
2013-05-01 |
Baxter International Inc. |
Therapeutic use of nucleic acid micropheres
|
US20080103053A1
(en)
|
2005-11-22 |
2008-05-01 |
Helicos Biosciences Corporation |
Methods and compositions for sequencing a nucleic acid
|
CA2568772A1
(en)
|
2004-06-01 |
2005-12-15 |
San Diego State University Foundation |
Expression system based on recombinant vesicular stomatitis virus synthesizing t7 rna polymerase
|
CN101133157A
(zh)
*
|
2004-06-03 |
2008-02-27 |
阿什洛米克斯控股有限公司 |
诊断应激的药物和方法
|
AU2005251403B2
(en)
|
2004-06-07 |
2011-09-01 |
Arbutus Biopharma Corporation |
Cationic lipids and methods of use
|
CA2569664C
(en)
|
2004-06-07 |
2013-07-16 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering rna
|
JP2008502739A
(ja)
|
2004-06-11 |
2008-01-31 |
トラスティーズ オブ タフツ カレッジ |
絹に基づく薬物送達システム
|
US7527947B2
(en)
|
2004-06-14 |
2009-05-05 |
Novozymes A/S |
Signal peptide for producing a polypeptide
|
WO2006046978A2
(en)
|
2004-06-28 |
2006-05-04 |
Argos Therapeutics, Inc. |
Cationic peptide-mediated transformation
|
AU2005260763B2
(en)
|
2004-06-30 |
2011-12-22 |
Nektar Therapeutics |
Polymer-factor IX moiety conjugates
|
US7700555B2
(en)
|
2004-07-15 |
2010-04-20 |
Joslin Diabetes Center, Inc. |
Methods of treating diabetes
|
DE102004035227A1
(de)
|
2004-07-21 |
2006-02-16 |
Curevac Gmbh |
mRNA-Gemisch zur Vakzinierung gegen Tumorerkrankungen
|
CA2574088C
(en)
|
2004-07-21 |
2013-09-17 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a modified or non-natural nucleobase
|
US7603349B1
(en)
|
2004-07-29 |
2009-10-13 |
Yahoo! Inc. |
User interfaces for search systems using in-line contextual queries
|
GB0417487D0
(en)
|
2004-08-05 |
2004-09-08 |
Novartis Ag |
Organic compound
|
US7291208B2
(en)
|
2004-08-13 |
2007-11-06 |
Gore Enterprise Holdings, Inc. |
Grooved active and passive adsorbent filters
|
CN102078622A
(zh)
|
2004-08-13 |
2011-06-01 |
巴里.J.马沙尔 |
细菌递送系统
|
SE0402025D0
(sv)
|
2004-08-13 |
2004-08-13 |
Active Biotech Ab |
Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
|
CA2478458A1
(en)
|
2004-08-20 |
2006-02-20 |
Michael Panzara |
Treatment of pediatric multiple sclerosis
|
AU2005276145C1
(en)
|
2004-08-26 |
2011-01-06 |
Engeneic Molecular Delivery Pty Ltd |
Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
|
US7348391B2
(en)
*
|
2004-09-02 |
2008-03-25 |
Isis Pharmaceuticals, Inc. |
Polymeric beads for oligomer synthesis
|
DE102004042546A1
(de)
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
US7501486B2
(en)
|
2004-09-07 |
2009-03-10 |
Burnham Institute For Medical Research |
Peptides that selectively home to heart vasculature and related conjugates and methods
|
JP2008513513A
(ja)
*
|
2004-09-21 |
2008-05-01 |
アネシヴァ, インコーポレイテッド |
ポリヌクレオチドの送達
|
GB0421639D0
(en)
|
2004-09-29 |
2004-10-27 |
Proteome Sciences Plc |
Methods and compositions relating to alzheimer's disease
|
US8663599B1
(en)
|
2004-10-05 |
2014-03-04 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
WO2006041088A1
(ja)
|
2004-10-12 |
2006-04-20 |
Tissue Targeting Japan Inc. |
脳移行性骨髄前駆細胞
|
US9611230B2
(en)
|
2004-10-13 |
2017-04-04 |
Ptc Therapeutics, Inc. |
1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
|
US8057821B2
(en)
|
2004-11-03 |
2011-11-15 |
Egen, Inc. |
Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
|
US20080261905A1
(en)
|
2004-11-08 |
2008-10-23 |
K.U. Leuven Research And Development |
Modified Nucleosides for Rna Interference
|
MX2007006179A
(es)
|
2004-11-23 |
2007-06-20 |
Ptc Therapeutics Inc |
Tetrahidrocarbazoles como agentes activos para inhibir la produccion del factor de crecimiento endotelial vascular por control de la traduccion.
|
US7964571B2
(en)
|
2004-12-09 |
2011-06-21 |
Egen, Inc. |
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
|
EP1856179B1
(en)
|
2004-12-10 |
2013-05-15 |
Kala Pharmaceuticals, Inc. |
Functionalized poly (ether-anhydride) block copolymers
|
US9068969B2
(en)
|
2004-12-28 |
2015-06-30 |
Ptc Therapeutics, Inc. |
Cell based methods and systems for the identification of RNA regulatory sequences and compounds that modulate their functions
|
US8187570B1
(en)
|
2005-01-04 |
2012-05-29 |
Gp Medical, Inc. |
Nanoparticles for protein drug delivery
|
US8192718B1
(en)
|
2005-01-04 |
2012-06-05 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
US7655762B2
(en)
*
|
2005-01-07 |
2010-02-02 |
Lexicon Pharmaceuticals, Inc. |
Monoclonal antibodies against ANGPTL4
|
US8535702B2
(en)
|
2005-02-01 |
2013-09-17 |
Boston Scientific Scimed, Inc. |
Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
EP2290363B1
(en)
|
2005-03-11 |
2014-01-08 |
Firalis SAS |
Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
|
US20060257902A1
(en)
*
|
2005-03-25 |
2006-11-16 |
Ambion, Inc. |
Methods and compositions for depleting abundant RNA transcripts
|
US8415325B2
(en)
|
2005-03-31 |
2013-04-09 |
University Of Delaware |
Cell-mediated delivery and targeted erosion of noncovalently crosslinked hydrogels
|
JP4390845B2
(ja)
|
2005-04-01 |
2009-12-24 |
インテザイン テクノロジーズ, インコーポレイテッド |
薬物送達のためのポリマーミセル
|
EP2062591A1
(en)
|
2005-04-07 |
2009-05-27 |
Novartis Vaccines and Diagnostics, Inc. |
CACNA1E in cancer diagnosis detection and treatment
|
EP2083088A3
(en)
|
2005-04-07 |
2009-10-14 |
Novartis Vaccines and Diagnostics, Inc. |
Cancer-related genes
|
WO2006110776A2
(en)
|
2005-04-12 |
2006-10-19 |
Nektar Therapeutics Al, Corporation |
Polyethylene glycol cojugates of antimicrobial agents
|
AU2006241149A1
(en)
|
2005-04-26 |
2006-11-02 |
Coley Pharmaceutical Gmbh |
Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
|
CN109485727A
(zh)
|
2005-05-09 |
2019-03-19 |
小野药品工业株式会社 |
程序性死亡-1(pd-1)的人单克隆抗体及使用抗pd-1抗体来治疗癌症的方法
|
US8246995B2
(en)
|
2005-05-10 |
2012-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
|
US20070072175A1
(en)
*
|
2005-05-13 |
2007-03-29 |
Biogen Idec Ma Inc. |
Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
|
US20060265771A1
(en)
|
2005-05-17 |
2006-11-23 |
Lewis David L |
Monitoring microrna expression and function
|
DE102005023170A1
(de)
|
2005-05-19 |
2006-11-23 |
Curevac Gmbh |
Optimierte Formulierung für mRNA
|
ES2564823T3
(es)
*
|
2005-05-27 |
2016-03-29 |
Ospedale San Raffaele S.R.L. |
Vector génico que comprende miARN
|
US20090208500A1
(en)
|
2005-06-03 |
2009-08-20 |
Genentech, Inc. |
Method of producing antibodies with improved function
|
US7550264B2
(en)
|
2005-06-10 |
2009-06-23 |
Datascope Investment Corporation |
Methods and kits for sense RNA synthesis
|
EP1896082B1
(en)
|
2005-06-16 |
2012-12-26 |
Nektar Therapeutics |
Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
|
US8202835B2
(en)
|
2005-06-17 |
2012-06-19 |
Yitzchak Hillman |
Disease treatment via antimicrobial peptides or their inhibitors
|
EP1904932A4
(en)
|
2005-06-17 |
2013-02-27 |
Univ North Carolina |
METHODS, SYSTEMS AND MATERIALS FOR MANUFACTURING NANOPARTICLES
|
US8101385B2
(en)
|
2005-06-30 |
2012-01-24 |
Archemix Corp. |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
CA2613442C
(en)
|
2005-06-30 |
2016-08-23 |
Archemix Corp. |
Materials and methods for the generation of fully 2'-modified nucleic acid transcripts
|
US20080220471A1
(en)
|
2005-07-27 |
2008-09-11 |
Genentech, Inc. |
Vectors and Methods Using Same
|
CA2618681C
(en)
|
2005-08-10 |
2015-10-27 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant fc regions and methods of using same
|
US9012219B2
(en)
|
2005-08-23 |
2015-04-21 |
The Trustees Of The University Of Pennsylvania |
RNA preparations comprising purified modified RNA for reprogramming cells
|
EP4174179A3
(en)
|
2005-08-23 |
2023-09-27 |
The Trustees of the University of Pennsylvania |
Rna containing modified nucleosides and methods of use thereof
|
US20070048741A1
(en)
|
2005-08-24 |
2007-03-01 |
Getts Robert C |
Methods and kits for sense RNA synthesis
|
US8715677B2
(en)
|
2005-09-01 |
2014-05-06 |
Celgene Corporation |
Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapy
|
JP5135220B2
(ja)
|
2005-09-01 |
2013-02-06 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー |
血清群c髄膜炎菌を含む複数ワクチン接種
|
US8420605B2
(en)
|
2005-09-07 |
2013-04-16 |
The University Of Strathclyde |
Hydrogel compositions
|
US20120021042A1
(en)
|
2005-09-15 |
2012-01-26 |
Steffen Panzner |
Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances
|
DE102005046490A1
(de)
|
2005-09-28 |
2007-03-29 |
Johannes-Gutenberg-Universität Mainz |
Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
|
US20070087437A1
(en)
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
DK1951299T3
(da)
|
2005-11-04 |
2012-04-02 |
Novartis Vaccines & Diagnostic |
Influenzavacciner indeholdende kombinationer af partikelformige adjuvanser og immunforstærkere
|
US20070105124A1
(en)
|
2005-11-08 |
2007-05-10 |
Getts Robert C |
Methods and kits for nucleic acid amplification
|
EP1960538A2
(en)
|
2005-11-18 |
2008-08-27 |
Bioline Limited |
A method for enhancing enzymatic dna polymerase reactions
|
JP5525729B2
(ja)
|
2005-11-28 |
2014-06-18 |
ゲンマブ エー/エス |
組換え一価抗体およびその作製方法
|
TWI389709B
(zh)
|
2005-12-01 |
2013-03-21 |
Novartis Ag |
經皮治療系統
|
US8603457B2
(en)
|
2005-12-02 |
2013-12-10 |
University Of Rochester |
Nonsense suppression and genetic codon alteration by targeted modification
|
JP5806444B2
(ja)
|
2005-12-02 |
2015-11-10 |
ノバルティス アーゲー |
免疫原性組成物で使用するためのナノ粒子
|
US8242081B2
(en)
|
2005-12-06 |
2012-08-14 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
US7579318B2
(en)
|
2005-12-06 |
2009-08-25 |
Centre De La Recherche De La Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
RU2008127252A
(ru)
|
2005-12-08 |
2010-01-20 |
Новартис АГ (CH) |
Эффекты ингибиторов fgfr3 на транскрипцию генов
|
EP1795599A1
(en)
|
2005-12-09 |
2007-06-13 |
Schuler, Gerold, Prof. Dr. |
Methods for generating antigen-specific effector T cells
|
EP2206724A1
(en)
|
2005-12-13 |
2010-07-14 |
Kyoto University |
Nuclear reprogramming factor
|
AU2006325030B2
(en)
|
2005-12-16 |
2012-07-26 |
Cellectis |
Cell penetrating peptide conjugates for delivering nucleic acids into cells
|
WO2007082304A2
(en)
|
2006-01-12 |
2007-07-19 |
Massachusetts Institute Of Technology |
Biodegradable elastomers
|
WO2007087178A2
(en)
|
2006-01-13 |
2007-08-02 |
The Trustees Of The University Of Pennsylvania |
Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same
|
PT1981902E
(pt)
|
2006-01-27 |
2015-11-02 |
Biogen Ma Inc |
Antagonistas dos recetores nogo
|
DK2314594T3
(da)
|
2006-01-27 |
2014-10-27 |
Isis Pharmaceuticals Inc |
6-modificerede bicykliske nukleinsyreanaloger
|
US20070178103A1
(en)
|
2006-01-30 |
2007-08-02 |
Fey Georg H |
CD19-specific immunotoxin and treatment method
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
DE102006007433A1
(de)
|
2006-02-17 |
2007-08-23 |
Curevac Gmbh |
Adjuvanz in Form einer Lipid-modifizierten Nukleinsäure
|
JP5295785B2
(ja)
|
2006-02-20 |
2013-09-18 |
エファ・ユニバーシティ・インダストリー・コラボレイション・ファウンデイション |
細胞膜透過性ペプチド
|
EP2319542B1
(en)
|
2006-02-21 |
2018-03-21 |
Nektar Therapeutics |
Segmented degradable polymers and conjugates made therefrom
|
JP2009527572A
(ja)
|
2006-02-24 |
2009-07-30 |
ノバルティス アーゲー |
免疫原性組成物に使用するための生分解性ポリマーおよびカチオン性多糖を含むミクロ粒子
|
WO2007100789A2
(en)
*
|
2006-02-24 |
2007-09-07 |
Wyeth |
Gpat3 encodes a mammalian, microsomal acyl-coa:glycerol 3-phosphate acyltransferase
|
US7910152B2
(en)
|
2006-02-28 |
2011-03-22 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
|
EP1988921A4
(en)
|
2006-02-28 |
2010-02-10 |
Elan Pharm Inc |
METHOD FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES WITH NATALIZUMAB
|
GB0605217D0
(en)
|
2006-03-15 |
2006-04-26 |
Novartis Ag |
Method and compositions for assessing acute rejection
|
US8231907B2
(en)
|
2006-03-21 |
2012-07-31 |
Morehouse School Of Medicine |
Nanoparticles for delivery of active agents
|
ES2776100T3
(es)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
US8257685B2
(en)
|
2006-04-04 |
2012-09-04 |
Stc.Unm |
Swellable particles for drug delivery
|
AU2007238624B2
(en)
|
2006-04-14 |
2012-05-31 |
Cellscript, Llc |
Kits and methods for generating 5' capped RNA
|
WO2007118939A1
(fr)
|
2006-04-19 |
2007-10-25 |
Arcelor France |
Procede de fabrication d'une piece soudee a tres hautes caracteristiques mecaniques a partir d'une tole laminee et revetue
|
EP1852127A1
(en)
|
2006-05-02 |
2007-11-07 |
Charité - Universitätsmedizin Berlin |
Use of a B-cell-depleting antibody for treatment of polyoma virus infections
|
CN101573141B
(zh)
|
2006-05-15 |
2016-05-04 |
麻省理工学院 |
用于功能性颗粒的聚合物
|
WO2007135172A2
(en)
|
2006-05-24 |
2007-11-29 |
Laboratoires Serono S.A. |
Cladribine regimen for treating multiple sclerosis
|
US9150626B2
(en)
|
2006-06-02 |
2015-10-06 |
President And Fellows Of Harvard College |
Protein surface remodeling
|
EP2038303A2
(en)
*
|
2006-06-21 |
2009-03-25 |
Genentech, Inc. |
Crystal structure of ox40l and ox40l complexed with ox40 receptor
|
JP5605895B2
(ja)
|
2006-07-04 |
2014-10-15 |
ゲンマブ エー/エス |
Copdを処置するためのcd20結合分子
|
EP2037899B1
(en)
|
2006-07-07 |
2011-03-30 |
Aarhus Universitet |
Nanoparticles for nucleic acid delivery
|
CA2655360C
(en)
|
2006-07-12 |
2014-09-16 |
Novartis Ag |
Actinically crosslinkable copolymers for manufacturing contact lenses
|
EP2051993A2
(en)
|
2006-07-20 |
2009-04-29 |
Novartis Ag |
Amigo-2 inhibitors for treating, diagnosing or detecting cancer
|
US8728527B2
(en)
|
2006-07-24 |
2014-05-20 |
Luminus Biosciences, Inc. |
Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
|
CA2659301A1
(en)
|
2006-07-28 |
2008-02-07 |
Applera Corporation |
Dinucleotide mrna cap analogs
|
JP2010507361A
(ja)
|
2006-07-31 |
2010-03-11 |
キュアバック ゲーエムベーハー |
具体的には免疫刺激剤/アジュバントとしての、一般式(I):GlXmGn、または一般式(II):ClXmCnで表される核酸
|
DE102006035618A1
(de)
|
2006-07-31 |
2008-02-07 |
Curevac Gmbh |
Nukleinsäure der Formel (I): GlXmGn, insbesondere als immunstimulierendes Adjuvanz
|
AU2007281677A1
(en)
|
2006-08-07 |
2008-02-14 |
Genzyme Corporation |
Combination therapy
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
AU2007286059A1
(en)
|
2006-08-18 |
2008-02-21 |
Mdrna, Inc. |
Dicer substrate RNA peptide conjugates and methods for RNA therapeutics
|
US8658211B2
(en)
|
2006-08-18 |
2014-02-25 |
Arrowhead Madison Inc. |
Polyconjugates for in vivo delivery of polynucleotides
|
CA2957056A1
(en)
|
2006-09-06 |
2008-03-13 |
C3 Jian, Inc. |
Selectively targeted antimicrobial peptides and the use thereof
|
AU2007293662B2
(en)
|
2006-09-07 |
2012-10-04 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
|
EP2061433B1
(en)
|
2006-09-08 |
2011-02-16 |
Johns Hopkins University |
Compositions for enhancing transport through mucus
|
US8454948B2
(en)
|
2006-09-14 |
2013-06-04 |
Medgenics Medical Israel Ltd. |
Long lasting drug formulations
|
GB0619182D0
(en)
|
2006-09-29 |
2006-11-08 |
Leuven K U Res & Dev |
Oligonucleotide arrays
|
MX363224B
(es)
|
2006-10-03 |
2019-03-15 |
Alnylam Pharmaceuticals Inc |
Formulaciones que contienen lipidos.
|
JP2010505877A
(ja)
|
2006-10-05 |
2010-02-25 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
スマートな高分子ナノ粒子を用いた低水溶性薬物用の水分散性経口、非経口および局所的製剤
|
GB0619816D0
(en)
*
|
2006-10-06 |
2006-11-15 |
Viragen Inc |
Novel interferon-alpha constructs for use in the treatment of cancer
|
DE102006051516A1
(de)
*
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
US8414927B2
(en)
|
2006-11-03 |
2013-04-09 |
Boston Scientific Scimed, Inc. |
Cross-linked polymer particles
|
EP2489360A1
(en)
|
2006-11-15 |
2012-08-22 |
Dana-Farber Cancer Institute, Inc. |
Stabilized MAML peptides and uses thereof
|
US7999087B2
(en)
|
2006-11-15 |
2011-08-16 |
Agilent Technologies, Inc. |
2′-silyl containing thiocarbonate protecting groups for RNA synthesis
|
US8242258B2
(en)
|
2006-12-03 |
2012-08-14 |
Agilent Technologies, Inc. |
Protecting groups for RNA synthesis
|
US8399007B2
(en)
|
2006-12-05 |
2013-03-19 |
Landec Corporation |
Method for formulating a controlled-release pharmaceutical formulation
|
US20110045022A1
(en)
|
2006-12-06 |
2011-02-24 |
Theodore Tsai |
Vaccines including antigen from four strains of influenza virus
|
US9034348B2
(en)
|
2006-12-11 |
2015-05-19 |
Chi2Gel Ltd. |
Injectable chitosan mixtures forming hydrogels
|
EA035911B1
(ru)
|
2006-12-18 |
2020-08-31 |
Акселерон Фарма Инк. |
Применение полипептида, который ингибирует опосредованный активином сигнальный путь, в качестве лекарственного средства
|
EP2104739B1
(en)
|
2006-12-21 |
2013-06-19 |
Novozymes Inc. |
Modified messenger rna stabilizing sequences for expressing genes in bacterial cells
|
US20100184659A1
(en)
|
2006-12-21 |
2010-07-22 |
Warren Jaworowicz |
Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents
|
CA2673029C
(en)
|
2006-12-22 |
2017-03-28 |
Archemix Corp. |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
DE102006061015A1
(de)
|
2006-12-22 |
2008-06-26 |
Curevac Gmbh |
Verfahren zur Reinigung von RNA im präparativen Maßstab mittels HPLC
|
US8338166B2
(en)
|
2007-01-04 |
2012-12-25 |
Lawrence Livermore National Security, Llc |
Sorting, amplification, detection, and identification of nucleic acid subsequences in a complex mixture
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
WO2008091799A2
(en)
|
2007-01-22 |
2008-07-31 |
The Trustees Of Columbia University In The City Of New York |
Cell-based methods for identifying inhibitors of parkinson's disease-associated lrrk2 mutants
|
EP2450371B1
(en)
|
2007-01-30 |
2015-04-29 |
Epivax, Inc. |
Regulatory t cell epitopes, compositions and uses thereof
|
US8859229B2
(en)
|
2007-02-02 |
2014-10-14 |
Yale University |
Transient transfection with RNA
|
TWI548647B
(zh)
|
2007-02-02 |
2016-09-11 |
艾瑟勒朗法瑪公司 |
衍生自ActRIIB的變體與其用途
|
WO2008096370A2
(en)
|
2007-02-05 |
2008-08-14 |
Natco Pharma Limited |
An efficient and novel purification method of recombinant hg-csf
|
US8333799B2
(en)
|
2007-02-12 |
2012-12-18 |
C. R. Bard, Inc. |
Highly flexible stent and method of manufacture
|
JP2010519203A
(ja)
|
2007-02-16 |
2010-06-03 |
メルク・シャープ・エンド・ドーム・コーポレイション |
生物活性分子の活性を強化するための組成物及び方法
|
WO2008104294A1
(en)
*
|
2007-02-27 |
2008-09-04 |
Bayer Schering Pharma Aktiengesellschaft |
Myh7 as a biomarker for ppara modulators
|
US8242087B2
(en)
|
2007-02-27 |
2012-08-14 |
K.U.Leuven Research & Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
ES2397274T3
(es)
|
2007-03-02 |
2013-03-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Mejora de la producción de proteínas
|
EP1964922A1
(en)
|
2007-03-02 |
2008-09-03 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Improvement of protein production
|
WO2008109712A2
(en)
|
2007-03-05 |
2008-09-12 |
Washington University |
Nanoparticle delivery systems for membrane-integrating peptides
|
JP2010521966A
(ja)
|
2007-03-20 |
2010-07-01 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
α4β7インテグリンに結合するヒト化免疫グロブリンをコードする核酸
|
PT2136788E
(pt)
|
2007-03-30 |
2012-02-03 |
Bind Biosciences Inc |
Direccionamento a células de cancro utilizando nanopartículas
|
MX2009011581A
(es)
|
2007-04-27 |
2010-02-17 |
Echo Therapeutics Inc |
Dispositivo de permeacion en la piel para deteccion de analito o suministro de farmaco transdermico.
|
JP2010526088A
(ja)
|
2007-04-30 |
2010-07-29 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
抗il−5抗体を投与するための方法
|
US8703204B2
(en)
|
2007-05-03 |
2014-04-22 |
Bend Research, Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
|
US7682789B2
(en)
|
2007-05-04 |
2010-03-23 |
Ventana Medical Systems, Inc. |
Method for quantifying biomolecules conjugated to a nanoparticle
|
EP2157982B1
(en)
|
2007-05-04 |
2014-12-17 |
Marina Biotech, Inc. |
Amino acid lipids and uses thereof
|
US8728491B2
(en)
|
2007-05-07 |
2014-05-20 |
Alba Therapeutics Corporation |
Transcutaneous delivery of therapeutic agents
|
JP5296328B2
(ja)
|
2007-05-09 |
2013-09-25 |
独立行政法人理化学研究所 |
1本鎖環状rnaおよびその製造方法
|
HUE028389T2
(en)
|
2007-05-10 |
2016-12-28 |
Agilent Technologies Inc |
For the synthesis of thiocarbons protecting groups RNSS
|
ES2558689T3
(es)
|
2007-05-14 |
2016-02-08 |
Medimmune, Llc |
Métodos para reducir los niveles de eosinófilos
|
WO2008144365A2
(en)
|
2007-05-17 |
2008-11-27 |
Novartis Ag |
Method for making dry powder compositions containing ds-rna based on supercritical fluid technology
|
CA2687850C
(en)
*
|
2007-05-22 |
2017-11-21 |
Mdrna, Inc. |
Oligomers for therapeutics
|
EA200901550A1
(ru)
|
2007-05-22 |
2010-10-29 |
Новартис Аг |
Способы лечения, диагностирования и выявления ассоциированных с fgf21 нарушений
|
CA2689923A1
(en)
|
2007-05-30 |
2008-12-11 |
Northwestern University |
Nucleic acid functionalized nanoparticles for therapeutic applications
|
US20100184051A1
(en)
|
2007-05-30 |
2010-07-22 |
The General Hospital Corporation |
Methods of generating pluripotent cells from somatic cells
|
AU2008265683B2
(en)
|
2007-06-19 |
2013-08-29 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Synthesis and use of anti-reverse phosphorothioate analogs of the messenger RNA cap
|
CA2707436C
(en)
|
2007-06-29 |
2014-01-28 |
Epicentre Technologies Corporation |
Copy dna and sense rna
|
US8367318B2
(en)
|
2007-07-23 |
2013-02-05 |
Dharmacon, Inc. |
Screening of micro-RNA cluster inhibitor pools
|
US20090042825A1
(en)
|
2007-08-06 |
2009-02-12 |
Majed Matar |
Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer
|
US9144546B2
(en)
|
2007-08-06 |
2015-09-29 |
Clsn Laboratories, Inc. |
Nucleic acid-lipopolymer compositions
|
EP2183390A1
(en)
|
2007-08-23 |
2010-05-12 |
Novartis Ag |
Methods for detecting oligonucleotides
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
KR101234436B1
(ko)
|
2007-09-05 |
2013-02-18 |
로슈 글리카트 아게 |
유형 ⅰ 및 유형 ⅱ 항-cd20 항체를 사용하는 병용 치료요법
|
US8506928B2
(en)
|
2007-09-07 |
2013-08-13 |
The Regents Of The University Of California |
Methods and compounds for targeting tissues
|
US20110086904A1
(en)
|
2007-09-17 |
2011-04-14 |
The Trustees Of The University Of Pennsylvania |
GENERATION OF HYPERSTABLE mRNAs
|
US8394763B2
(en)
|
2007-09-26 |
2013-03-12 |
Oregon Health & Science University |
Cyclic undecapeptides and derivatives as multiple sclerosis therapies
|
RU2524431C2
(ru)
|
2007-09-26 |
2014-07-27 |
Интрексон Корпорейшн |
Синтетические 5 utr (нетранслируемые области), экспрессионные векторы и способ повышения трансгенной экспрессии
|
EP2042193A1
(en)
|
2007-09-28 |
2009-04-01 |
Biomay AG |
RNA Vaccines
|
WO2009046388A1
(en)
|
2007-10-03 |
2009-04-09 |
United States Medical Research & Material Command |
Cr-2 binding peptide p28 as molecular adjuvant for dna vaccines
|
WO2009046739A1
(en)
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating prostate cancer (pca)
|
WO2009046738A1
(en)
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
|
CN105770878A
(zh)
|
2007-10-12 |
2016-07-20 |
麻省理工学院 |
疫苗纳米技术
|
US20090098118A1
(en)
|
2007-10-15 |
2009-04-16 |
Thomas Friess |
Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent
|
EP2217221B1
(en)
*
|
2007-10-17 |
2018-06-27 |
Korea Advanced Institute of Science and Technology |
Ldl-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same
|
GB0720486D0
(en)
*
|
2007-10-19 |
2007-11-28 |
Univ Edinburgh |
Cationic lipids
|
US20110091473A1
(en)
|
2007-10-22 |
2011-04-21 |
Genmab A/S |
Novel antibody therapies
|
WO2009058911A2
(en)
|
2007-10-31 |
2009-05-07 |
Applied Biosystems Inc. |
Preparation and isolation of 5' capped mrna
|
WO2009058446A1
(en)
|
2007-11-01 |
2009-05-07 |
University Of Rochester |
Recombinant factor viii having increased stability
|
AU2008323815B2
(en)
|
2007-11-09 |
2013-09-19 |
Novartis Ag |
Uses of anti-CD40 antibodies
|
US8470771B2
(en)
|
2007-11-14 |
2013-06-25 |
Institute Of Microbiology, Chinese Academy Of Sciences |
Method and medicament for inhibiting the infection of influenza virus
|
EP2277124B1
(en)
*
|
2007-11-21 |
2016-11-09 |
Medizinische Hochschule Hannover |
Means for treating myosin-related diseases
|
EP2615115A3
(en)
|
2007-11-30 |
2014-01-08 |
Glaxo Group Limited |
Antigen-binding constructs
|
EP2617828B1
(en)
|
2007-12-10 |
2014-09-24 |
Alnylam Pharmaceuticals Inc. |
Compositions and methods for inhibiting expression of factor VII gene
|
SG10201408165WA
(en)
|
2007-12-11 |
2015-01-29 |
Scripps Research Inst |
Compositions and methods related to mrna translational enhancer elements
|
EP2229459B1
(en)
|
2007-12-13 |
2014-08-27 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for prevention or treatment of RSV infection
|
EP2072618A1
(en)
|
2007-12-14 |
2009-06-24 |
Johannes Gutenberg-Universität Mainz |
Use of RNA for reprogramming somatic cells
|
EP2231183A2
(en)
|
2007-12-21 |
2010-09-29 |
Genentech, Inc. |
Therapy of rituximab-refractory rheumatoid arthritis patients
|
JP5645044B2
(ja)
|
2008-01-22 |
2014-12-24 |
独立行政法人医薬基盤研究所 |
遺伝子発現制御機構を含む新規Adベクター
|
KR20100120663A
(ko)
|
2008-01-23 |
2010-11-16 |
아지노모토 가부시키가이샤 |
L-아미노산의 제조법
|
EP2246422A4
(en)
|
2008-01-24 |
2012-07-25 |
Nat Inst Of Advanced Ind Scien |
POLYNUCLEOTIDE OR ITS ANALOGUE, AND METHOD OF REGULATING GENE EXPRESSION USING THE POLYNUCLEOTIDE OR ITS ANALOGUE
|
HUE025027T2
(en)
|
2008-01-31 |
2016-07-28 |
Curevac Gmbh |
(NuGiXmGnNv) nucleic acids and derivatives of the formula as immunostimulants / adjuvants
|
EP2250252A2
(en)
|
2008-02-11 |
2010-11-17 |
Cambridge Enterprise Limited |
Improved reprogramming of mammalian cells, and the cells obtained
|
US8343140B2
(en)
|
2008-02-13 |
2013-01-01 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
DE102008009920A1
(de)
|
2008-02-15 |
2009-08-20 |
Aj Innuscreen Gmbh |
Mobiles Gerät für die Nukleinsäureisolierung
|
US20120027813A1
(en)
|
2008-02-22 |
2012-02-02 |
Novartis Vaccines And Diagnostics Srl |
Adjuvanted influenza vaccines for pediatric use
|
US8506966B2
(en)
|
2008-02-22 |
2013-08-13 |
Novartis Ag |
Adjuvanted influenza vaccines for pediatric use
|
WO2009108891A2
(en)
|
2008-02-29 |
2009-09-03 |
Egen, Inc. |
Modified poloxamers for gene expression and associated methods
|
BRPI0822447A2
(pt)
|
2008-03-14 |
2015-06-16 |
Biocon Ltd |
Anticorpo monoclonal e método do mesmo
|
CA2717370A1
(en)
|
2008-03-14 |
2009-09-17 |
Egen, Inc. |
Biodegradable cross-linked branched poly (alkylene imines)
|
EA201071137A1
(ru)
|
2008-03-28 |
2011-04-29 |
ГЛЭКСОСМИТКЛАЙН ЭлЭлСи |
Способы лечения
|
NZ588583A
(en)
|
2008-04-15 |
2012-08-31 |
Protiva Biotherapeutics Inc |
Novel lipid formulations for nucleic acid delivery
|
WO2009127230A1
(en)
|
2008-04-16 |
2009-10-22 |
Curevac Gmbh |
MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
|
CA3013503A1
(en)
|
2008-04-25 |
2009-10-29 |
Northwestern University |
Nanostructures suitable for sequestering cholesterol and other molecules
|
US20110112040A1
(en)
|
2008-04-28 |
2011-05-12 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
AU2009241354B2
(en)
|
2008-04-30 |
2014-06-12 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Chimeric West Nile/Dengue viruses
|
US9394538B2
(en)
|
2008-05-07 |
2016-07-19 |
Shi-Lung Lin |
Development of universal cancer drugs and vaccines
|
CN102202708B
(zh)
|
2008-05-08 |
2015-01-21 |
迷你泵有限责任公司 |
药物输送泵及其制造方法
|
US8697098B2
(en)
|
2011-02-25 |
2014-04-15 |
South Dakota State University |
Polymer conjugated protein micelles
|
JP5911723B2
(ja)
|
2008-05-13 |
2016-04-27 |
ユニヴァーシティ オブ ワシントン |
細胞内に送達するためのジブロックコポリマーおよびそのポリヌクレオチド複合体
|
WO2009141146A1
(en)
|
2008-05-21 |
2009-11-26 |
Gunther Hartmann |
5' triphosphate oligonucleotide with blunt end and uses thereof
|
WO2009144230A1
(en)
|
2008-05-26 |
2009-12-03 |
Universität Zürich |
Protamine/rna nanoparticles for immunostimulation
|
FR2931824B1
(fr)
|
2008-05-29 |
2014-11-28 |
Centre Nat Rech Scient |
Procede de synthese d'arn par voie chimique.
|
JP2011520472A
(ja)
|
2008-05-29 |
2011-07-21 |
ハナル バイオファーマ カンパニー リミテッド |
増加されたタンパク質分解酵素抵抗性を表す修飾型エリスロポエチン(epo)ポリペプチド及びその医薬組成物
|
WO2009148528A2
(en)
*
|
2008-05-30 |
2009-12-10 |
Millennium Pharmaceuticals, Inc. |
Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment
|
ES2524699T3
(es)
|
2008-06-05 |
2014-12-11 |
Immunovaccine Technologies Inc. |
Composiciones que comprenden liposomas, un antígeno, un polinucleótido y un vehículo que comprende una fase continua de una sustancia hidrófoba
|
PL215513B1
(pl)
|
2008-06-06 |
2013-12-31 |
Univ Warszawski |
Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
MX2010014018A
(es)
|
2008-06-16 |
2011-06-21 |
Bind Biosciences Inc |
Nanopartículas poliméricas cargadas con fármaco y métodos de preparación y uso de las mismas.
|
HUE035770T2
(en)
|
2008-06-16 |
2018-05-28 |
Pfizer |
Process for the preparation of diblock copolymers functionalized with targeting material for use in the preparation of therapeutic nanoparticles
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
US8318211B2
(en)
|
2008-06-16 |
2012-11-27 |
Bind Biosciences, Inc. |
Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
|
US9347088B2
(en)
*
|
2008-06-27 |
2016-05-24 |
Institut Pasteur |
Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen
|
EP2320925B1
(en)
*
|
2008-07-10 |
2015-12-23 |
Regenesance B.V. |
Complement antagonists and uses thereof
|
US20100009424A1
(en)
|
2008-07-14 |
2010-01-14 |
Natasha Forde |
Sonoporation systems and methods
|
WO2010009065A2
(en)
|
2008-07-15 |
2010-01-21 |
Novartis Ag |
Amphipathic peptide compositions
|
EP2313085A2
(en)
|
2008-07-15 |
2011-04-27 |
Novartis AG |
Immunogenic amphipathic peptide compositions
|
CA2732229C
(en)
*
|
2008-07-25 |
2023-10-17 |
Alnylam Pharmaceuticals, Inc. |
Enhancement of sirna silencing activity using universal bases or mismatches in the sense strand
|
US20110224447A1
(en)
|
2008-08-18 |
2011-09-15 |
Bowman Keith A |
Novel Lipid Nanoparticles and Novel Components for Delivery of Nucleic Acids
|
PT2329020E
(pt)
*
|
2008-08-28 |
2013-06-20 |
Novartis Ag |
Apresentação na superfície celular de isoformas de polipéptidos através da transleitura de codões de terminação
|
EP2331561A4
(en)
|
2008-09-03 |
2013-02-27 |
Xenome Ltd |
PEPTIDE CONJUGATE LIBRARIES AND METHODS OF MAKING SAME
|
AU2009288632B2
(en)
|
2008-09-06 |
2015-08-13 |
Chemgenes Corporation |
RNA synthesis - phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3' - end
|
WO2010027903A2
(en)
|
2008-09-08 |
2010-03-11 |
Fred Hutchinson Cancer Research Center |
Lung cancer diagnosis
|
US20100087337A1
(en)
|
2008-09-10 |
2010-04-08 |
Bind Biosciences, Inc. |
High Throughput Fabrication of Nanoparticles
|
TW201438738A
(zh)
|
2008-09-16 |
2014-10-16 |
Genentech Inc |
治療進展型多發性硬化症之方法
|
WO2010033906A2
(en)
|
2008-09-19 |
2010-03-25 |
President And Fellows Of Harvard College |
Efficient induction of pluripotent stem cells using small molecule compounds
|
US8962580B2
(en)
*
|
2008-09-23 |
2015-02-24 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
WO2010042490A1
(en)
|
2008-10-06 |
2010-04-15 |
Boston Medical Center Corporation |
A single lentiviral vector system for induced pluripotent (ips) stem cells derivation
|
CN104119242B
(zh)
*
|
2008-10-09 |
2017-07-07 |
泰米拉制药公司 |
改善的氨基脂质和递送核酸的方法
|
US8535655B2
(en)
|
2008-10-10 |
2013-09-17 |
Polyactiva Pty Ltd. |
Biodegradable polymer—bioactive moiety conjugates
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
WO2010047765A2
(en)
|
2008-10-20 |
2010-04-29 |
Massachussetts Institute Of Technology |
Nanostructures for drug delivery
|
US20120015899A1
(en)
|
2008-10-25 |
2012-01-19 |
Plant Bioscience, Limited |
Modified plant virus particles and uses therefor
|
CN104910025B
(zh)
|
2008-11-07 |
2019-07-16 |
麻省理工学院 |
氨基醇类脂质和其用途
|
EP3699172A3
(en)
|
2008-11-10 |
2020-11-18 |
Arbutus Biopharma Corporation |
Novel lipids and compositions for the delivery of therapeutics
|
WO2010057203A2
(en)
|
2008-11-17 |
2010-05-20 |
The Board Of Regents Of The University Of Texas System |
Hdl particles for delivery of nucleic acids
|
KR101073875B1
(ko)
*
|
2008-11-28 |
2011-10-14 |
한국생명공학연구원 |
대장암 진단 마커 및 이를 이용한 대장암 진단방법
|
EP2191840A1
(en)
|
2008-11-28 |
2010-06-02 |
Sanofi-Aventis |
Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan
|
AU2009324534B2
(en)
|
2008-12-10 |
2015-07-30 |
Alnylam Pharmaceuticals, Inc. |
GNAQ targeted dsRNA compositions and methods for inhibiting expression
|
EP2196476A1
(en)
|
2008-12-10 |
2010-06-16 |
Novartis Ag |
Antibody formulation
|
US8512964B2
(en)
|
2008-12-12 |
2013-08-20 |
The Regents Of The University Of California |
Targets for treatment of hypercholesterolemia
|
US8563041B2
(en)
|
2008-12-12 |
2013-10-22 |
Bind Therapeutics, Inc. |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
WO2010075072A2
(en)
|
2008-12-15 |
2010-07-01 |
Bind Biosciences |
Long circulating nanoparticles for sustained release of therapeutic agents
|
WO2010080724A1
(en)
|
2009-01-12 |
2010-07-15 |
Merck Sharp & Dohme Corp. |
Novel lipid nanoparticles and novel components for delivery of nucleic acids
|
AU2010204666A1
(en)
|
2009-01-16 |
2011-07-21 |
Glaxosmithkline Llc |
Treatment of a cancer using a combination of bendamustine and an anti-CD20 antibody
|
WO2010084371A1
(en)
|
2009-01-26 |
2010-07-29 |
Mitoprod |
Novel circular interfering rna molecules
|
US20120101148A1
(en)
|
2009-01-29 |
2012-04-26 |
Alnylam Pharmaceuticals, Inc. |
lipid formulation
|
US8669085B2
(en)
|
2009-02-05 |
2014-03-11 |
Ut-Battelle, Llc |
Transformation of gram positive bacteria by sonoporation
|
WO2010088927A1
(en)
|
2009-02-09 |
2010-08-12 |
Curevac Gmbh |
Use of pei for the improvement of endosomal release and expression of transfected nucleic acids, complexed with cationic or polycationic compounds
|
US20140141089A1
(en)
|
2009-02-11 |
2014-05-22 |
Colorado School Of Mines |
Nanoparticles, Compositions Thereof, and Methods of Use, and Methods of Making the Same
|
CA2753362C
(en)
|
2009-02-24 |
2018-06-19 |
The Scripps Research Institute |
Reengineering mrna primary structure for enhanced protein production
|
WO2010141135A2
(en)
|
2009-03-05 |
2010-12-09 |
Trustees Of Boston University |
Bacteriophages expressing antimicrobial peptides and uses thereof
|
WO2010102065A1
(en)
|
2009-03-05 |
2010-09-10 |
Bend Research, Inc. |
Pharmaceutical compositions of dextran polymer derivatives
|
CN102348569B
(zh)
|
2009-03-12 |
2015-08-19 |
伊利诺斯工具制品有限公司 |
误加燃料禁止装置
|
EP2406379A4
(en)
|
2009-03-13 |
2012-09-26 |
Egen Inc |
COMPOSITIONS AND METHODS FOR RELEASING BIOLOGICALLY ACTIVE RNA
|
CN104922676B
(zh)
|
2009-03-20 |
2019-03-12 |
Clsn实验室股份有限公司 |
聚胺衍生物
|
WO2010111290A1
(en)
|
2009-03-23 |
2010-09-30 |
University Of Utah Research Foundation |
Methods and compositions related to modified guanine bases for controlling off-target effects in rna interference
|
EP2412020B1
(en)
|
2009-03-24 |
2020-09-30 |
University Of Chicago |
Slip chip device and methods
|
RU2541635C2
(ru)
|
2009-03-24 |
2015-02-20 |
Каунсел Оф Сайнтифик Энд Индастриал Рисерч |
Способ получения полимерной агарозы из экстракта морских водорослей
|
JP5622254B2
(ja)
|
2009-03-31 |
2014-11-12 |
国立大学法人東京大学 |
二本鎖リボ核酸ポリイオンコンプレックス
|
PL3281947T3
(pl)
|
2009-04-03 |
2020-07-27 |
The University Of Chicago |
Kompozycje i sposoby związane z wariantami białka A (SpA)
|
CN107252489A
(zh)
|
2009-04-13 |
2017-10-17 |
法国健康和医学研究院 |
Hpv颗粒及其用途
|
EP2419137A4
(en)
|
2009-04-17 |
2013-01-09 |
Biogen Idec Inc |
COMPOSITIONS AND METHOD FOR TREATING ACUTE MYELOGENIC LEUKEMIA
|
BRPI1011836A2
(pt)
|
2009-04-21 |
2017-05-16 |
Selecta Biosciences Inc |
imunonanoterapêuticos que fornecem uma resposta induzida por th1
|
WO2010123501A1
(en)
|
2009-04-22 |
2010-10-28 |
Massachusetts Institute Of Technology |
Innate immune suppression enables repeated delivery of long rna molecules
|
CA2993053A1
(en)
|
2009-04-27 |
2010-11-04 |
Novartis Ag |
Antagonistic activin receptor iib (actriib) antibodies for increasing muscle growth
|
US8715736B2
(en)
|
2009-04-30 |
2014-05-06 |
Florida Agricultural And Mechanical University |
Nanoparticle formulations for skin delivery
|
US8287910B2
(en)
|
2009-04-30 |
2012-10-16 |
Intezyne Technologies, Inc. |
Polymeric micelles for polynucleotide encapsulation
|
WO2010127029A1
(en)
|
2009-05-01 |
2010-11-04 |
Ophthotech Corporation |
Methods for treating or preventing ophthalmological diseases
|
KR20180094137A
(ko)
|
2009-05-05 |
2018-08-22 |
알닐람 파마슈티칼스 인코포레이티드 |
지질 조성물
|
DE202009007116U1
(de)
|
2009-05-18 |
2010-10-14 |
Amoena Medizin-Orthopädie-Technik GmbH |
Antidekubituskissen
|
EA022699B1
(ru)
|
2009-05-27 |
2016-02-29 |
Селекта Байосайенсиз, Инк. |
НАЦЕЛЕННЫЕ СИНТЕТИЧЕСКИЕ НАНОНОСИТЕЛИ С pH-ЧУВСТВИТЕЛЬНЫМ ВЫСВОБОЖДЕНИЕМ ИММУНОМОДУЛИРУЮЩИХ СРЕДСТВ
|
US8574835B2
(en)
|
2009-05-29 |
2013-11-05 |
Life Technologies Corporation |
Scaffolded nucleic acid polymer particles and methods of making and using
|
EP2440556A1
(en)
|
2009-06-10 |
2012-04-18 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of phosphatidylinositol 3-kinase
|
US8158601B2
(en)
|
2009-06-10 |
2012-04-17 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulation
|
US8765370B2
(en)
|
2009-06-11 |
2014-07-01 |
Scinopharm Taiwan, Ltd |
Inhibition-based high-throughput screen strategy for cell clones
|
NZ597504A
(en)
|
2009-06-15 |
2013-10-25 |
Alnylam Pharmaceuticals Inc |
Lipid formulated dsrna targeting the pcsk9 gene
|
US20110097329A1
(en)
|
2009-06-26 |
2011-04-28 |
Massachusetts Institute Of Technology |
Compositions and methods for treating cancer and modulating stress granule formation
|
WO2011000106A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Improved cationic lipids and methods for the delivery of therapeutic agents
|
WO2011000107A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for delivery of therapeutic agents to solid tumors
|
EP2451475A2
(en)
|
2009-07-06 |
2012-05-16 |
Novartis AG |
Self replicating rna molecules and uses thereof
|
DE102009033507A1
(de)
*
|
2009-07-15 |
2011-01-20 |
Niro-Plan Ag |
Vorrichtung und Verfahren zum Erzeugen von gekühltem Kaffee
|
CN102473288A
(zh)
|
2009-07-30 |
2012-05-23 |
皇家飞利浦电子股份有限公司 |
分布式图像重定向
|
DK2459231T3
(en)
|
2009-07-31 |
2016-09-05 |
Ethris Gmbh |
RNA with a combination of unmodified and modified nucleotides for protein expression
|
EP2281579A1
(en)
|
2009-08-05 |
2011-02-09 |
BioNTech AG |
Vaccine composition comprising 5'-Cap modified RNA
|
US9181295B2
(en)
|
2009-08-20 |
2015-11-10 |
Sirna Therapeutics, Inc. |
Cationic lipids with various head groups for oligonucleotide delivery
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
US20110070227A1
(en)
|
2009-09-18 |
2011-03-24 |
Anna-Marie Novotney-Barry |
Treatment of Autoimmune and Inflammatory Diseases
|
WO2011043913A2
(en)
|
2009-10-08 |
2011-04-14 |
Merck Sharp & Dohme Corp. |
Novel cationic lipids with short lipid chains for oligonucleotide delivery
|
US8859284B2
(en)
|
2009-10-22 |
2014-10-14 |
The United States Of America, As Represented By The Secretary Of The Navy |
Delivery of nanoparticles to neurons
|
EP2496700B1
(en)
|
2009-11-04 |
2017-03-01 |
The University Of British Columbia |
Nucleic acid-containing lipid particles and related methods
|
US8449916B1
(en)
|
2009-11-06 |
2013-05-28 |
Iowa State University Research Foundation, Inc. |
Antimicrobial compositions and methods
|
WO2011060250A1
(en)
|
2009-11-13 |
2011-05-19 |
Bend Research, Inc. |
Cationic dextran polymer derivatives
|
WO2011062965A2
(en)
|
2009-11-18 |
2011-05-26 |
University Of Washington Through Its Center For Commercialization |
Targeting monomers and polymers having targeting blocks
|
US8530429B2
(en)
|
2009-11-24 |
2013-09-10 |
Arch Cancer Therapeutics, Inc. |
Brain tumor targeting peptides and methods
|
ME03091B
(me)
*
|
2009-12-01 |
2019-01-20 |
Translate Bio Inc |
Isporuka irnk za povećanje ekspresije proteina i enzima u humanim genetskim oboljenjima
|
DE102009056884B4
(de)
|
2009-12-03 |
2021-03-18 |
Novartis Ag |
Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
|
US20110245756A1
(en)
|
2009-12-03 |
2011-10-06 |
Rishi Arora |
Devices for material delivery, electroporation, sonoporation, and/or monitoring electrophysiological activity
|
PL3326643T3
(pl)
|
2009-12-06 |
2021-10-25 |
Bioverativ Therapeutics Inc. |
Chimeryczne i hybrydowe polipeptydy czynnika VIII-FC oraz sposoby ich zastosowania
|
CA2783372C
(en)
|
2009-12-07 |
2019-07-16 |
Muthiah Manoharan |
Compositions for nucleic acid delivery
|
US20130189741A1
(en)
|
2009-12-07 |
2013-07-25 |
Cellscript, Inc. |
Compositions and methods for reprogramming mammalian cells
|
PL2510099T3
(pl)
|
2009-12-07 |
2018-01-31 |
The Trustees Of Univ Of Pennsylvania |
Preparaty RNA zawierające oczyszczony zmodyfikowany RNA do przeprogramowywania komórek
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
WO2011069528A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Lyophilization of nucleic acids in lactate-containing solutions
|
EA036522B1
(ru)
|
2009-12-11 |
2020-11-19 |
Пфайзер Инк. |
Фармацевтическая композиция, пригодная для лиофилизации, содержащая множество терапевтических частиц
|
EA201290498A1
(ru)
|
2009-12-15 |
2013-01-30 |
Байнд Байосайенсиз, Инк. |
Терапевтические полимерные наночастицы, включающие эпотилон, и способы их получения и применения
|
EP2512487A4
(en)
|
2009-12-15 |
2013-08-07 |
|
THERAPEUTIC POLYMERNANOPARTICLES WITH CORTICOSTEROIDS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
JP5965844B2
(ja)
|
2009-12-15 |
2016-08-10 |
バインド セラピューティックス インコーポレイテッド |
高いガラス転移温度または高分子量のコポリマーを有する治療用ポリマーナノ粒子組成物
|
DE102009058769A1
(de)
|
2009-12-16 |
2011-06-22 |
MagForce Nanotechnologies AG, 10589 |
Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung
|
WO2011084620A2
(en)
|
2009-12-16 |
2011-07-14 |
Brigham And Women's Hospital, Inc. |
Particles for multiple agent delivery
|
ES2749426T3
(es)
|
2009-12-18 |
2020-03-20 |
Univ British Columbia |
Métodos y composiciones para administración de ácidos nucleicos
|
EP2338520A1
(de)
|
2009-12-21 |
2011-06-29 |
Ludwig Maximilians Universität |
Konjugat mit Zielfindungsligand und dessen Verwendung
|
EP2516010A2
(en)
|
2009-12-23 |
2012-10-31 |
Novartis AG |
Lipids, lipid compositions, and methods of using them
|
WO2011085231A2
(en)
|
2010-01-08 |
2011-07-14 |
Selecta Biosciences, Inc. |
Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines
|
WO2011088309A1
(en)
|
2010-01-14 |
2011-07-21 |
Regulus Therapeutics Inc. |
Microrna compositions and methods
|
EP2526113B1
(en)
|
2010-01-22 |
2016-08-10 |
Sirna Therapeutics, Inc. |
Post-synthetic chemical modification of rna at the 2'-position of the ribose ring via "click" chemistry
|
PT2525815E
(pt)
|
2010-01-24 |
2015-03-05 |
Novartis Ag |
Micropartículas de polímero biodegradável irradiadas
|
EP2354247A1
(en)
*
|
2010-02-11 |
2011-08-10 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Means and methods for typing a sample for rheumatoid arthritis or spondyloarthritis
|
SG183374A1
(en)
|
2010-02-24 |
2012-09-27 |
Arrowhead Res Corp |
Compositions for targeted delivery of sirna
|
CA2791278C
(en)
|
2010-02-25 |
2015-11-24 |
The Johns Hopkins University |
Sustained delivery of therapeutic agents to an eye compartment
|
CN102884191B
(zh)
|
2010-02-26 |
2018-04-27 |
凯杰有限公司 |
用于平行分离和/或纯化rna和dna的方法
|
US20110218170A1
(en)
|
2010-03-02 |
2011-09-08 |
Southern Research Institute |
Use of 2'-deoxy-4'-thiocytidine and its analogues as dna hypomethylating anticancer agents
|
US20130133483A1
(en)
|
2010-03-08 |
2013-05-30 |
University Of Rochester |
Synthesis of Nanoparticles Using Reducing Gases
|
AU2011227264A1
(en)
|
2010-03-16 |
2012-10-04 |
University Of Utah Research Foundation |
Cleavable modifications to reducible poly (amido ethylenimines)s to enhance nucleotide delivery
|
WO2011116072A1
(en)
|
2010-03-16 |
2011-09-22 |
Escape Therapeutics, Inc. |
Hybrid hydrogel scaffold compositions and methods of use
|
EP2547345A1
(en)
|
2010-03-18 |
2013-01-23 |
Merck Sharp & Dohme Corp. |
Endosomolytic poly(amidoamine) disulfide polymers for the delivery of oligonucleotides
|
US20110230816A1
(en)
|
2010-03-18 |
2011-09-22 |
Tyco Healthcare Group Lp |
Gels for Transdermal Delivery
|
US9149432B2
(en)
|
2010-03-19 |
2015-10-06 |
Massachusetts Institute Of Technology |
Lipid vesicle compositions and methods of use
|
GB201005005D0
(en)
|
2010-03-25 |
2010-05-12 |
Angeletti P Ist Richerche Bio |
New vaccine
|
WO2011120053A1
(en)
|
2010-03-26 |
2011-09-29 |
Mersana Therapeutics, Inc. |
Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof
|
US8207290B2
(en)
|
2010-03-26 |
2012-06-26 |
Cerulean Pharma Inc. |
Methods and systems for generating nanoparticles
|
US20110247090A1
(en)
|
2010-04-02 |
2011-10-06 |
Intrexon Corporation |
Synthetic 5'UTRs, Expression Vectors, and Methods for Increasing Transgene Expression
|
JP2013523818A
(ja)
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法
|
EP2556151A1
(en)
|
2010-04-07 |
2013-02-13 |
Novartis AG |
Method for generating a parvovirus b19 virus-like particle
|
EP2558074B1
(en)
|
2010-04-08 |
2018-06-06 |
The Trustees of Princeton University |
Preparation of lipid nanoparticles
|
ES2745113T3
(es)
|
2010-04-09 |
2020-02-27 |
Pacira Pharmaceuticals Inc |
Método para formular liposomas multivesiculares
|
US20130071430A1
(en)
|
2010-04-09 |
2013-03-21 |
The University Of Tokyo |
Microrna-controlled recombinant vaccinia virus and use thereof
|
US20110262491A1
(en)
|
2010-04-12 |
2011-10-27 |
Selecta Biosciences, Inc. |
Emulsions and methods of making nanocarriers
|
KR101196667B1
(ko)
|
2010-04-15 |
2012-11-02 |
포항공과대학교 산학협력단 |
피에이치 민감성 금속 나노 입자를 이용한 항암제 전달 시스템
|
WO2011127933A1
(en)
|
2010-04-16 |
2011-10-20 |
Nuevolution A/S |
Bi-functional complexes and methods for making and using such complexes
|
WO2011130624A2
(en)
|
2010-04-16 |
2011-10-20 |
Immune Disease Institute, Inc. |
Sustained polypeptide expression from synthetic, modified rnas and uses thereof
|
EP2377938A1
(en)
|
2010-04-16 |
2011-10-19 |
Eukarys |
Capping-prone RNA polymerase enzymes and their applications
|
US20130260460A1
(en)
|
2010-04-22 |
2013-10-03 |
Isis Pharmaceuticals Inc |
Conformationally restricted dinucleotide monomers and oligonucleotides
|
EP3536781A1
(en)
|
2010-04-23 |
2019-09-11 |
University of Massachusetts |
Cns targeting aav vectors and methods of use thereof
|
WO2012046149A1
(en)
|
2010-04-28 |
2012-04-12 |
Kimberly-Clark Worldwide, Inc. |
Method for increasing permeability of an epithelial barrier
|
US20130156845A1
(en)
|
2010-04-29 |
2013-06-20 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulated single stranded rna
|
AU2011245372A1
(en)
|
2010-04-30 |
2012-11-29 |
Novartis Ag |
Predictive markers useful in the treatment of Fragile X Syndrome (FXS)
|
WO2011143230A1
(en)
|
2010-05-10 |
2011-11-17 |
Alnylam Pharmaceuticals |
Methods and compositions for delivery of active agents
|
WO2011141705A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc. |
Novel cationic lipids and methods of use thereof
|
WO2011141704A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc |
Novel cyclic cationic lipids and methods of use
|
EP2387999A1
(en)
|
2010-05-21 |
2011-11-23 |
CureVac GmbH |
Histidine-containing solution for transfection and/or injection of nucleic acids and uses thereof
|
JP2013531634A
(ja)
|
2010-05-24 |
2013-08-08 |
メルク・シャープ・エンド・ドーム・コーポレイション |
オリゴヌクレオチド送達のための新規なアミノアルコールカチオン性脂質
|
CN107029223A
(zh)
|
2010-05-26 |
2017-08-11 |
西莱克塔生物科技公司 |
合成纳米载体联合疫苗
|
CN103096875B
(zh)
|
2010-06-03 |
2016-08-17 |
阿尔尼拉姆医药品有限公司 |
用于递送活性剂的生物可降解脂质
|
DK2575767T3
(en)
|
2010-06-04 |
2017-03-13 |
Sirna Therapeutics Inc |
HOWEVER UNKNOWN LOW MOLECULAR CATIONIC LIPIDS TO PROCESS OIGONUCLEOTIDES
|
EP2579899B1
(en)
|
2010-06-14 |
2017-03-15 |
F. Hoffmann-La Roche AG |
Cell-penetrating peptides and uses thereof
|
WO2011163121A1
(en)
|
2010-06-21 |
2011-12-29 |
Alnylam Pharmaceuticals, Inc. |
Multifunctional copolymers for nucleic acid delivery
|
CA2803239A1
(en)
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Combinations of meningococcal factor h binding proteins
|
US9066971B2
(en)
|
2010-07-01 |
2015-06-30 |
Postech Academy-Industry Foundation |
Method for treating and diagnosing cancer by using cell-derived microvesicles
|
KR101130137B1
(ko)
|
2010-07-02 |
2012-03-28 |
연세대학교 산학협력단 |
발광다이오드 모듈
|
JP6002128B2
(ja)
|
2010-07-02 |
2016-10-05 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
プロテインA(SpA)変種に関連する組成物および方法
|
LT3243526T
(lt)
|
2010-07-06 |
2020-02-10 |
Glaxosmithkline Biologicals S.A. |
Rnr pristatymas, skirtas keleto imuninio atsako paleidimui
|
CA2804492A1
(en)
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Immunisation of large mammals with low doses of rna
|
SI2590626T1
(sl)
|
2010-07-06 |
2016-01-29 |
Glaxosmithkline Biologicals S.A. |
Liposomi z lipidi, ki imajo koristno pKa vrednost, za dostavo RNA
|
US9192661B2
(en)
|
2010-07-06 |
2015-11-24 |
Novartis Ag |
Delivery of self-replicating RNA using biodegradable polymer particles
|
BR112013000391B8
(pt)
|
2010-07-06 |
2022-10-04 |
Novartis Ag |
Composição de emulsão catiônica de óleo em água e seu uso
|
WO2012004276A2
(en)
*
|
2010-07-06 |
2012-01-12 |
Fondazione Telethon |
Multiprotein biomarkers of amyotrophic lateral sclerosis in peripheral blood mononuclear cells, diagnostic methods and kits
|
US9770463B2
(en)
|
2010-07-06 |
2017-09-26 |
Glaxosmithkline Biologicals Sa |
Delivery of RNA to different cell types
|
BR112013000392B8
(pt)
|
2010-07-06 |
2022-10-04 |
Novartis Ag |
Composição farmacêutica contendo partícula de distribuição semelhante a vírion para moléculas de rna autorreplicantes e seu uso
|
EP3508573A1
(en)
|
2010-07-09 |
2019-07-10 |
Bioverativ Therapeutics Inc. |
Systems for factor viii processing and methods thereof
|
NZ605348A
(en)
|
2010-07-09 |
2015-01-30 |
Biogen Idec Hemophilia Inc |
Factor ix polypeptides and methods of use thereof
|
WO2012009406A2
(en)
|
2010-07-13 |
2012-01-19 |
University Of Utah Research Foundation |
Gold particles and methods of making and using the same in cancer treatment
|
GB201012410D0
(en)
|
2010-07-23 |
2010-09-08 |
Medical Res Council |
Intracellular immunity
|
DE102010032758B4
(de)
|
2010-07-29 |
2012-02-23 |
Fujitsu Technology Solutions Intellectual Property Gmbh |
Computersystem, Verfahren zum Programmieren einer Echtzeituhr und Computerprogrammprodukt
|
BR112013002298A2
(pt)
|
2010-07-30 |
2016-05-24 |
Curevac Gmbh |
complexação de ácidos nucleicos com componentes catiônicos reticulados com dissulfeto para transfecção e estimulação imunológica.
|
WO2012016269A1
(en)
|
2010-08-02 |
2012-02-09 |
Curtin University Of Technology |
Determining location of, and imaging, a subsurface boundary
|
CA2807552A1
(en)
*
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
US9121065B2
(en)
|
2010-08-09 |
2015-09-01 |
The Trustees Of The University Of Pennsylvania |
Nanoparticle-oligonucleotide hybrid structures and methods of use thereof
|
WO2012019630A1
(en)
|
2010-08-13 |
2012-02-16 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
|
US8829329B2
(en)
|
2010-08-18 |
2014-09-09 |
International Business Machines Corporation |
Solar cell and battery 3D integration
|
WO2012024621A2
(en)
|
2010-08-20 |
2012-02-23 |
Selecta Biosciences, Inc. |
Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
|
EP2605792B1
(en)
|
2010-08-20 |
2014-12-10 |
Novartis AG |
Soluble needle arrays for delivery of influenza vaccines
|
JP5756858B2
(ja)
|
2010-08-20 |
2015-07-29 |
セルリアン・ファーマ・インコーポレイテッド |
複合体、粒子、組成物および関連の方法
|
EP2605816B1
(en)
|
2010-08-20 |
2019-01-23 |
University Of Washington |
Circumferential aerosol device for delivering drugs to olfactory epithelium and brain
|
JP5911870B2
(ja)
|
2010-08-31 |
2016-04-27 |
ノバルティス アーゲー |
免疫原をコードするrnaの送達のためのpeg化リポソーム
|
SI4008357T1
(sl)
|
2010-08-31 |
2023-04-28 |
Glaxosmithkline Biologicals Sa |
Mali liposomi za dostavo imunogen-kodirajoče RNA
|
CA3201524A1
(en)
|
2010-08-31 |
2012-03-08 |
Theraclone Sciences, Inc. |
Human immunodeficiency virus (hiv)-neutralizing antibodies
|
EP2611420B1
(en)
|
2010-08-31 |
2019-03-27 |
GlaxoSmithKline Biologicals SA |
Lipids suitable for liposomal delivery of protein-coding rna
|
EP3406730B1
(en)
|
2010-08-31 |
2022-02-23 |
Sirna Therapeutics, Inc. |
Novel single chemical entities and methods for delivery of oligonucleotides
|
WO2012031205A2
(en)
|
2010-09-03 |
2012-03-08 |
The Brigham And Women's Hospital, Inc. |
Lipid-polymer hybrid particles
|
WO2012034067A1
(en)
|
2010-09-09 |
2012-03-15 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
US20130236419A1
(en)
|
2010-09-09 |
2013-09-12 |
The University Of Chicago |
Compositions and methods related to attenuated staphylococcal strains
|
WO2012039979A2
(en)
|
2010-09-10 |
2012-03-29 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
US8466122B2
(en)
|
2010-09-17 |
2013-06-18 |
Protiva Biotherapeutics, Inc. |
Trialkyl cationic lipids and methods of use thereof
|
JP5961170B2
(ja)
|
2010-09-20 |
2016-08-02 |
サーナ・セラピューティクス・インコーポレイテッドSirna Therapeutics,Inc. |
オリゴヌクレオチドの送達のための新規な低分子量カチオン性脂質
|
US20130183718A1
(en)
|
2010-09-21 |
2013-07-18 |
RibpxX GmbH |
Method for Synthesizing RNA using DNA Template
|
EP2618821A4
(en)
|
2010-09-24 |
2014-08-13 |
Brigham & Womens Hospital |
NANOSTRUCTURED GELS FOR CONTROLLED RELEASE OF CAPSUED MEDIUM
|
WO2012050975A2
(en)
|
2010-09-29 |
2012-04-19 |
The University Of North Carolina At Chapel Hill |
Novel circular mammalian rna molecules and uses thereof
|
EP2621480B1
(en)
|
2010-09-30 |
2018-08-15 |
Sirna Therapeutics, Inc. |
Low molecular weight cationic lipids for oligonucleotide delivery
|
ES2862955T3
(es)
|
2010-10-01 |
2021-10-08 |
Modernatx Inc |
Acidos nucleicos manipulados y métodos de uso de los mismos
|
US10078075B2
(en)
|
2011-12-09 |
2018-09-18 |
Vanderbilt University |
Integrated organ-on-chip systems and applications of the same
|
US8898864B1
(en)
|
2010-10-08 |
2014-12-02 |
David Porter |
Integrated rockably released leverage snap fastening system
|
WO2012051220A1
(en)
|
2010-10-11 |
2012-04-19 |
Wichita State University |
Composite magnetic nanoparticle drug delivery system
|
US20140030292A1
(en)
|
2010-10-11 |
2014-01-30 |
Novartis Ag |
Antigen delivery platforms
|
US9029590B2
(en)
|
2010-10-21 |
2015-05-12 |
Sirna Therapeutics, Inc. |
Low molecular weight cationic lipids for oligonucleotide delivery
|
JP2013543844A
(ja)
|
2010-10-22 |
2013-12-09 |
バインド セラピューティックス インコーポレイテッド |
高分子コポリマーを含む治療用ナノ粒子
|
AU2011367817B2
(en)
|
2010-10-29 |
2015-05-28 |
Merck Sharp & Dohme Corp. |
Recombinant subunit dengue virus vaccine
|
AU2011323250B2
(en)
|
2010-11-05 |
2015-11-19 |
The Johns Hopkins University |
Compositions and methods relating to reduced mucoadhesion
|
WO2012061259A2
(en)
|
2010-11-05 |
2012-05-10 |
Merck Sharp & Dohme Corp. |
Novel low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery
|
CN103201386A
(zh)
|
2010-11-09 |
2013-07-10 |
加利福尼亚大学董事会 |
皮肤穿透及细胞进入(space)肽及其使用方法
|
BR112013011705B1
(pt)
|
2010-11-12 |
2022-04-05 |
The Trustees Of The University Of Pennsylvania |
Antígenos de próstata de consenso, molécula de ácido nucleico quecodifica os mesmos e vacina e usos compreendendo os mesmos
|
DK2640426T3
(en)
|
2010-11-16 |
2016-05-02 |
Selecta Biosciences Inc |
Immunostimulating Oligonucleotides
|
DK2640842T3
(en)
|
2010-11-17 |
2018-08-13 |
Aduro Biotech Inc |
Methods and compositions for inducing an immune response to EGFRVIII
|
US8987377B2
(en)
|
2010-11-19 |
2015-03-24 |
Alnylam Pharmaceuticals, Inc. |
Poly(amide) polymers for the delivery of oligonucleotides
|
US20140053294A1
(en)
*
|
2010-11-19 |
2014-02-20 |
The University Of Queensland |
Pongamia Genetic Markers and Method of Use
|
AU2011329668B2
(en)
|
2010-11-19 |
2016-07-28 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
WO2012075040A2
(en)
|
2010-11-30 |
2012-06-07 |
Shire Human Genetic Therapies, Inc. |
mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
|
WO2012072096A1
(en)
|
2010-12-03 |
2012-06-07 |
Biontech Ag |
Method for cellular rna expression
|
EP2651445A2
(en)
|
2010-12-16 |
2013-10-23 |
SPRNA GmbH |
Pharmaceutical composition consisting of rna having alkali metal as counter ion and formulated with dications
|
US8501930B2
(en)
|
2010-12-17 |
2013-08-06 |
Arrowhead Madison Inc. |
Peptide-based in vivo siRNA delivery system
|
US8901101B2
(en)
|
2010-12-17 |
2014-12-02 |
Sirna Therapeutics, Inc. |
Membrane lytic poly(amido amine) polymers for the delivery of oligonucleotides
|
US9394537B2
(en)
|
2010-12-22 |
2016-07-19 |
President And Fellows Of Harvard College |
Continuous directed evolution
|
WO2012089225A1
(en)
|
2010-12-29 |
2012-07-05 |
Curevac Gmbh |
Combination of vaccination and inhibition of mhc class i restricted antigen presentation
|
KR20130108655A
(ko)
|
2010-12-29 |
2013-10-04 |
에프. 호프만-라 로슈 아게 |
핵산의 세포내 전달을 위한 소분자 접합체
|
US20120171229A1
(en)
|
2010-12-30 |
2012-07-05 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers with reactive groups that release biologically active agents
|
WO2012094304A1
(en)
|
2011-01-04 |
2012-07-12 |
Brown University |
Nanotubes as carriers of nucleic acids into cells
|
WO2012094574A2
(en)
|
2011-01-06 |
2012-07-12 |
The Johns Hopkins University |
Stabilized polyribonucleotide nanoparticles
|
US20140080766A1
(en)
|
2011-01-07 |
2014-03-20 |
Massachusetts Institute Of Technology |
Compositions and methods for macromolecular drug delivery
|
AU2012207606B2
(en)
|
2011-01-11 |
2017-02-23 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
DE102011002640B4
(de)
|
2011-01-13 |
2021-10-07 |
Evonik Operations Gmbh |
Verfahren zur Aufreinigung von Biphephos
|
WO2012099805A2
(en)
|
2011-01-19 |
2012-07-26 |
Ocean Nanotech, Llc |
Nanoparticle based immunological stimulation
|
US20140065172A1
(en)
|
2011-01-26 |
2014-03-06 |
Cenix Bioscience Gmbh |
Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes
|
US10363309B2
(en)
|
2011-02-04 |
2019-07-30 |
Case Western Reserve University |
Targeted nanoparticle conjugates
|
WO2012109121A1
(en)
|
2011-02-07 |
2012-08-16 |
Purdue Research Foundation |
Carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide
|
WO2012116715A1
(en)
|
2011-03-02 |
2012-09-07 |
Curevac Gmbh |
Vaccination in newborns and infants
|
US20120207840A1
(en)
|
2011-02-10 |
2012-08-16 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Non-Melanoma Skin Cancer
|
US20140038185A1
(en)
|
2011-02-14 |
2014-02-06 |
Swift Biosciences, Inc. |
Polynucleotide primers and probes
|
EP2675918B1
(en)
|
2011-02-15 |
2017-11-08 |
Merrimack Pharmaceuticals, Inc. |
Compositions and methods for delivering nucleic acid to a cell
|
WO2012112689A1
(en)
|
2011-02-15 |
2012-08-23 |
The University Of North Carolina At Chapel Hill |
Nanoparticle, liposomes, polymers, agents and proteins modified with reversible linkers
|
EP2489371A1
(en)
|
2011-02-18 |
2012-08-22 |
Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria |
Carrier peptides for drug delivery
|
WO2012113413A1
(en)
|
2011-02-21 |
2012-08-30 |
Curevac Gmbh |
Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
|
BR112013021494B1
(pt)
|
2011-02-22 |
2021-09-08 |
California Institute Of Technology |
Vetor viral, polinucleotídeo isolado, uso de um vírus adeno-associado (aav) recombinante e método para produzir o mesmo
|
US8696637B2
(en)
|
2011-02-28 |
2014-04-15 |
Kimberly-Clark Worldwide |
Transdermal patch containing microneedles
|
WO2012117377A1
(en)
|
2011-03-02 |
2012-09-07 |
Novartis Ag |
Combination vaccines with lower doses of antigen and/or adjuvant
|
WO2012116714A1
(en)
|
2011-03-02 |
2012-09-07 |
Curevac Gmbh |
Vaccination in elderly patients
|
EP2683812A4
(en)
|
2011-03-07 |
2014-12-03 |
Massachusetts Inst Technology |
METHODS FOR TRANSFECTING CELLS WITH NUCLEIC ACIDS
|
US20120237565A1
(en)
|
2011-03-14 |
2012-09-20 |
Intezyne Technologies, Incorporated |
Pegylated polyplexes containing two or more different polymers for polynucleotide delivery
|
WO2012125680A1
(en)
|
2011-03-16 |
2012-09-20 |
Novartis Ag |
Methods of treating vasculitis using an il-17 binding molecule
|
WO2012125987A2
(en)
|
2011-03-17 |
2012-09-20 |
Massachusetts Institute Of Technology |
Delivery system
|
KR20140012137A
(ko)
|
2011-03-17 |
2014-01-29 |
노파르티스 아게 |
Hr 양성 대상체에서의 유방암용 바이오마커로서의 fgfr 및 이의 리간드
|
ES2785108T3
(es)
|
2011-03-24 |
2020-10-05 |
Glaxosmithkline Biologicals Sa |
Nanoemulsiones adyuvantes con fosfolípidos
|
WO2012129648A1
(en)
|
2011-03-25 |
2012-10-04 |
University Of Guelph |
Enhancing protein expression of adeno-associated virus vectors
|
BR112013024655A2
(pt)
|
2011-03-25 |
2016-12-20 |
Selecta Biosciences Inc |
nanotransportadores sintéticos para liberação mediada de modo osmótico
|
PL2691443T3
(pl)
|
2011-03-28 |
2021-08-30 |
Massachusetts Institute Of Technology |
Sprzężone lipomery i ich zastosowania
|
EP2691538A1
(en)
|
2011-03-28 |
2014-02-05 |
Novartis AG |
Markers associated with cyclin-dependent kinase inhibitors
|
AU2012237262A1
(en)
|
2011-03-31 |
2013-11-14 |
Ingell Technologies Holding B.V. |
Biodegradable compositions suitable for controlled release
|
WO2012131104A2
(en)
|
2011-03-31 |
2012-10-04 |
Ingell Technologies Holding B.V. |
Biodegradable compositions suitable for controlled release
|
US8710200B2
(en)
|
2011-03-31 |
2014-04-29 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids encoding a modified erythropoietin and their expression
|
AU2012234259A1
(en)
|
2011-03-31 |
2013-10-03 |
Libera-Korner, Jeanette |
Perfluorinated compounds for the non-viral transfer of nucleic acids
|
EP2694550B1
(en)
*
|
2011-04-01 |
2019-11-27 |
Universität Stuttgart |
Recombinant tnf ligand family member polypeptides with antibody binding domain and uses thereof
|
EP3460064B8
(en)
|
2011-04-03 |
2024-03-20 |
The General Hospital Corporation d/b/a Massachusetts General Hospital |
Efficient protein expression in vivo using modified rna (mod-rna)
|
WO2012138530A1
(en)
|
2011-04-04 |
2012-10-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
2'-o-aminooxymethyl nucleoside derivatives for use in the synthesis and modification of nucleosides, nucleotides and oligonucleotides
|
WO2012142132A1
(en)
|
2011-04-11 |
2012-10-18 |
Life Technologies Corporation |
Polymer particles and methods of making and using same
|
US11135174B2
(en)
|
2011-04-13 |
2021-10-05 |
The Trustees Of The University Of Pennsylvania |
Coated mesoporous nanoparticles
|
WO2013158127A1
(en)
|
2012-04-16 |
2013-10-24 |
Molecular Transfer, Inc. |
Agents for improved delivery of nucleic acids to eukaryotic cells
|
US20140178894A1
(en)
|
2011-04-20 |
2014-06-26 |
Novartis Forschungsstiftung, Zweigniederlassung |
Culture medium suitable for the culture of undifferentiated cells
|
EP2701734B1
(en)
|
2011-04-26 |
2019-09-25 |
Molecular Express, Inc. |
Liposomal formulations
|
WO2012148684A1
(en)
|
2011-04-27 |
2012-11-01 |
President And Fellows Of Harvard College |
Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation
|
US20160272697A2
(en)
|
2011-04-28 |
2016-09-22 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Neutralizing Antibodies to Nipah and Hendra Virus
|
CA2834365A1
(en)
|
2011-04-28 |
2012-11-01 |
Sandia Corporation |
Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
|
US20120301498A1
(en)
|
2011-04-29 |
2012-11-29 |
Selecta Biosciences, Inc. |
Controlled release of immunosuppressants from synthetic nanocarriers
|
US20140056912A1
(en)
|
2011-04-29 |
2014-02-27 |
Novartis Ag |
Methods of treating squamous cell carcinoma
|
US20120283503A1
(en)
|
2011-04-29 |
2012-11-08 |
The Johns Hopkins University |
Nanoparticle loaded stem cells and their use in mri guided hyperthermia
|
ES2957478T3
(es)
|
2011-05-02 |
2024-01-19 |
Univ Wayne State |
Una tecnología de células madre pluripotentes inducidas por proteínas y usos de las mismas
|
UA116189C2
(uk)
|
2011-05-02 |
2018-02-26 |
Мілленніум Фармасьютікалз, Інк. |
КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
|
US9981068B2
(en)
|
2011-05-04 |
2018-05-29 |
The University Of Nottingham |
Polymers which resist bacterial attachment
|
US9327029B2
(en)
|
2011-05-05 |
2016-05-03 |
Celacare Technologies, Llc |
Antimicrobial silver hydrogel composition for the treatment of burns and wounds
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
WO2012152810A1
(de)
|
2011-05-10 |
2012-11-15 |
Basf Se |
Öl-in-wasser-emulsionen
|
WO2012153297A1
(en)
|
2011-05-11 |
2012-11-15 |
Ramot At Tel-Aviv University Ltd. |
Targeted polymeric conjugates and uses thereof
|
US20140072657A1
(en)
|
2011-05-12 |
2014-03-13 |
Helmut Vockner |
Novel pharmaceutical formulation
|
ES2762224T3
(es)
|
2011-05-12 |
2020-05-22 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Liposomas que comprenden lípidos conjugados con polímero y usos relacionados
|
CN103842374A
(zh)
|
2011-05-13 |
2014-06-04 |
诺华股份有限公司 |
融合前的rsv f抗原
|
BR112013029490A2
(pt)
|
2011-05-17 |
2019-09-24 |
Moderna Therapeutics Inc |
ácidos nucleicos projetados e métodos de uso dos mesmos para vertebrados não humanos
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
US8978170B2
(en)
|
2011-05-20 |
2015-03-17 |
Kohler Co. |
Toilet installation system and method
|
DK2714071T3
(da)
|
2011-05-24 |
2019-09-16 |
Biontech Rna Pharmaceuticals Gmbh |
Individualiserede vacciner mod cancer
|
BR112013029787A2
(pt)
|
2011-05-25 |
2017-01-17 |
Novartis Ag |
biomarcadores para câncer de pulmão
|
US20120302940A1
(en)
|
2011-05-26 |
2012-11-29 |
Jackson State University |
Popcorn Shape Gold Nanoparticle For Targeted Diagnosis, Photothermal Treatment and In-Situ Monitoring Therapy Response for Cancer and Multiple Drug Resistance Bacteria
|
US20140308363A1
(en)
|
2011-05-31 |
2014-10-16 |
Bind Therapeutics, Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
DK2714017T3
(en)
|
2011-06-02 |
2018-09-03 |
Univ California |
MEMBRANE-WRAPPED NANOPARTICLES AND METHOD OF USE
|
RU2602185C2
(ru)
|
2011-06-02 |
2016-11-10 |
Новартис Аг |
Биомаркеры для терапии на основе ингибитора hedgehog
|
WO2012168259A1
(en)
|
2011-06-06 |
2012-12-13 |
Novartis Forschungsstiftung, Zweigniederlassung |
Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and triple-negative breast cancer
|
EP3354644A1
(en)
|
2011-06-08 |
2018-08-01 |
Translate Bio, Inc. |
Cleavable lipids
|
EP2717893B1
(en)
*
|
2011-06-08 |
2019-05-08 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mrna delivery
|
US8636696B2
(en)
|
2011-06-10 |
2014-01-28 |
Kimberly-Clark Worldwide, Inc. |
Transdermal device containing microneedles
|
WO2012170607A2
(en)
|
2011-06-10 |
2012-12-13 |
Novartis Ag |
Use of pcsk9 antagonists
|
WO2012168491A1
(en)
|
2011-06-10 |
2012-12-13 |
Novartis Ag |
Pharmaceutical formulations of pcsk9 antagonists
|
MX345704B
(es)
|
2011-06-10 |
2017-02-10 |
Novartis Tiergesundheit Ag |
Vacuna bovinas y métodos.
|
US8916696B2
(en)
|
2011-06-12 |
2014-12-23 |
City Of Hope |
Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use
|
WO2012172495A1
(en)
|
2011-06-14 |
2012-12-20 |
Novartis Ag |
Compositions and methods for antibodies targeting tem8
|
WO2012172424A1
(en)
|
2011-06-15 |
2012-12-20 |
Crontech Pharma Ab |
Injection needle and device
|
AU2012269929A1
(en)
|
2011-06-16 |
2013-12-12 |
Novartis Ag |
Soluble proteins for use as therapeutics
|
WO2012177760A1
(en)
|
2011-06-20 |
2012-12-27 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Computationally optimized broadly reactive antigens for h1n1 influenza
|
WO2013003475A1
(en)
|
2011-06-27 |
2013-01-03 |
Cellscript, Inc. |
Inhibition of innate immune response
|
WO2013066427A1
(en)
|
2011-06-28 |
2013-05-10 |
Inovio Pharmaceuticals, Inc. |
A miniminally invasive dermal electroporation device
|
EP2726099B1
(en)
|
2011-07-01 |
2018-07-25 |
Novartis AG |
Method for treating metabolic disorders
|
AU2012278910A1
(en)
|
2011-07-04 |
2014-01-16 |
Commonwealth Scientific And Industrial Research Organisation |
Nucleic acid complex
|
CA2840989A1
(en)
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Immunogenic combination compositions and uses thereof
|
JP6059220B2
(ja)
|
2011-07-06 |
2017-01-18 |
ノバルティス アーゲー |
核酸を含む水中油型エマルジョン
|
US20140141070A1
(en)
|
2011-07-06 |
2014-05-22 |
Andrew Geall |
Liposomes having useful n:p ratio for delivery of rna molecules
|
US11058762B2
(en)
|
2011-07-06 |
2021-07-13 |
Glaxosmithkline Biologicals Sa |
Immunogenic compositions and uses thereof
|
CN103796639B
(zh)
|
2011-07-06 |
2017-05-31 |
诺华股份有限公司 |
阳离子水包油乳液
|
WO2013006824A2
(en)
|
2011-07-07 |
2013-01-10 |
Life Technologies Corporation |
Polymer particles, nucleic acid polymer particles and methods of making and using the same
|
US20130012566A1
(en)
|
2011-07-10 |
2013-01-10 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment of Alopecia
|
WO2013009717A1
(en)
|
2011-07-10 |
2013-01-17 |
Elisabet De Los Pinos |
Virion derived protein nanoparticles for delivering diagnostic or therapeutic agents for the treatment of skin-related diseases
|
WO2013009736A2
(en)
|
2011-07-10 |
2013-01-17 |
President And Fellows Of Harvard College |
Compositions and methods for self-assembly of polymers with complementary macroscopic and microscopic scale units
|
GB2492999A
(en)
|
2011-07-20 |
2013-01-23 |
Univ Central Lancashire |
Neutron detector
|
US20140148503A1
(en)
|
2011-07-20 |
2014-05-29 |
University Of Iowa Research Foundation |
Nucleic acid aptamers
|
EP2734184B1
(en)
|
2011-07-21 |
2018-03-28 |
Croda International Plc |
Branched polyether-polyamide block copolymers and methods of making and using the same
|
US9493549B2
(en)
|
2011-07-25 |
2016-11-15 |
The Rockefeller University |
Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth
|
US10030052B2
(en)
|
2011-07-25 |
2018-07-24 |
Glaxosmithkline Biologicals Sa |
Parvovirus Vp1 unique region polypeptides and compositions thereof
|
KR20140050698A
(ko)
|
2011-07-29 |
2014-04-29 |
셀렉타 바이오사이언시즈, 인크. |
체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
|
CN103906535B
(zh)
|
2011-08-15 |
2017-07-14 |
芝加哥大学 |
与葡萄球菌蛋白a的抗体相关的组合物和方法
|
CN104024328A
(zh)
|
2011-08-26 |
2014-09-03 |
箭头研究公司 |
用于体内核酸递送的聚(乙烯基酯)聚合物
|
WO2013033438A2
(en)
|
2011-08-31 |
2013-03-07 |
Mallinckrodt Llc |
Nanoparticle peg modification with h-phosphonates
|
BR112014004607A2
(pt)
|
2011-08-31 |
2017-03-21 |
Novartis Ag |
lipossomas peguilados para entrega de rna codificado imunogênico
|
US9126966B2
(en)
|
2011-08-31 |
2015-09-08 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use thereof
|
KR20140105433A
(ko)
|
2011-09-01 |
2014-09-01 |
아이알엠 엘엘씨 |
Pdgfr 키나제 억제제로서의 화합물 및 조성물
|
EA201490553A1
(ru)
|
2011-09-02 |
2014-08-29 |
Новартис Аг |
Органические композиции для лечения связанных с hsf1 заболеваний
|
EP3384938A1
(en)
|
2011-09-12 |
2018-10-10 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
EP2755986A4
(en)
*
|
2011-09-12 |
2015-05-20 |
Moderna Therapeutics Inc |
MODIFIED NUCLEIC ACIDS AND METHODS OF USE
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
ES2732708T3
(es)
|
2011-09-14 |
2019-11-25 |
Glaxosmithkline Biologicals Sa |
Procedimientos de fabricación de glucoconjugados de sacárido-proteína
|
WO2013040557A2
(en)
|
2011-09-16 |
2013-03-21 |
The Trustees Of The University Of Pennsylvania |
Rna engineered t cells for the treatment of cancer
|
US20150017245A1
(en)
|
2011-09-22 |
2015-01-15 |
Bind Therapeutics, Inc. |
Methods of treating cancers with therapeutic nanoparticles
|
WO2013072929A2
(en)
|
2011-09-23 |
2013-05-23 |
Indian Institute Of Technology |
Nanop article based cosmetic composition
|
JO3476B1
(ar)
|
2011-09-26 |
2020-07-05 |
Novartis Ag |
بروتينات مندمجة لعلاج الاضطرابات الايضية
|
US9458214B2
(en)
|
2011-09-26 |
2016-10-04 |
Novartis Ag |
Dual function fibroblast growth factor 21 proteins
|
WO2013049328A1
(en)
|
2011-09-27 |
2013-04-04 |
Alnylam Pharmaceuticals, Inc. |
Di-aliphatic substituted pegylated lipids
|
WO2013049389A1
(en)
|
2011-09-27 |
2013-04-04 |
Yale University |
Compositions and methods for transient expression of recombinant rna
|
WO2013045505A1
(en)
|
2011-09-28 |
2013-04-04 |
Novartis Ag |
Biomarkers for raas combination therapy
|
WO2013052523A1
(en)
|
2011-10-03 |
2013-04-11 |
modeRNA Therapeutics |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
GB201117279D0
(en)
*
|
2011-10-06 |
2011-11-16 |
Nexeon Ltd |
Etched silicon structures, method of forming etched silicon structures and uses thereof
|
WO2013055971A1
(en)
|
2011-10-11 |
2013-04-18 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Polymers for delivering a substance into a cell
|
BR112014008694A2
(pt)
|
2011-10-11 |
2017-06-20 |
Novartis Ag |
moléculas de ácido nucleico policistrônico recombinante
|
WO2014066811A1
(en)
|
2012-10-25 |
2014-05-01 |
The Johns Hopkins University |
Bioreducible poly (b-amino ester)s for sirna delivery
|
EP2766407B1
(en)
|
2011-10-12 |
2018-06-27 |
The Curators Of The University Of Missouri |
Pentablock polymers
|
US8673184B2
(en)
*
|
2011-10-13 |
2014-03-18 |
Flexcon Company, Inc. |
Systems and methods for providing overcharge protection in capacitive coupled biomedical electrodes
|
ES2769786T3
(es)
|
2011-10-14 |
2020-06-29 |
Recordati Ag |
Anticuerpos y métodos para enfermedades relacionadas con la vía Wnt
|
EP2765997A4
(en)
|
2011-10-14 |
2015-06-24 |
Stc Unm |
POROUS NANOPARTICLE-SUPPORTED LIPIDIC BILCHES (PROTOCELLS) FOR TARGETED DELIVERY, COMPRISING TRANSDERMAL DELIVERY OF CARGO MOLECULE, AND ASSOCIATED METHODS
|
WO2013059496A1
(en)
|
2011-10-18 |
2013-04-25 |
Dicerna Pharmaceuticals, Inc. |
Amine cationic lipids and uses thereof
|
WO2013059509A1
(en)
|
2011-10-18 |
2013-04-25 |
Micell Technologies, Inc. |
Drug delivery medical device
|
EP2768528A1
(en)
|
2011-10-20 |
2014-08-27 |
Novartis AG |
Adjuvanted influenza b virus vaccines for pediatric priming
|
JP6162705B2
(ja)
|
2011-10-20 |
2017-07-12 |
ノバルティス アーゲー |
アルファ7ニコチン性アセチルコリン受容体活性化剤による処置に対する応答性を予測するバイオマーカー
|
US20140328759A1
(en)
|
2011-10-25 |
2014-11-06 |
The University Of British Columbia |
Limit size lipid nanoparticles and related methods
|
US20130110043A1
(en)
|
2011-10-26 |
2013-05-02 |
Nanopass Technologies Ltd. |
Microneedle Intradermal Drug Delivery Device with Auto-Disable Functionality
|
EA201891809A1
(ru)
|
2011-10-27 |
2019-05-31 |
Массачусетс Инститьют Оф Текнолоджи |
Аминокислотные производные, функционализованные на n-конце, способные образовывать микросферы, инкапсулирующие лекарственное средство
|
KR20220051429A
(ko)
|
2011-10-27 |
2022-04-26 |
소렌토 쎄라퓨틱스, 인코포레이티드 |
고점도 생체활성 제제의 경피 전달 방법
|
CN104023748B
(zh)
|
2011-10-28 |
2018-03-02 |
诚信生物公司 |
含有氨基酸的蛋白质制剂
|
EP2771043A4
(en)
|
2011-10-28 |
2015-04-29 |
Presage Biosciences Inc |
METHODS OF DRUG DELIVERY
|
WO2013062140A1
(en)
|
2011-10-28 |
2013-05-02 |
Kyoto University |
Method for efficiently inducing differentiation of pluripotent stem cells into hepatic lineage cells
|
EP2773426B1
(en)
|
2011-10-31 |
2018-08-22 |
Mallinckrodt LLC |
Combinational liposome compositions for cancer therapy
|
KR20140084078A
(ko)
|
2011-10-31 |
2014-07-04 |
제넨테크, 인크. |
항체 제제
|
WO2013067537A1
(en)
|
2011-11-04 |
2013-05-10 |
Univertiy Of Notre Dame Du Lac |
Nanoparticle-based drug delivery
|
JP6143269B2
(ja)
|
2011-11-04 |
2017-06-07 |
エージェンシー フォー サイエンス,テクノロジー アンド リサーチ |
自己組織化複合超小型ペプチドポリマーヒドロゲル
|
US9579338B2
(en)
*
|
2011-11-04 |
2017-02-28 |
Nitto Denko Corporation |
Method of producing lipid nanoparticles for drug delivery
|
DK2773326T3
(en)
|
2011-11-04 |
2019-04-15 |
Nitto Denko Corp |
PROCEDURE FOR STERILE PREPARATION OF LIPID NUCLEIC ACID PARTICLES
|
WO2013067355A1
(en)
|
2011-11-04 |
2013-05-10 |
Novartis Ag |
Low density lipoprotein-related protein 6 (lrp6) - half life extender constructs
|
US20130116408A1
(en)
|
2011-11-05 |
2013-05-09 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy
|
US20130115247A1
(en)
|
2011-11-05 |
2013-05-09 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy
|
EP2776838A1
(en)
|
2011-11-08 |
2014-09-17 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Early diagnostic of neurodegenerative diseases
|
US9849087B2
(en)
|
2011-11-08 |
2017-12-26 |
The Board Of Trustees Of The University Of Arkansas |
Methods and compositions for X-ray induced release from pH sensitive liposomes
|
US20140314787A1
(en)
|
2011-11-08 |
2014-10-23 |
Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute |
Treatment for neurodegenerative diseases
|
WO2013068413A1
(en)
|
2011-11-08 |
2013-05-16 |
Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute For Biomedical Research |
Rod cell-specific promoter
|
US10203325B2
(en)
|
2011-11-09 |
2019-02-12 |
Board Of Trustees Of Michigan State University |
Metallic nanoparticle synthesis with carbohydrate capping agent
|
CN104271745A
(zh)
|
2011-11-11 |
2015-01-07 |
变异生物技术公司 |
用于治疗巨细胞病毒的组合物和方法
|
WO2013071047A1
(en)
|
2011-11-11 |
2013-05-16 |
Children's Medical Center Corporation |
Compositions and methods for in vitro transcription of rna
|
US9393300B2
(en)
|
2011-11-14 |
2016-07-19 |
Novartis Ag |
Immunogenic complexes of polyanionic carbomers and Env polypeptides and methods of manufacture and use thereof
|
MX2014005927A
(es)
|
2011-11-15 |
2014-06-05 |
Novartis Ag |
Combinacion de un inhibidor de la fosfoinositida-3-cinasa y un modulador de la senda del transductor y activador de la señal de transcripcion 5 de la cinasa janus 2.
|
ES2775104T5
(es)
|
2011-11-18 |
2023-06-08 |
Regeneron Pharma |
Método de fabricación de una formulación farmacéutica de liberación prolongada que comprende micropartículas de proteínas recubiertas de polímero utilizando secado por pulverización
|
RU2014125071A
(ru)
|
2011-11-21 |
2015-12-27 |
Новартис Аг |
Способы лечения псориатического артрита (psa) с использованием антагонистов il-17 и аллелей ответа psa или отсутствия ответа psa
|
WO2013078199A2
(en)
|
2011-11-23 |
2013-05-30 |
Children's Medical Center Corporation |
Methods for enhanced in vivo delivery of synthetic, modified rnas
|
WO2013078416A2
(en)
*
|
2011-11-23 |
2013-05-30 |
Proteus Digital Health, Inc. |
Apparatus, system, and method to promote behavior change based on mindfulness methodologies
|
US8930541B2
(en)
*
|
2011-11-25 |
2015-01-06 |
International Business Machines Corporation |
System, method and program product for cost-aware selection of templates for provisioning shared resources
|
WO2013081978A1
(en)
*
|
2011-11-28 |
2013-06-06 |
Expanergy, Llc |
Energy search engine methods and systems
|
CN103136247B
(zh)
*
|
2011-11-29 |
2015-12-02 |
阿里巴巴集团控股有限公司 |
属性数据区间划分方法及装置
|
US20150037428A1
(en)
|
2011-11-29 |
2015-02-05 |
The University Of North Carolina At Chapel Hill |
Geometrically engineered particles and methods for modulating macrophage or immune responses
|
CA2857502C
(en)
|
2011-11-30 |
2019-08-13 |
3M Innovative Properties Company |
Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same
|
US9364549B2
(en)
|
2011-11-30 |
2016-06-14 |
Andreas Voigt |
Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition
|
DE102011087509A1
(de)
*
|
2011-12-01 |
2013-06-06 |
Robert Bosch Gmbh |
Sensorübertragungsvorrichtung und Verfahren zur Übertragung von Nutzdaten von einer Mehrzahl von Sensoren an eine Bussteuervorrichtung für ein Fahrzeug
|
WO2013082590A1
(en)
|
2011-12-02 |
2013-06-06 |
Invivo Therapeutics Corporation |
Peg based hydrogel for peripheral nerve injury applications and compositions and method of use of synthetic hydrogel sealants
|
AU2012345726B2
(en)
|
2011-12-02 |
2017-04-13 |
Pegasus Laboratories, Inc. |
Amphipathic lipid-based sustained release compositions
|
WO2013082529A1
(en)
|
2011-12-02 |
2013-06-06 |
Yale University |
Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
|
EP2788439A4
(en)
|
2011-12-05 |
2015-09-02 |
Nano Prec Medical Inc |
DEVICE HAVING A MEMBRANE FOR TITANIUM DIOXIDE NANOTUBE FOR DRUG DELIVERY
|
WO2013086008A1
(en)
|
2011-12-05 |
2013-06-13 |
Factor Bioscience Inc. |
Methods and products for transfecting cells
|
US8497124B2
(en)
|
2011-12-05 |
2013-07-30 |
Factor Bioscience Inc. |
Methods and products for reprogramming cells to a less differentiated state
|
CA3170051A1
(en)
|
2011-12-07 |
2013-06-13 |
Alnylam Pharmaceuticals, Inc. |
Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents
|
DK3988537T1
(da)
|
2011-12-07 |
2022-05-23 |
Alnylam Pharmaceuticals Inc |
Bionedbrydelige lipider til afgivelse af aktive midler
|
GB201121070D0
(en)
|
2011-12-07 |
2012-01-18 |
Isis Innovation |
composition for delivery of biotherapeutics
|
WO2013086373A1
(en)
|
2011-12-07 |
2013-06-13 |
Alnylam Pharmaceuticals, Inc. |
Lipids for the delivery of active agents
|
EP2787977A4
(en)
|
2011-12-09 |
2015-05-06 |
Univ California |
LIPOSOMAL ACTIVE INVERTING
|
WO2013086486A1
(en)
|
2011-12-09 |
2013-06-13 |
President And Fellows Of Harvard College |
Integrated human organ-on-chip microphysiological systems
|
WO2013086502A1
(en)
|
2011-12-09 |
2013-06-13 |
President And Fellows Of Harvard College |
Organ chips and uses thereof
|
US9839616B2
(en)
|
2011-12-12 |
2017-12-12 |
Kyowa Hakko Kirin Co., Ltd. |
Lipid nano particles comprising cationic lipid for drug delivery system
|
CA2858884A1
(en)
|
2011-12-12 |
2013-06-20 |
The Trustees Of The University Of Pennsylvania |
Proteins comprising mrsa pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat mrsa infections
|
TW201330874A
(zh)
|
2011-12-12 |
2013-08-01 |
Kyowa Hakko Kirin Co Ltd |
含有陽離子性脂質之組合之脂質奈米粒子
|
US20150000936A1
(en)
|
2011-12-13 |
2015-01-01 |
Schlumberger Technology Corporation |
Energization of an element with a thermally expandable material
|
EP2604253A1
(en)
|
2011-12-13 |
2013-06-19 |
Otto Glatter |
Water-in-oil emulsions and methods for their preparation
|
HUE052136T2
(hu)
|
2011-12-13 |
2021-04-28 |
Engeneic Molecular Delivery Pty Ltd |
Bakteriális eredetû intakt minisejtek terápiás szerek agydaganatokba történõ bejuttatására
|
US20140343129A1
(en)
|
2011-12-14 |
2014-11-20 |
Moderna Therapeutics, Inc. |
Modified nucleic acids, and acute care uses thereof
|
EP2791364A4
(en)
|
2011-12-14 |
2015-11-11 |
Moderna Therapeutics Inc |
METHODS OF RESPONSE TO A BIOLOGICAL THREAT
|
WO2013090897A1
(en)
|
2011-12-15 |
2013-06-20 |
The Trustees Of The University Of Pennsylvania |
Using adaptive immunity to detect drug resistance
|
US9636414B2
(en)
|
2011-12-15 |
2017-05-02 |
Biontech Ag |
Particles comprising single stranded RNA and double stranded RNA for immunomodulation
|
CA2859205A1
(en)
|
2011-12-16 |
2013-06-20 |
Massachusetts Institute Of Technology |
Alpha-aminoamidine polymers and uses thereof
|
CN104114572A
(zh)
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
WO2013090601A2
(en)
|
2011-12-16 |
2013-06-20 |
Massachusetts Institute Of Technology |
Compact nanoparticles for biological applications
|
US20140359902A1
(en)
|
2011-12-16 |
2014-12-04 |
Synthon Biopharmaceuticals B.V. |
EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED
|
MX2014007277A
(es)
|
2011-12-16 |
2014-07-28 |
Novartis Ag |
Aparato de aerosolizacion para administracion de farmaco independiente del perfil de inhalacion.
|
EP2790673B1
(en)
|
2011-12-16 |
2017-07-05 |
Allergan, Inc. |
Ophthalmic compositions comprising polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymers (soluplus)
|
EP2794701B1
(en)
|
2011-12-19 |
2017-03-08 |
The University Of Sydney |
A peptide-hydrogel composite
|
US9241829B2
(en)
|
2011-12-20 |
2016-01-26 |
Abbott Medical Optics Inc. |
Implantable intraocular drug delivery apparatus, system and method
|
CA2859691A1
(en)
|
2011-12-21 |
2013-06-27 |
Moderna Therapeutics, Inc. |
Methods of increasing the viability or longevity of an organ or organ explant
|
WO2013096812A1
(en)
|
2011-12-23 |
2013-06-27 |
Genentech, Inc. |
Articles of manufacture and methods for co-administration of antibodies
|
WO2013101908A1
(en)
|
2011-12-27 |
2013-07-04 |
Massachusetts Institute Of Technology |
Microneedle devices and uses thereof
|
WO2013101690A1
(en)
|
2011-12-29 |
2013-07-04 |
modeRNA Therapeutics |
Modified mrnas encoding cell-penetrating polypeptides
|
WO2013098589A1
(en)
|
2011-12-29 |
2013-07-04 |
Novartis Ag |
Adjuvanted combinations of meningococcal factor h binding proteins
|
WO2013102203A1
(en)
|
2011-12-30 |
2013-07-04 |
Cellscript, Inc. |
MAKING AND USING IN VITRO-SYNTHESIZED ssRNA FOR INTRODUCING INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT
|
CA2861643C
(en)
|
2012-01-06 |
2020-10-06 |
Charles L. Bisgaier |
Methods of reducing risk of cardiovascular disease
|
US20150030576A1
(en)
|
2012-01-10 |
2015-01-29 |
Moderna Therapeutics, Inc. |
Methods and compositions for targeting agents into and across the blood-brain barrier
|
WO2013112778A1
(en)
|
2012-01-26 |
2013-08-01 |
Life Technologies Corporation |
Methods for increasing the infectivity of viruses
|
KR20140129054A
(ko)
|
2012-01-26 |
2014-11-06 |
라이프 테크놀로지스 코포레이션 |
바이러스의 감염성을 증가시키는 방법
|
WO2013113325A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Negatively charged nucleic acid comprising complexes for immunostimulation
|
EP2623121A1
(en)
|
2012-01-31 |
2013-08-07 |
Bayer Innovation GmbH |
Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen
|
WO2013113326A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
|
KR102019297B1
(ko)
|
2012-02-09 |
2019-09-06 |
라이프 테크놀로지스 코포레이션 |
친수성 중합체성 입자 및 그의 제조 방법
|
WO2013120497A1
(en)
*
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
EP2817345A1
(en)
|
2012-02-22 |
2014-12-31 |
Cerulean Pharma Inc. |
Conjugates, particles, compositions, and related methods
|
US20130243867A1
(en)
|
2012-02-23 |
2013-09-19 |
University Of South Florida (A Florida Non-Profit Corporation) |
Micelle compositions and methods for their use
|
US20130224268A1
(en)
|
2012-02-27 |
2013-08-29 |
Newgen Biopharma Corp. |
Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same
|
JP6407726B2
(ja)
|
2012-03-01 |
2018-10-24 |
アムゲン リサーチ (ミュンヘン) ゲーエムベーハーAMGEN Research(Munich)GmbH |
長寿命ポリペプチド結合分子
|
US20150094259A1
(en)
|
2012-03-13 |
2015-04-02 |
University Of Kwazulu-Natal |
Transdermal Delivery Devices
|
US10322089B2
(en)
|
2012-03-14 |
2019-06-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Nanoparticles, nanoparticle delivery methods, and systems of delivery
|
JP6527331B2
(ja)
|
2012-03-16 |
2019-06-05 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
標的指向アミノ酸脂質
|
EP2825206A1
(en)
|
2012-03-16 |
2015-01-21 |
The Johns Hopkins University |
Controlled release formulations for the delivery of hif-1 inhibitors
|
US10159743B2
(en)
|
2012-03-16 |
2018-12-25 |
The Johns Hopkins University |
Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
|
CN103325662B
(zh)
|
2012-03-21 |
2016-03-30 |
清华大学 |
半导体性单壁碳纳米管的制备方法
|
US9610346B2
(en)
|
2012-03-23 |
2017-04-04 |
International Aids Vaccine Initiative |
Recombinant viral vectors
|
WO2013142349A1
(en)
|
2012-03-23 |
2013-09-26 |
University Of Chicago |
Compositions and methods related to staphylococcal sbi
|
WO2013148186A1
(en)
|
2012-03-26 |
2013-10-03 |
President And Fellows Of Harvard College |
Lipid-coated nucleic acid nanostructures of defined shape
|
WO2013143555A1
(en)
|
2012-03-26 |
2013-10-03 |
Biontech Ag |
Rna formulation for immunotherapy
|
CN108929880A
(zh)
|
2012-03-27 |
2018-12-04 |
库瑞瓦格股份公司 |
包含5′toputr的人工核酸分子
|
AU2013240051B2
(en)
|
2012-03-27 |
2017-11-30 |
Sirna Therapeutics, Inc. |
Diether based biodegradable cationic lipids for siRNA delivery
|
AU2013242403B2
(en)
|
2012-03-27 |
2018-10-18 |
Curevac Ag |
Artificial nucleic acid molecules
|
ES2654205T3
(es)
|
2012-03-27 |
2018-02-12 |
Curevac Ag |
Moléculas artificiales de ácido nucleico para la expresión mejorada de proteínas o péptidos
|
ES2858523T3
(es)
|
2012-03-29 |
2021-09-30 |
Translate Bio Inc |
Nanopartículas neutras derivadas de lípidos
|
US20150050354A1
(en)
|
2012-04-02 |
2015-02-19 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the treatment of otic diseases and conditions
|
EP2833920A2
(en)
|
2012-04-02 |
2015-02-11 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of biologics and proteins associated with human disease
|
AU2013243949A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of biologics and proteins associated with human disease
|
US10501513B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides for the production of oncology-related proteins and peptides
|
US9283287B2
(en)
*
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
US20140275229A1
(en)
|
2012-04-02 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Modified polynucleotides encoding udp glucuronosyltransferase 1 family, polypeptide a1
|
WO2013151771A1
(en)
|
2012-04-05 |
2013-10-10 |
Massachusetts Institute Of Technology |
Immunostimulatory compositions and methods of use thereof
|
EP2833926A4
(en)
|
2012-04-05 |
2015-11-25 |
Univ Florida |
NEUROPHILIC NANOPARTICLES
|
WO2013152351A2
(en)
|
2012-04-06 |
2013-10-10 |
The Trustees Of Columbia University In The City Of New York |
Fusion polypeptides and methods of use thereof
|
EP2836200B1
(en)
|
2012-04-08 |
2020-07-15 |
Urogen Pharma Ltd. |
Reverse thermal hydrogel preparations for use in the treatment of disorders of the urothelium
|
KR101607422B1
(ko)
|
2012-04-11 |
2016-03-29 |
인터자인 테크놀로지스, 인코포레이티드 |
안정된 미셀을 위한 블록 공중합체
|
WO2013155493A1
(en)
|
2012-04-12 |
2013-10-17 |
Yale University |
Methods of treating inflammatory and autoimmune diseases and disorders
|
US11001797B2
(en)
|
2012-04-13 |
2021-05-11 |
President And Fellows Of Harvard College |
Devices and methods for in vitro aerosol delivery
|
WO2013154766A1
(en)
|
2012-04-13 |
2013-10-17 |
New York University |
Microrna control of ldl receptor pathway
|
KR20150001710A
(ko)
|
2012-04-18 |
2015-01-06 |
애로우헤드 리서치 코오포레이션 |
In Vivo 핵산 전달용 폴리(아크릴레이트) 고분자
|
JP6232416B2
(ja)
|
2012-04-19 |
2017-11-15 |
サーナ・セラピューティクス・インコーポレイテッドSirna Therapeutics,Inc. |
オリゴヌクレオチド送達のための、新規なジエステルおよびトリエステルベースの低分子量、生分解性カチオン性脂質
|
EP2841056A4
(en)
|
2012-04-23 |
2015-09-16 |
Massachusetts Inst Technology |
COATED PARTICLES LAYER BY LAYER STABLE
|
AR090825A1
(es)
|
2012-04-25 |
2014-12-10 |
Regulus Therapeutics Inc |
COMPUESTO DE microARN Y METODOS DE MODULACION DE LA ACTIVIDAD DE miR-21
|
EP4008355A1
(en)
|
2012-05-03 |
2022-06-08 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
EP2849728A1
(en)
|
2012-05-04 |
2015-03-25 |
The Johns Hopkins University |
Lipid-based drug carriers for rapid penetration through mucus linings
|
WO2013173657A1
(en)
|
2012-05-16 |
2013-11-21 |
Micell Technologies, Inc. |
Low burst sustained release lipophilic and biologic agent compositions
|
US9399672B2
(en)
|
2012-05-17 |
2016-07-26 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Hepatitis C virus neutralizing antibody
|
WO2013173693A1
(en)
|
2012-05-18 |
2013-11-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nanoparticles with enhanced entry into cancer cells
|
EP2852380A4
(en)
|
2012-05-23 |
2016-01-20 |
Univ Ohio State |
LIPID-COATED ALBUMIN NANOPARTICLE COMPOSITIONS AND METHOD FOR THE PREPARATION AND METHOD OF USE THEREOF
|
EP2854857B1
(en)
|
2012-05-25 |
2018-11-28 |
CureVac AG |
Reversible immobilization and/or controlled release of nucleic acid containing nanoparticles by (biodegradable) polymer coatings
|
NZ702283A
(en)
|
2012-06-06 |
2016-09-30 |
Loma Vista Medical Inc |
Inflatable medical devices
|
ES2826203T3
(es)
|
2012-06-08 |
2021-05-17 |
Ethris Gmbh |
Suministro pulmonar de ARN mensajero
|
RS58108B9
(sr)
|
2012-06-08 |
2022-11-30 |
Nitto Denko Corp |
Lipidi za formulacije za dostavu terapeutskih agenasa
|
EP3884949A1
(en)
|
2012-06-08 |
2021-09-29 |
Translate Bio, Inc. |
Pulmonary delivery of mrna to non-lung target cells
|
US9993439B2
(en)
|
2012-06-20 |
2018-06-12 |
University Of Waterloo |
Mucoadhesive nanoparticle delivery system
|
US20150218252A1
(en)
|
2012-06-20 |
2015-08-06 |
President And Fellows Of Harvard College |
Self-assembling peptides, peptide nanostructures and uses thereof
|
US9803010B2
(en)
|
2012-06-27 |
2017-10-31 |
Merck Sharp & Dohme Corp. |
Crystalline anti-human IL-23p19 antibodies
|
US9150841B2
(en)
|
2012-06-29 |
2015-10-06 |
Shire Human Genetic Therapies, Inc. |
Cells for producing recombinant iduronate-2-sulfatase
|
US9956291B2
(en)
|
2012-07-10 |
2018-05-01 |
Shaker A. Mousa |
Nanoformulation and methods of use of thyroid receptor beta1 agonists for liver targeting
|
EP2872120B1
(en)
|
2012-07-16 |
2017-05-03 |
Nanoderm Sciences, Inc. |
Therapeutic nanoparticles with a polymyxin b as targeting agent
|
EP2687251A1
(en)
|
2012-07-17 |
2014-01-22 |
Sanofi-Aventis Deutschland GmbH |
Drug delivery device
|
EP2687252A1
(en)
|
2012-07-17 |
2014-01-22 |
Sanofi-Aventis Deutschland GmbH |
Drug delivery device
|
CN112587658A
(zh)
|
2012-07-18 |
2021-04-02 |
博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
WO2014015334A1
(en)
|
2012-07-20 |
2014-01-23 |
Brown University |
System and methods for nanostructure protected delivery of treatment agent and selective release thereof
|
KR20160073936A
(ko)
|
2012-07-24 |
2016-06-27 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵산 나노구조의 자기-조립
|
WO2014015422A1
(en)
|
2012-07-27 |
2014-01-30 |
Ontario Institute For Cancer Research |
Cellulose-based nanoparticles for drug delivery
|
GB201213624D0
(en)
|
2012-07-27 |
2012-09-12 |
Univ Ulster The |
Method and system for production of conjugated nanoparticles
|
WO2014024193A1
(en)
|
2012-08-07 |
2014-02-13 |
Prodel Pharma Ltd. |
Compositions and methods for rapid transmucosal delivery of pharmaceutical ingredients
|
WO2014025795A1
(en)
|
2012-08-07 |
2014-02-13 |
Northeastern University |
Compositions for the delivery of rna and drugs into cells
|
AU2013299537A1
(en)
|
2012-08-08 |
2015-02-19 |
Presage Biosciences, Inc. |
Extrusion methods and devices for drug delivery
|
US9974886B2
(en)
|
2012-08-08 |
2018-05-22 |
Nanyang Technological University |
Methods of manufacturing hydrogel microparticles having living cells, and compositions for manufacturing a scaffold for tissue engineering
|
US9314532B2
(en)
|
2012-08-10 |
2016-04-19 |
University Of North Texas Health Science Center |
Drug delivery vehicle
|
CA2884870C
(en)
|
2012-08-13 |
2022-03-29 |
Massachusetts Institute Of Technology |
Amine-containing lipidoids and uses thereof
|
WO2014027006A1
(en)
|
2012-08-13 |
2014-02-20 |
Edko Pazarlama Tanitim Ticaret Limited Sirketi |
Bioadhesive formulations for use in drug delivery
|
WO2014028429A2
(en)
|
2012-08-14 |
2014-02-20 |
Moderna Therapeutics, Inc. |
Enzymes and polymerases for the synthesis of rna
|
WO2014026284A1
(en)
|
2012-08-14 |
2014-02-20 |
Froese Aaron |
Internal structured self assembling liposomes
|
WO2014028209A1
(en)
|
2012-08-14 |
2014-02-20 |
The Trustees Of The University Of Pennsylvania |
Stabilizing shear-thinning hydrogels
|
US10231997B2
(en)
|
2012-08-15 |
2019-03-19 |
The University Of Chicago |
Exosome-based therapeutics against neurodegenerative disorders
|
US10179134B2
(en)
|
2012-09-05 |
2019-01-15 |
Creighton University |
Polymeric nanoparticles in a thermosensitive gel for coital-independent vaginal prophylaxis of HIV
|
US8703197B2
(en)
|
2012-09-13 |
2014-04-22 |
International Business Machines Corporation |
Branched polyamines for delivery of biologically active materials
|
WO2014043618A1
(en)
|
2012-09-17 |
2014-03-20 |
Bind Therapeutics, Inc. |
Process for preparing therapeutic nanoparticles
|
AU2013315125B2
(en)
|
2012-09-17 |
2018-07-26 |
Pfizer Inc. |
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
|
WO2014047649A1
(en)
|
2012-09-24 |
2014-03-27 |
The Regents Of The University Of California |
Methods for arranging and packing nucleic acids for unusual resistance to nucleases and targeted delivery for gene therapy
|
WO2014052634A1
(en)
|
2012-09-27 |
2014-04-03 |
The University Of North Carolina At Chapel Hill |
Lipid coated nanoparticles containing agents having low aqueous and lipid solubilities and methods thereof
|
WO2014093924A1
(en)
|
2012-12-13 |
2014-06-19 |
Moderna Therapeutics, Inc. |
Modified nucleic acid molecules and uses thereof
|
WO2014053879A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
WO2014053880A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
US20140100178A1
(en)
|
2012-10-04 |
2014-04-10 |
Aslam Ansari |
Composition and methods for site-specific drug delivery to treat malaria and other liver diseases
|
EP2716655A1
(en)
|
2012-10-04 |
2014-04-09 |
Institut Pasteur |
Neutralizing antibodies directed against Hepatitis C virus ectodomain glycoprotein E2
|
WO2014053881A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
US20150202153A1
(en)
|
2012-10-04 |
2015-07-23 |
University Of The Witwatersrand, Johannesburg |
Liposomal drug delivery system
|
WO2014053882A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
WO2014064534A2
(en)
|
2012-10-05 |
2014-05-01 |
Chrontech Pharma Ab |
Injection needle, device, immunogenic compositions and method of use
|
EP2716689A1
(en)
|
2012-10-05 |
2014-04-09 |
National University of Ireland, Galway |
Polymer comprising a plurality of branches having at least one disulfide group and/or at least one vinyl group
|
WO2014059022A1
(en)
|
2012-10-09 |
2014-04-17 |
The Brigham And Women's Hospital, Inc. |
Nanoparticles for targeted delivery of multiple therapeutic agents and methods of use
|
US20140106260A1
(en)
|
2012-10-11 |
2014-04-17 |
The Trustees Of The University Of Pennsylvania |
Core-shell nanoparticulate compositions and methods
|
CA2887727A1
(en)
|
2012-10-16 |
2014-04-24 |
Endocyte, Inc. |
Drug delivery conjugates containing unnatural amino acids and methods for using
|
CA2888659A1
(en)
|
2012-10-18 |
2014-04-24 |
Rockefeller University (The) |
Broadly-neutralizing anti-hiv antibodies
|
AU2013336237A1
(en)
|
2012-10-22 |
2015-06-11 |
Sabag-Rfa Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
MX2015005328A
(es)
|
2012-10-26 |
2015-09-25 |
Nlife Therapeutics S L |
Composiciones y metodos para la administracion selectiva de moleculas de oligonucleotidos a tipos de celulas.
|
WO2014066912A1
(en)
|
2012-10-26 |
2014-05-01 |
Vanderbilt University |
Polymeric nanoparticles
|
WO2014066898A1
(en)
|
2012-10-26 |
2014-05-01 |
The Johns Hopkins University |
A layer-by-layer approach to co-deliver dna and sirna via aunps: a potential platform for modifying release kinetics
|
EP2912180A1
(en)
|
2012-10-29 |
2015-09-02 |
Technische Universität Dortmund |
T7 rna polymerase variants and methods of using the same
|
WO2014067110A1
(zh)
*
|
2012-10-31 |
2014-05-08 |
华为终端有限公司 |
绘图控制方法、装置及移动终端
|
WO2014071219A1
(en)
|
2012-11-01 |
2014-05-08 |
Factor Bioscience Inc. |
Methods and products for expressing proteins in cells
|
US9444624B2
(en)
|
2012-11-02 |
2016-09-13 |
Facebook, Inc. |
Providing user authentication
|
WO2014071072A2
(en)
|
2012-11-02 |
2014-05-08 |
Pungente Michael D |
Novel cationic carotenoid-based lipids for cellular nucleic acid uptake
|
WO2014068542A1
(en)
|
2012-11-05 |
2014-05-08 |
Fondazione Centro San Raffaele |
Novel targets in multiple myeloma and other disorders
|
WO2014074597A1
(en)
|
2012-11-06 |
2014-05-15 |
President And Fellows Of Harvard College |
Compositions and methods relating to complex nucleic acid nanostructures
|
MX367301B
(es)
|
2012-11-06 |
2019-08-14 |
Rochal Ind Llc |
Liberacion de agentes biologicamente activos utilizando disolventes hidrofobicos volatiles.
|
US9669104B2
(en)
|
2012-11-07 |
2017-06-06 |
Council Of Scientific And Industrial Research |
Nanocomplex containing amphipathic peptide useful for efficient transfection of biomolecules
|
WO2014072999A1
(en)
|
2012-11-07 |
2014-05-15 |
Council Of Scientific And Industrial Research |
Nanocomplex containing cationic peptide for biomolecule delivery
|
TW201428101A
(zh)
|
2012-11-08 |
2014-07-16 |
Inviragen Inc |
登革熱病毒血清型4型之建構物的組成物、方法及用途
|
BR112015010566A2
(pt)
|
2012-11-08 |
2017-07-11 |
Clearside Biomedical Inc |
métodos e dispositivos para o tratamento de doenças oculares em indivíduos humanos
|
BR112015010318A2
(pt)
|
2012-11-08 |
2017-08-22 |
Albumedix As |
Variantes de albumina
|
AU2013342163B2
(en)
|
2012-11-08 |
2018-08-16 |
F. Hoffmann-La Roche Ltd |
IL-6 antagonists and uses thereof
|
ES2676470T3
(es)
|
2012-11-09 |
2018-07-19 |
Biontech Rna Pharmaceuticals Gmbh |
Método para la expresión de ARN en células
|
US9200119B2
(en)
|
2012-11-09 |
2015-12-01 |
Momentive Performance Materials Inc. |
Silicon-containing zwitterionic linear copolymer composition
|
WO2014072468A1
(en)
|
2012-11-09 |
2014-05-15 |
Velin-Pharma A/S |
Compositions for pulmonary delivery
|
WO2014071963A1
(en)
|
2012-11-09 |
2014-05-15 |
Biontech Ag |
Method for cellular rna expression
|
WO2014075047A2
(en)
|
2012-11-12 |
2014-05-15 |
Genvec, Inc. |
Malaria antigens and methods of use
|
JP2016500058A
(ja)
|
2012-11-12 |
2016-01-07 |
レッドウッド バイオサイエンス, インコーポレイテッド |
化合物および抱合体を生成するための方法
|
GB201220354D0
(en)
|
2012-11-12 |
2012-12-26 |
Medpharm Ltd |
Dermal compositions
|
US9943608B2
(en)
|
2012-11-13 |
2018-04-17 |
Baylor College Of Medicine |
Multi-arm biodegradable polymers for nucleic acid delivery
|
WO2014078636A1
(en)
|
2012-11-16 |
2014-05-22 |
President And Fellows Of Harvard College |
Nucleic acid hydrogel self-assembly
|
US9310374B2
(en)
|
2012-11-16 |
2016-04-12 |
Redwood Bioscience, Inc. |
Hydrazinyl-indole compounds and methods for producing a conjugate
|
CN104853747B
(zh)
|
2012-11-19 |
2020-06-19 |
理工研究与开发基金公司 |
用于体内递送的脂质体
|
EP2732825B1
(en)
|
2012-11-19 |
2015-07-01 |
Invivogen |
Conjugates of a TLR7 and/or TLR8 agonist and a TLR2 agonist
|
WO2014081849A1
(en)
|
2012-11-20 |
2014-05-30 |
Phasebio Pharmaceuticals, Inc. |
Formulations of active agents for sustained release
|
US20140141037A1
(en)
|
2012-11-20 |
2014-05-22 |
Novartis Ag |
Rsv f prefusion trimers
|
WO2014081300A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Channel protein activatable liposomes
|
WO2014081303A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Chemically cleavable group
|
WO2014081299A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Activatable liposomes
|
PL2922554T3
(pl)
|
2012-11-26 |
2022-06-20 |
Modernatx, Inc. |
Na zmodyfikowany na końcach
|
WO2014093574A1
(en)
|
2012-12-13 |
2014-06-19 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for altering cell phenotype
|
MX2015008847A
(es)
|
2013-01-10 |
2015-10-30 |
Novartis Ag |
Composiciones inmunogenicas de virus de influenza y usos de las mismas.
|
EP2946014A2
(en)
|
2013-01-17 |
2015-11-25 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
US20160022840A1
(en)
|
2013-03-09 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Heterologous untranslated regions for mrna
|
WO2014158795A1
(en)
|
2013-03-12 |
2014-10-02 |
Moderna Therapeutics, Inc. |
Diagnosis and treatment of fibrosis
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
US10258698B2
(en)
|
2013-03-14 |
2019-04-16 |
Modernatx, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
CA2902884C
(en)
|
2013-03-14 |
2021-05-25 |
Shire Human Genetic Therapies, Inc. |
Ribonucleic acids with 4'-thio-modified nucleotides and related methods
|
US10077439B2
(en)
|
2013-03-15 |
2018-09-18 |
Modernatx, Inc. |
Removal of DNA fragments in mRNA production process
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
US10590161B2
(en)
|
2013-03-15 |
2020-03-17 |
Modernatx, Inc. |
Ion exchange purification of mRNA
|
WO2014144711A1
(en)
|
2013-03-15 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Analysis of mrna heterogeneity and stability
|
US10138507B2
(en)
|
2013-03-15 |
2018-11-27 |
Modernatx, Inc. |
Manufacturing methods for production of RNA transcripts
|
WO2014144039A1
(en)
|
2013-03-15 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Characterization of mrna molecules
|
EP4279610A3
(en)
|
2013-03-15 |
2024-01-03 |
ModernaTX, Inc. |
Ribonucleic acid purification
|
AU2014287009B2
(en)
|
2013-07-11 |
2020-10-29 |
Modernatx, Inc. |
Compositions comprising synthetic polynucleotides encoding CRISPR related proteins and synthetic sgRNAs and methods of use
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
AU2014315287A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
WO2015038892A1
(en)
|
2013-09-13 |
2015-03-19 |
Moderna Therapeutics, Inc. |
Polynucleotide compositions containing amino acids
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
EP3052479A4
(en)
|
2013-10-02 |
2017-10-25 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
WO2015051169A2
(en)
|
2013-10-02 |
2015-04-09 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
EP3052521A1
(en)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
EP3058082A4
(en)
|
2013-10-18 |
2017-04-26 |
ModernaTX, Inc. |
Compositions and methods for tolerizing cellular systems
|
US20170173128A1
(en)
|
2013-12-06 |
2017-06-22 |
Moderna TX, Inc. |
Targeted adaptive vaccines
|
EP3053585A1
(en)
|
2013-12-13 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
EP3092250A4
(en)
|
2014-01-08 |
2017-05-24 |
Moderna Therapeutics, Inc. |
Polynucleotides for the in vivo production of antibodies
|
SG11201608798YA
(en)
|
2014-04-23 |
2016-11-29 |
Modernatx Inc |
Nucleic acid vaccines
|
EP2942143B1
(en)
|
2014-05-09 |
2017-03-15 |
Gestamp HardTech AB |
Methods for joining two blanks and blanks and products obtained
|
WO2015196130A2
(en)
|
2014-06-19 |
2015-12-23 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
US10286086B2
(en)
|
2014-06-19 |
2019-05-14 |
Modernatx, Inc. |
Alternative nucleic acid molecules and uses thereof
|
WO2015196118A1
(en)
|
2014-06-19 |
2015-12-23 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
EP4159741A1
(en)
|
2014-07-16 |
2023-04-05 |
ModernaTX, Inc. |
Method for producing a chimeric polynucleotide encoding a polypeptide having a triazole-containing internucleotide linkage
|
AU2015289656A1
(en)
|
2014-07-16 |
2017-02-16 |
Modernatx, Inc. |
Circular polynucleotides
|
WO2016016676A1
(fr)
|
2014-07-30 |
2016-02-04 |
ArcelorMittal Investigación y Desarrollo, S.L. |
Procédé de fabrication de tôles d'acier, pour durcissement sous presse, et pièces obtenues par ce procédé
|
EP3188749A4
(en)
|
2014-09-03 |
2018-06-13 |
Moderna Therapeutics, Inc. |
Tolerogenic compositions and methods
|
JP6399106B2
(ja)
|
2014-11-19 |
2018-10-03 |
新日鐵住金株式会社 |
レーザー溶接継手、自動車部品、レーザー溶接継手の製造方法および自動車部品の製造方法
|
WO2016118724A1
(en)
|
2015-01-21 |
2016-07-28 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
WO2016118725A1
(en)
|
2015-01-23 |
2016-07-28 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
CN108289981B
(zh)
|
2015-11-12 |
2021-03-26 |
皇家飞利浦有限公司 |
用于吸乳泵的乳房罩装置、吸乳泵及其操作方法
|
US10870110B2
(en)
|
2015-12-11 |
2020-12-22 |
Babson Diagnostics, Inc. |
Specimen container and centrifugation method for separating serum or plasma from whole blood therewith
|
US10563897B2
(en)
|
2018-02-13 |
2020-02-18 |
Carrier Corporation |
Transport refrigeration unit with a renewable energy source and method of operation
|